<!DOCTYPE html>
<html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled" lang="en" dir="ltr">
<head>
<meta charset="UTF-8">
<title>ALS - Wikipedia</title>
<script>document.documentElement.className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled";(function(){var cookie=document.cookie.match(/(?:^|; )enwikimwclientprefs=([^;]+)/);if(cookie){var featureName=cookie[1];document.documentElement.className=document.documentElement.className.replace(featureName+'-enabled',featureName+'-disabled');}}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"4743a595-52c4-4582-9b14-157c5a61b88e","wgCSPNonce":false,
"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"ALS","wgTitle":"ALS","wgCurRevisionId":1161884281,"wgRevisionId":1161884281,"wgArticleId":19375577,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with short description","Short description matches Wikidata","Use dmy dates from September 2020","Short description is different from Wikidata","Commons category link is on Wikidata","Articles with BNF identifiers","Articles with BNFdata identifiers","Articles with J9U identifiers","Articles with LCCN identifiers","Articles with LNB identifiers","Articles with NDL identifiers","Articles with NKC identifiers","Wikipedia medicine articles ready to translate","Wikipedia neurology articles ready to translate","Amyotrophic lateral sclerosis","Motor neuron diseases","Rare diseases","Unsolved problems in neuroscience",
"Systemic atrophies primarily affecting the central nervous system","Cytoskeletal defects","Neuromuscular disorders","Idiopathic diseases"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"ALS","wgRelevantArticleId":19375577,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Amyotrophic_lateral_sclerosis","wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":100000,"wgNoticeProject":"wikipedia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":10,"wgULSCurrentAutonym":"English","wgInternalRedirectTargetUrl":"/wiki/ALS","wgEditSubmitButtonLabelPublish":true,
"wgCentralAuthMobileDomain":false,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q206901","GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false};RLSTATE={"skins.vector.user.styles":"ready","ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","skins.vector.user":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","ext.tmh.player.styles":"ready","codex-search-styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.wikimediaBadges":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["mediawiki.action.view.redirect","ext.cite.ux-enhancements","ext.tmh.player",
"site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","mmv.head","mmv.bootstrap.autostart","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.cx.eventlogging.campaigns","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","ext.echo.centralauth","ext.uls.compactlinks","ext.uls.interface","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.growthExperiments.SuggestedEditSession"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=codex-search-styles%7Cext.cite.styles%7Cext.tmh.player.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cskins.vector.icons%2Cstyles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022">
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022"></script>
<meta name="ResourceLoaderDynamicStyles" content="">
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022">
<meta name="generator" content="MediaWiki 1.41.0-wmf.13">
<meta name="referrer" content="origin">
<meta name="referrer" content="origin-when-crossorigin">
<meta name="referrer" content="origin-when-cross-origin">
<meta name="robots" content="max-image-preview:standard">
<meta name="format-detection" content="telephone=no">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/1/16/ALS_Affected_neurons_and_muscles.png/1200px-ALS_Affected_neurons_and_muscles.png">
<meta property="og:image:width" content="1200">
<meta property="og:image:height" content="1065">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/1/16/ALS_Affected_neurons_and_muscles.png/800px-ALS_Affected_neurons_and_muscles.png">
<meta property="og:image:width" content="800">
<meta property="og:image:height" content="710">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/1/16/ALS_Affected_neurons_and_muscles.png/640px-ALS_Affected_neurons_and_muscles.png">
<meta property="og:image:width" content="640">
<meta property="og:image:height" content="568">
<meta name="viewport" content="width=1000">
<meta property="og:title" content="ALS - Wikipedia">
<meta property="og:type" content="website">
<link rel="preconnect" href="//upload.wikimedia.org">
<link rel="alternate" media="only screen and (max-width: 720px)" href="//en.m.wikipedia.org/wiki/ALS">
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=ALS&amp;action=edit">
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png">
<link rel="icon" href="/static/favicon/wikipedia.ico">
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)">
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd">
<link rel="canonical" href="https://en.wikipedia.org/wiki/ALS">
<link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en">
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom">
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<link rel="dns-prefetch" href="//login.wikimedia.org">
</head>
<body class="skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-ALS rootpage-ALS skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a>
<div class="vector-header-container">
	<header class="vector-header mw-header">
		<div class="vector-header-start">
			<nav class="vector-main-menu-landmark" aria-label="Site" role="navigation">
				
<div id="vector-main-menu-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right"  >
	<input type="checkbox"
		id="vector-main-menu-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-main-menu-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Main menu"
		
	/>
	<label
		id="vector-main-menu-dropdown-label"
		for="vector-main-menu-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span>


		<span class="vector-menu-heading-label">Main menu</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


				<div id="vector-main-menu-unpinned-container" class="vector-unpinned-container">
		
<div id="vector-main-menu" class="vector-main-menu vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="main-menu-pinned"
	data-pinnable-element-id="vector-main-menu"
	data-pinned-container-id="vector-main-menu-pinned-container"
	data-unpinned-container-id="vector-main-menu-unpinned-container"
>
	<div class="vector-pinnable-header-label">Main menu</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button>
</div>

	
<div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation"  >
	<div class="vector-menu-heading">
		Navigation
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li><li id="n-sitesupport" class="mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation"><span>Donate</span></a></li></ul>
		
	</div>
</div>

	
	
<div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction"  >
	<div class="vector-menu-heading">
		Contribute
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li></ul>
		
	</div>
</div>

	
<div class="vector-main-menu-action vector-main-menu-action-lang-alert">
	<div class="vector-main-menu-action-item">
		<div class="vector-main-menu-action-heading vector-menu-heading">Languages</div>
		<div class="vector-main-menu-action-content vector-menu-content">
			<div class="mw-message-box-notice vector-language-sidebar-alert mw-message-box">Language links are at the top of the page across from the title.</div>
		</div>
	</div>
</div>

</div>

				</div>

	</div>
</div>
		</nav>
			
<a href="/wiki/Main_Page" class="mw-logo">
	<img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt=""
		aria-hidden="true" height="50" width="50">
	<span class="mw-logo-container">
		<img class="mw-logo-wordmark" alt="Wikipedia"
			src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;">
		<img class="mw-logo-tagline"
			alt="The Free Encyclopedia"
			src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;">
	</span>
</a>

		</div>
		<div class="vector-header-end">
			
<div id="p-search" role="search" class="vector-search-box-vue  vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box">
	<a href="/wiki/Special:Search"
	
		id=""
		class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle"
		title="Search Wikipedia [f]"accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span>

<span>Search</span>
	</a>
	
	<div class="vector-typeahead-search-container">
		<div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width">
			<form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button">
				<div id="simpleSearch" class="cdx-search-input__input-wrapper"  data-search-loc="header-moved">
					<div class="cdx-text-input cdx-text-input--has-start-icon">
						<input
							class="cdx-text-input__input"
							 type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput"
							
						>
						<span class="cdx-text-input__icon cdx-text-input__start-icon"></span>
					</div>
					<input type="hidden" name="title" value="Special:Search">
				</div>
				<button class="cdx-button cdx-search-input__end-button">Search</button>
			</form>
		</div>
	</div>
</div>

			<nav class="vector-user-links" aria-label="Personal tools" role="navigation" >
	
<div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet mw-portlet-vector-user-menu-overflow"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=ALS" title="You are encouraged to create an account and log in; however, it is not mandatory"><span>Create account</span></a></li><li id="pt-login-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=ALS" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span>Log in</span></a></li></ul>
		
	</div>
</div>

	
<div id="vector-user-links-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out"  title="Log in and more options" >
	<input type="checkbox"
		id="vector-user-links-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-user-links-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Personal tools"
		
	/>
	<label
		id="vector-user-links-dropdown-label"
		for="vector-user-links-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span>


		<span class="vector-menu-heading-label">Personal tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


		
<div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item"  title="User menu" >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=ALS" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=ALS" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li></ul>
		
	</div>
</div>

<div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor"  >
	<div class="vector-menu-heading">
		Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a>
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li></ul>
		
	</div>
</div>

	
	</div>
</div>
</nav>

		</div>
	</header>
</div>
<div class="mw-page-container">
	<div class="mw-page-container-inner">
		<div class="vector-main-menu-container ">
			<div id="mw-navigation">
				<nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site" role="navigation">
					<div id="vector-main-menu-pinned-container" class="vector-pinned-container">
				
					</div>
		</nav>
			</div>
		</div>
		<div class="vector-sitenotice-container">
			<div id="siteNotice"><!-- CentralNotice --></div>
		</div>
		<input type="checkbox" id="vector-toc-collapsed-checkbox" class="vector-menu-checkbox">
		<nav id="mw-panel-toc" role="navigation" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark vector-sticky-pinned-container">
			<div id="vector-toc-pinned-container" class="vector-pinned-container">
					<div id="vector-toc" class="vector-toc vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned"
	data-feature-name="toc-pinned"
	data-pinnable-element-id="vector-toc"
	
	
>
	<h2 class="vector-pinnable-header-label">Contents</h2>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button>
</div>


	<ul class="vector-toc-contents" id="mw-panel-toc-list">
		<li id="toc-mw-content-text"
			class="vector-toc-list-item vector-toc-level-1">
			<a href="#" class="vector-toc-link">
				<div class="vector-toc-text">(Top)</div>
			</a>
		</li>
		<li id="toc-Classification"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Classification">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">1</span>Classification</div>
		</a>
		
			<button aria-controls="toc-Classification-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Classification subsection</span>
			</button>
		
		<ul id="toc-Classification-sublist" class="vector-toc-list">
			<li id="toc-Subtypes_of_motor_neuron_degeneration"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Subtypes_of_motor_neuron_degeneration">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">1.1</span>Subtypes of motor neuron degeneration</div>
			</a>
			
			<ul id="toc-Subtypes_of_motor_neuron_degeneration-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Rare_isolated_variants_of_ALS"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Rare_isolated_variants_of_ALS">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">1.2</span>Rare isolated variants of ALS</div>
			</a>
			
			<ul id="toc-Rare_isolated_variants_of_ALS-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Age_of_onset"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Age_of_onset">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">1.3</span>Age of onset</div>
			</a>
			
			<ul id="toc-Age_of_onset-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Signs_and_symptoms"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Signs_and_symptoms">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">2</span>Signs and symptoms</div>
		</a>
		
			<button aria-controls="toc-Signs_and_symptoms-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Signs and symptoms subsection</span>
			</button>
		
		<ul id="toc-Signs_and_symptoms-sublist" class="vector-toc-list">
			<li id="toc-Initial_symptoms"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Initial_symptoms">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.1</span>Initial symptoms</div>
			</a>
			
			<ul id="toc-Initial_symptoms-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Progression"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Progression">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.2</span>Progression</div>
			</a>
			
			<ul id="toc-Progression-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Late_stage_disease_management"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Late_stage_disease_management">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.3</span>Late stage disease management</div>
			</a>
			
			<ul id="toc-Late_stage_disease_management-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Prognosis,_staging,_and_survival"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Prognosis,_staging,_and_survival">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.4</span>Prognosis, staging, and survival</div>
			</a>
			
			<ul id="toc-Prognosis,_staging,_and_survival-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Cognitive,_emotional,_and_behavioral_symptoms"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Cognitive,_emotional,_and_behavioral_symptoms">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.5</span>Cognitive, emotional, and behavioral symptoms</div>
			</a>
			
			<ul id="toc-Cognitive,_emotional,_and_behavioral_symptoms-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Cause"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Cause">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">3</span>Cause</div>
		</a>
		
			<button aria-controls="toc-Cause-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Cause subsection</span>
			</button>
		
		<ul id="toc-Cause-sublist" class="vector-toc-list">
			<li id="toc-Genetics_and_genetic_testing"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Genetics_and_genetic_testing">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.1</span>Genetics and genetic testing</div>
			</a>
			
			<ul id="toc-Genetics_and_genetic_testing-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Environmental_and_other_factors"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Environmental_and_other_factors">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.2</span>Environmental and other factors</div>
			</a>
			
			<ul id="toc-Environmental_and_other_factors-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Pathophysiology"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Pathophysiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">4</span>Pathophysiology</div>
		</a>
		
			<button aria-controls="toc-Pathophysiology-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Pathophysiology subsection</span>
			</button>
		
		<ul id="toc-Pathophysiology-sublist" class="vector-toc-list">
			<li id="toc-Neuropathology"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Neuropathology">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">4.1</span>Neuropathology</div>
			</a>
			
			<ul id="toc-Neuropathology-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Biochemistry"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Biochemistry">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">4.2</span>Biochemistry</div>
			</a>
			
			<ul id="toc-Biochemistry-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Diagnosis"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Diagnosis">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">5</span>Diagnosis</div>
		</a>
		
			<button aria-controls="toc-Diagnosis-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Diagnosis subsection</span>
			</button>
		
		<ul id="toc-Diagnosis-sublist" class="vector-toc-list">
			<li id="toc-Differential_diagnosis"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Differential_diagnosis">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.1</span>Differential diagnosis</div>
			</a>
			
			<ul id="toc-Differential_diagnosis-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Management"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Management">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">6</span>Management</div>
		</a>
		
			<button aria-controls="toc-Management-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Management subsection</span>
			</button>
		
		<ul id="toc-Management-sublist" class="vector-toc-list">
			<li id="toc-Medications"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Medications">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.1</span>Medications</div>
			</a>
			
			<ul id="toc-Medications-sublist" class="vector-toc-list">
				<li id="toc-Disease-slowing_treatments"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Disease-slowing_treatments">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.1.1</span>Disease-slowing treatments</div>
			</a>
			
			<ul id="toc-Disease-slowing_treatments-sublist" class="vector-toc-list">
				<li id="toc-Symptomatic_treatments"
			class="vector-toc-list-item vector-toc-level-4">
			<a class="vector-toc-link" href="#Symptomatic_treatments">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.1.1.1</span>Symptomatic treatments</div>
			</a>
			
			<ul id="toc-Symptomatic_treatments-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
		</li>
	</ul>
		</li>
		<li id="toc-Breathing_support"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Breathing_support">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2</span>Breathing support</div>
			</a>
			
			<ul id="toc-Breathing_support-sublist" class="vector-toc-list">
				<li id="toc-Non-invasive_ventilation"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Non-invasive_ventilation">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2.1</span>Non-invasive ventilation</div>
			</a>
			
			<ul id="toc-Non-invasive_ventilation-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Invasive_ventilation"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Invasive_ventilation">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2.2</span>Invasive ventilation</div>
			</a>
			
			<ul id="toc-Invasive_ventilation-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
		</li>
		<li id="toc-Therapy"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Therapy">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.3</span>Therapy</div>
			</a>
			
			<ul id="toc-Therapy-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Nutrition"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Nutrition">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.4</span>Nutrition</div>
			</a>
			
			<ul id="toc-Nutrition-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-End-of-life_care"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#End-of-life_care">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.5</span>End-of-life care</div>
			</a>
			
			<ul id="toc-End-of-life_care-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Epidemiology"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Epidemiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">7</span>Epidemiology</div>
		</a>
		
		<ul id="toc-Epidemiology-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-History"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#History">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">8</span>History</div>
		</a>
		
			<button aria-controls="toc-History-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle History subsection</span>
			</button>
		
		<ul id="toc-History-sublist" class="vector-toc-list">
			<li id="toc-Diagnostic_criteria"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Diagnostic_criteria">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">8.1</span>Diagnostic criteria</div>
			</a>
			
			<ul id="toc-Diagnostic_criteria-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Name"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Name">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">8.2</span>Name</div>
			</a>
			
			<ul id="toc-Name-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Society_and_culture"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Society_and_culture">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">9</span>Society and culture</div>
		</a>
		
		<ul id="toc-Society_and_culture-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-References"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#References">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">10</span>References</div>
		</a>
		
		<ul id="toc-References-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-External_links"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#External_links">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">11</span>External links</div>
		</a>
		
		<ul id="toc-External_links-sublist" class="vector-toc-list">
		</ul>
	</li>
</ul>
</div>

			</div>
		</nav>
		<div class="mw-content-container">
			<main id="content" class="mw-body" role="main">
				<header class="mw-body-header vector-page-titlebar">
					<label
						id="vector-toc-collapsed-button"
						class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet vector-button-flush-left cdx-button--icon-only"
						for="vector-toc-collapsed-checkbox"
						role="button"
						aria-controls="vector-toc"
						tabindex="0"
						title="Table of Contents">
						<span class="vector-icon mw-ui-icon-wikimedia-listBullet"></span>
						<span>Toggle the table of contents</span>
					</label>
				
					<nav role="navigation" aria-label="Contents" class="vector-toc-landmark">
						
<div id="vector-page-titlebar-toc" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-titlebar-toc vector-button-flush-left"  >
	<input type="checkbox"
		id="vector-page-titlebar-toc-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-titlebar-toc"
		class="vector-menu-checkbox "
		
		aria-label="Toggle the table of contents"
		
	/>
	<label
		id="vector-page-titlebar-toc-label"
		for="vector-page-titlebar-toc-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span>


		<span class="vector-menu-heading-label">Toggle the table of contents</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


							<div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container">
			</div>
		
	</div>
</div>
					</nav>
					<h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">ALS</span></h1>
				
							
<div id="p-lang-btn" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-lang"  >
	<input type="checkbox"
		id="p-lang-btn-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-lang-btn"
		class="vector-menu-checkbox mw-interlanguage-selector"
		aria-label="Go to an article in another language. Available in 63 languages"
		
		
	/>
	<label
		id="p-lang-btn-label"
		for="p-lang-btn-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-63"
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span>


		<span class="vector-menu-heading-label">63 languages</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

		<div class="vector-menu-content">
			
			<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-af mw-list-item"><a href="https://af.wikipedia.org/wiki/Motorneuronsiekte" title="Motorneuronsiekte – Afrikaans" lang="af" hreflang="af" class="interlanguage-link-target"><span>Afrikaans</span></a></li><li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D8%AA%D8%B5%D9%84%D8%A8_%D8%AC%D8%A7%D9%86%D8%A8%D9%8A_%D8%B6%D9%85%D9%88%D8%B1%D9%8A" title="تصلب جانبي ضموري – Arabic" lang="ar" hreflang="ar" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-ast mw-list-item"><a href="https://ast.wikipedia.org/wiki/Esclerosis_llateral_amiotr%C3%B3fica" title="Esclerosis llateral amiotrófica – Asturian" lang="ast" hreflang="ast" class="interlanguage-link-target"><span>Asturianu</span></a></li><li class="interlanguage-link interwiki-az mw-list-item"><a href="https://az.wikipedia.org/wiki/Yan_amiotrofik_skleroz" title="Yan amiotrofik skleroz – Azerbaijani" lang="az" hreflang="az" class="interlanguage-link-target"><span>Azərbaycanca</span></a></li><li class="interlanguage-link interwiki-bg mw-list-item"><a href="https://bg.wikipedia.org/wiki/%D0%90%D0%BC%D0%B8%D0%BE%D1%82%D1%80%D0%BE%D1%84%D0%B8%D1%87%D0%BD%D0%B0_%D0%BB%D0%B0%D1%82%D0%B5%D1%80%D0%B0%D0%BB%D0%BD%D0%B0_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7%D0%B0" title="Амиотрофична латерална склероза – Bulgarian" lang="bg" hreflang="bg" class="interlanguage-link-target"><span>Български</span></a></li><li class="interlanguage-link interwiki-bs mw-list-item"><a href="https://bs.wikipedia.org/wiki/ALS4" title="ALS4 – Bosnian" lang="bs" hreflang="bs" class="interlanguage-link-target"><span>Bosanski</span></a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/Esclerosi_lateral_amiotr%C3%B2fica" title="Esclerosi lateral amiotròfica – Catalan" lang="ca" hreflang="ca" class="interlanguage-link-target"><span>Català</span></a></li><li class="interlanguage-link interwiki-cs mw-list-item"><a href="https://cs.wikipedia.org/wiki/Amyotrofick%C3%A1_later%C3%A1ln%C3%AD_skler%C3%B3za" title="Amyotrofická laterální skleróza – Czech" lang="cs" hreflang="cs" class="interlanguage-link-target"><span>Čeština</span></a></li><li class="interlanguage-link interwiki-da mw-list-item"><a href="https://da.wikipedia.org/wiki/Amyotrofisk_lateral_sklerose" title="Amyotrofisk lateral sklerose – Danish" lang="da" hreflang="da" class="interlanguage-link-target"><span>Dansk</span></a></li><li class="interlanguage-link interwiki-de mw-list-item"><a href="https://de.wikipedia.org/wiki/Amyotrophe_Lateralsklerose" title="Amyotrophe Lateralsklerose – German" lang="de" hreflang="de" class="interlanguage-link-target"><span>Deutsch</span></a></li><li class="interlanguage-link interwiki-et mw-list-item"><a href="https://et.wikipedia.org/wiki/Am%C3%BCotroofne_lateraalskleroos" title="Amüotroofne lateraalskleroos – Estonian" lang="et" hreflang="et" class="interlanguage-link-target"><span>Eesti</span></a></li><li class="interlanguage-link interwiki-el mw-list-item"><a href="https://el.wikipedia.org/wiki/%CE%91%CE%BC%CF%85%CE%BF%CF%84%CF%81%CE%BF%CF%86%CE%B9%CE%BA%CE%AE_%CF%80%CE%BB%CE%B5%CF%85%CF%81%CE%B9%CE%BA%CE%AE_%CF%83%CE%BA%CE%BB%CE%AE%CF%81%CF%85%CE%BD%CF%83%CE%B7" title="Αμυοτροφική πλευρική σκλήρυνση – Greek" lang="el" hreflang="el" class="interlanguage-link-target"><span>Ελληνικά</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Esclerosis_lateral_amiotr%C3%B3fica" title="Esclerosis lateral amiotrófica – Spanish" lang="es" hreflang="es" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-eo mw-list-item"><a href="https://eo.wikipedia.org/wiki/Amiotrofa_lateralsklerozo" title="Amiotrofa lateralsklerozo – Esperanto" lang="eo" hreflang="eo" class="interlanguage-link-target"><span>Esperanto</span></a></li><li class="interlanguage-link interwiki-eu mw-list-item"><a href="https://eu.wikipedia.org/wiki/Alboko_esklerosi_amiotrofiko" title="Alboko esklerosi amiotrofiko – Basque" lang="eu" hreflang="eu" class="interlanguage-link-target"><span>Euskara</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%A7%D8%B3%DA%A9%D9%84%D8%B1%D9%88%D8%B2_%D8%AC%D8%A7%D9%86%D8%A8%DB%8C_%D8%A2%D9%85%DB%8C%D9%88%D8%AA%D8%B1%D9%88%D9%81%DB%8C%DA%A9" title="اسکلروز جانبی آمیوتروفیک – Persian" lang="fa" hreflang="fa" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Scl%C3%A9rose_lat%C3%A9rale_amyotrophique" title="Sclérose latérale amyotrophique – French" lang="fr" hreflang="fr" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-gl mw-list-item"><a href="https://gl.wikipedia.org/wiki/Esclerose_lateral_amiotr%C3%B3fica" title="Esclerose lateral amiotrófica – Galician" lang="gl" hreflang="gl" class="interlanguage-link-target"><span>Galego</span></a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/%EA%B7%BC%EC%9C%84%EC%B6%95%EC%84%B1_%EC%B8%A1%EC%82%AD%EA%B2%BD%ED%99%94%EC%A6%9D" title="근위축성 측삭경화증 – Korean" lang="ko" hreflang="ko" class="interlanguage-link-target"><span>한국어</span></a></li><li class="interlanguage-link interwiki-hy mw-list-item"><a href="https://hy.wikipedia.org/wiki/%D4%BF%D5%B8%D5%B2%D5%B4%D5%B6%D5%A1%D5%B5%D5%AB%D5%B6_%D5%A1%D5%B4%D5%AB%D5%B8%D5%BF%D6%80%D5%B8%D6%86%D5%AB%D5%AF_%D5%BD%D5%AF%D5%AC%D5%A5%D6%80%D5%B8%D5%A6" title="Կողմնային ամիոտրոֆիկ սկլերոզ – Armenian" lang="hy" hreflang="hy" class="interlanguage-link-target"><span>Հայերեն</span></a></li><li class="interlanguage-link interwiki-hi mw-list-item"><a href="https://hi.wikipedia.org/wiki/%E0%A4%AA%E0%A5%87%E0%A4%B6%E0%A5%80%E0%A4%B6%E0%A5%8B%E0%A4%B7%E0%A5%80_%E0%A4%AA%E0%A4%BE%E0%A4%B0%E0%A5%8D%E0%A4%B6%E0%A5%8D%E0%A4%B5_%E0%A4%95%E0%A4%BE%E0%A4%A0%E0%A4%BF%E0%A4%A8%E0%A5%8D%E0%A4%AF_(%E0%A4%8F%E0%A4%AE%E0%A4%BF%E0%A4%AF%E0%A5%8B%E0%A4%9F%E0%A5%8D%E0%A4%B0%E0%A5%89%E0%A4%AB%E0%A4%BC%E0%A4%BF%E0%A4%95_%E0%A4%B2%E0%A5%88%E0%A4%9F%E0%A4%B0%E0%A4%B2_%E0%A4%B8%E0%A5%8D%E0%A4%95%E0%A4%B2%E0%A4%BF%E0%A4%B0%E0%A5%89%E0%A4%B8%E0%A4%BF%E0%A4%B8)" title="पेशीशोषी पार्श्व काठिन्य (एमियोट्रॉफ़िक लैटरल स्कलिरॉसिस) – Hindi" lang="hi" hreflang="hi" class="interlanguage-link-target"><span>हिन्दी</span></a></li><li class="interlanguage-link interwiki-hr mw-list-item"><a href="https://hr.wikipedia.org/wiki/Amiotrofi%C4%8Dna_lateralna_skleroza" title="Amiotrofična lateralna skleroza – Croatian" lang="hr" hreflang="hr" class="interlanguage-link-target"><span>Hrvatski</span></a></li><li class="interlanguage-link interwiki-id mw-list-item"><a href="https://id.wikipedia.org/wiki/Sklerosis_lateral_amiotrofik" title="Sklerosis lateral amiotrofik – Indonesian" lang="id" hreflang="id" class="interlanguage-link-target"><span>Bahasa Indonesia</span></a></li><li class="interlanguage-link interwiki-is mw-list-item"><a href="https://is.wikipedia.org/wiki/Lou_Gehrig-sj%C3%BAkd%C3%B3mur" title="Lou Gehrig-sjúkdómur – Icelandic" lang="is" hreflang="is" class="interlanguage-link-target"><span>Íslenska</span></a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Sclerosi_laterale_amiotrofica" title="Sclerosi laterale amiotrofica – Italian" lang="it" hreflang="it" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%98%D7%A8%D7%A9%D7%AA_%D7%90%D7%9E%D7%99%D7%95%D7%98%D7%A8%D7%95%D7%A4%D7%99%D7%AA_%D7%A6%D7%99%D7%93%D7%99%D7%AA" title="טרשת אמיוטרופית צידית – Hebrew" lang="he" hreflang="he" class="interlanguage-link-target"><span>עברית</span></a></li><li class="interlanguage-link interwiki-ka mw-list-item"><a href="https://ka.wikipedia.org/wiki/%E1%83%90%E1%83%9B%E1%83%98%E1%83%9D%E1%83%A2%E1%83%A0%E1%83%9D%E1%83%A4%E1%83%A3%E1%83%9A%E1%83%98_%E1%83%92%E1%83%95%E1%83%94%E1%83%A0%E1%83%93%E1%83%98%E1%83%97%E1%83%98_%E1%83%A1%E1%83%99%E1%83%9A%E1%83%94%E1%83%A0%E1%83%9D%E1%83%96%E1%83%98" title="ამიოტროფული გვერდითი სკლეროზი – Georgian" lang="ka" hreflang="ka" class="interlanguage-link-target"><span>ქართული</span></a></li><li class="interlanguage-link interwiki-sw mw-list-item"><a href="https://sw.wikipedia.org/wiki/Sklerosisi_ya_kimiotrofia_ya_pembezoni" title="Sklerosisi ya kimiotrofia ya pembezoni – Swahili" lang="sw" hreflang="sw" class="interlanguage-link-target"><span>Kiswahili</span></a></li><li class="interlanguage-link interwiki-la mw-list-item"><a href="https://la.wikipedia.org/wiki/Sclerosis_lateralis_amyotrophica" title="Sclerosis lateralis amyotrophica – Latin" lang="la" hreflang="la" class="interlanguage-link-target"><span>Latina</span></a></li><li class="interlanguage-link interwiki-lv mw-list-item"><a href="https://lv.wikipedia.org/wiki/Amiotrof%C4%81_later%C4%81l%C4%81_skleroze" title="Amiotrofā laterālā skleroze – Latvian" lang="lv" hreflang="lv" class="interlanguage-link-target"><span>Latviešu</span></a></li><li class="interlanguage-link interwiki-li mw-list-item"><a href="https://li.wikipedia.org/wiki/ALS" title="ALS – Limburgish" lang="li" hreflang="li" class="interlanguage-link-target"><span>Limburgs</span></a></li><li class="interlanguage-link interwiki-hu mw-list-item"><a href="https://hu.wikipedia.org/wiki/Amiotr%C3%B3fi%C3%A1s_later%C3%A1lszkler%C3%B3zis" title="Amiotrófiás laterálszklerózis – Hungarian" lang="hu" hreflang="hu" class="interlanguage-link-target"><span>Magyar</span></a></li><li class="interlanguage-link interwiki-mk mw-list-item"><a href="https://mk.wikipedia.org/wiki/%D0%90%D0%BC%D0%B8%D0%BE%D1%82%D1%80%D0%BE%D1%84%D0%B8%D1%87%D0%BD%D0%B0_%D0%BB%D0%B0%D1%82%D0%B5%D1%80%D0%B0%D0%BB%D0%BD%D0%B0_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7%D0%B0" title="Амиотрофична латерална склероза – Macedonian" lang="mk" hreflang="mk" class="interlanguage-link-target"><span>Македонски</span></a></li><li class="interlanguage-link interwiki-ml mw-list-item"><a href="https://ml.wikipedia.org/wiki/%E0%B4%85%E0%B4%AE%E0%B4%BF%E0%B4%9F%E0%B5%8D%E0%B4%B0%E0%B5%8B%E0%B4%AB%E0%B4%BF%E0%B4%95%E0%B5%8D_%E0%B4%B2%E0%B4%BE%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B4%B1%E0%B5%BD_%E0%B4%B8%E0%B5%8D%E2%80%8C%E0%B4%95%E0%B5%8D%E0%B4%B2%E0%B5%80%E0%B4%B1%E0%B5%8B%E0%B4%B8%E0%B4%BF%E0%B4%B8%E0%B5%8D" title="അമിട്രോഫിക് ലാറ്ററൽ സ്‌ക്ലീറോസിസ് – Malayalam" lang="ml" hreflang="ml" class="interlanguage-link-target"><span>മലയാളം</span></a></li><li class="interlanguage-link interwiki-xmf mw-list-item"><a href="https://xmf.wikipedia.org/wiki/%E1%83%90%E1%83%9B%E1%83%98%E1%83%9D%E1%83%A2%E1%83%A0%E1%83%9D%E1%83%A4%E1%83%A3%E1%83%9A%E1%83%98_%E1%83%A1%E1%83%99%E1%83%9A%E1%83%94%E1%83%A0%E1%83%9D%E1%83%96%E1%83%98" title="ამიოტროფული სკლეროზი – Mingrelian" lang="xmf" hreflang="xmf" class="interlanguage-link-target"><span>მარგალური</span></a></li><li class="interlanguage-link interwiki-ms mw-list-item"><a href="https://ms.wikipedia.org/wiki/Sklerosis_lateral_amiotrofik" title="Sklerosis lateral amiotrofik – Malay" lang="ms" hreflang="ms" class="interlanguage-link-target"><span>Bahasa Melayu</span></a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Amyotrofe_laterale_sclerose" title="Amyotrofe laterale sclerose – Dutch" lang="nl" hreflang="nl" class="interlanguage-link-target"><span>Nederlands</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E7%AD%8B%E8%90%8E%E7%B8%AE%E6%80%A7%E5%81%B4%E7%B4%A2%E7%A1%AC%E5%8C%96%E7%97%87" title="筋萎縮性側索硬化症 – Japanese" lang="ja" hreflang="ja" class="interlanguage-link-target"><span>日本語</span></a></li><li class="interlanguage-link interwiki-no mw-list-item"><a href="https://no.wikipedia.org/wiki/Amyotrofisk_lateralsklerose" title="Amyotrofisk lateralsklerose – Norwegian Bokmål" lang="nb" hreflang="nb" class="interlanguage-link-target"><span>Norsk bokmål</span></a></li><li class="interlanguage-link interwiki-or mw-list-item"><a href="https://or.wikipedia.org/wiki/%E0%AC%86%E0%AC%AE%E0%AC%BE%E0%AD%9F%E0%AD%8B%E0%AC%9F%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%AB%E0%AC%BF%E0%AC%95%E0%AD%8D_%E0%AC%B2%E0%AC%BE%E0%AC%9F%E0%AD%87%E0%AC%B0%E0%AC%BE%E0%AC%B2_%E0%AC%B8%E0%AD%8D%E0%AC%95%E0%AD%8D%E0%AC%B2%E0%AD%87%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AC%BF%E0%AC%B8%E0%AD%8D" title="ଆମାୟୋଟ୍ରୋଫିକ୍ ଲାଟେରାଲ ସ୍କ୍ଲେରୋସିସ୍ – Odia" lang="or" hreflang="or" class="interlanguage-link-target"><span>ଓଡ଼ିଆ</span></a></li><li class="interlanguage-link interwiki-pl mw-list-item"><a href="https://pl.wikipedia.org/wiki/Stwardnienie_zanikowe_boczne" title="Stwardnienie zanikowe boczne – Polish" lang="pl" hreflang="pl" class="interlanguage-link-target"><span>Polski</span></a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/Esclerose_lateral_amiotr%C3%B3fica" title="Esclerose lateral amiotrófica – Portuguese" lang="pt" hreflang="pt" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Scleroz%C4%83_lateral%C4%83_amiotrofic%C4%83" title="Scleroză laterală amiotrofică – Romanian" lang="ro" hreflang="ro" class="interlanguage-link-target"><span>Română</span></a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%91%D0%BE%D0%BA%D0%BE%D0%B2%D0%BE%D0%B9_%D0%B0%D0%BC%D0%B8%D0%BE%D1%82%D1%80%D0%BE%D1%84%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7" title="Боковой амиотрофический склероз – Russian" lang="ru" hreflang="ru" class="interlanguage-link-target"><span>Русский</span></a></li><li class="interlanguage-link interwiki-si mw-list-item"><a href="https://si.wikipedia.org/wiki/%E0%B6%B4%E0%B7%9A%E0%B7%82%E0%B7%93%E0%B6%B4%E0%B7%9D%E0%B7%82%E0%B6%AB_%E0%B6%B4%E0%B7%8F%E0%B6%BB%E0%B7%8A%E0%B7%81%E0%B7%8A%E0%B7%80%E0%B7%93%E0%B6%BA_%E0%B6%A2%E0%B7%8F%E0%B6%BB%E0%B6%A8%E0%B7%8A%E2%80%8D%E0%B6%BA%E0%B6%BA" title="පේෂීපෝෂණ පාර්ශ්වීය ජාරඨ්‍යය – Sinhala" lang="si" hreflang="si" class="interlanguage-link-target"><span>සිංහල</span></a></li><li class="interlanguage-link interwiki-simple mw-list-item"><a href="https://simple.wikipedia.org/wiki/Motor_neurone_disease" title="Motor neurone disease – Simple English" lang="en-simple" hreflang="en-simple" class="interlanguage-link-target"><span>Simple English</span></a></li><li class="interlanguage-link interwiki-sk mw-list-item"><a href="https://sk.wikipedia.org/wiki/Amyotrofick%C3%A1_later%C3%A1lna_skler%C3%B3za" title="Amyotrofická laterálna skleróza – Slovak" lang="sk" hreflang="sk" class="interlanguage-link-target"><span>Slovenčina</span></a></li><li class="interlanguage-link interwiki-sl mw-list-item"><a href="https://sl.wikipedia.org/wiki/Amiotrofi%C4%8Dna_lateralna_skleroza" title="Amiotrofična lateralna skleroza – Slovenian" lang="sl" hreflang="sl" class="interlanguage-link-target"><span>Slovenščina</span></a></li><li class="interlanguage-link interwiki-ckb mw-list-item"><a href="https://ckb.wikipedia.org/wiki/%D8%A6%D8%A7%D9%85%DB%8C%DB%86%D8%AA%D8%B1%DB%86%D9%81%DB%8C%DA%A9_%D9%84%D8%A7%D8%AA%DB%8E%D8%B1%D8%A7%D9%84_%D8%B3%DA%A9%D9%84%DB%8E%D8%B1%DB%86%D8%B2%DB%8C%D8%B3" title="ئامیۆترۆفیک لاتێرال سکلێرۆزیس – Central Kurdish" lang="ckb" hreflang="ckb" class="interlanguage-link-target"><span>کوردی</span></a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/Amiotrofi%C4%8Dna_lateralna_skleroza" title="Amiotrofična lateralna skleroza – Serbian" lang="sr" hreflang="sr" class="interlanguage-link-target"><span>Српски / srpski</span></a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Amiotrofi%C4%8Dna_lateralna_skleroza" title="Amiotrofična lateralna skleroza – Serbo-Croatian" lang="sh" hreflang="sh" class="interlanguage-link-target"><span>Srpskohrvatski / српскохрватски</span></a></li><li class="interlanguage-link interwiki-fi mw-list-item"><a href="https://fi.wikipedia.org/wiki/ALS-tauti" title="ALS-tauti – Finnish" lang="fi" hreflang="fi" class="interlanguage-link-target"><span>Suomi</span></a></li><li class="interlanguage-link interwiki-sv mw-list-item"><a href="https://sv.wikipedia.org/wiki/Amyotrofisk_lateralskleros" title="Amyotrofisk lateralskleros – Swedish" lang="sv" hreflang="sv" class="interlanguage-link-target"><span>Svenska</span></a></li><li class="interlanguage-link interwiki-tl mw-list-item"><a href="https://tl.wikipedia.org/wiki/Amyotrophic_lateral_sclerosis" title="Amyotrophic lateral sclerosis – Tagalog" lang="tl" hreflang="tl" class="interlanguage-link-target"><span>Tagalog</span></a></li><li class="interlanguage-link interwiki-ta mw-list-item"><a href="https://ta.wikipedia.org/wiki/%E0%AE%A4%E0%AE%9A%E0%AF%88%E0%AE%AF%E0%AF%82%E0%AE%9F%E0%AF%8D%E0%AE%9F%E0%AE%AE%E0%AE%B1%E0%AF%8D%E0%AE%B1_%E0%AE%AA%E0%AE%95%E0%AF%8D%E0%AE%95_%E0%AE%AE%E0%AE%B0%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81_%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D" title="தசையூட்டமற்ற பக்க மரப்பு நோய் – Tamil" lang="ta" hreflang="ta" class="interlanguage-link-target"><span>தமிழ்</span></a></li><li class="interlanguage-link interwiki-th mw-list-item"><a href="https://th.wikipedia.org/wiki/%E0%B8%AD%E0%B8%B0%E0%B9%84%E0%B8%A1%E0%B9%82%E0%B8%AD%E0%B9%82%E0%B8%97%E0%B8%A3%E0%B8%9F%E0%B8%B4%E0%B8%81_%E0%B9%81%E0%B8%A5%E0%B9%80%E0%B8%97%E0%B8%AD%E0%B8%A3%E0%B8%B1%E0%B8%A5_%E0%B8%AA%E0%B9%80%E0%B8%81%E0%B8%A5%E0%B8%AD%E0%B9%82%E0%B8%A3%E0%B8%8B%E0%B8%B4%E0%B8%AA" title="อะไมโอโทรฟิก แลเทอรัล สเกลอโรซิส – Thai" lang="th" hreflang="th" class="interlanguage-link-target"><span>ไทย</span></a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/Amyotrofik_lateral_skleroz" title="Amyotrofik lateral skleroz – Turkish" lang="tr" hreflang="tr" class="interlanguage-link-target"><span>Türkçe</span></a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/%D0%91%D1%96%D1%87%D0%BD%D0%B8%D0%B9_%D0%B0%D0%BC%D1%96%D0%BE%D1%82%D1%80%D0%BE%D1%84%D1%96%D1%87%D0%BD%D0%B8%D0%B9_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7" title="Бічний аміотрофічний склероз – Ukrainian" lang="uk" hreflang="uk" class="interlanguage-link-target"><span>Українська</span></a></li><li class="interlanguage-link interwiki-vi mw-list-item"><a href="https://vi.wikipedia.org/wiki/X%C6%A1_c%E1%BB%A9ng_teo_c%C6%A1_m%E1%BB%99t_b%C3%AAn" title="Xơ cứng teo cơ một bên – Vietnamese" lang="vi" hreflang="vi" class="interlanguage-link-target"><span>Tiếng Việt</span></a></li><li class="interlanguage-link interwiki-wuu mw-list-item"><a href="https://wuu.wikipedia.org/wiki/%E8%82%8C%E8%90%8E%E7%BC%A9%E6%80%A7%E8%84%8A%E9%AB%93%E4%BE%A7%E7%B4%A2%E7%A1%AC%E5%8C%96%E7%97%87" title="肌萎缩性脊髓侧索硬化症 – Wu Chinese" lang="wuu" hreflang="wuu" class="interlanguage-link-target"><span>吴语</span></a></li><li class="interlanguage-link interwiki-yi mw-list-item"><a href="https://yi.wikipedia.org/wiki/ALS" title="ALS – Yiddish" lang="yi" hreflang="yi" class="interlanguage-link-target"><span>ייִדיש</span></a></li><li class="interlanguage-link interwiki-zh-yue mw-list-item"><a href="https://zh-yue.wikipedia.org/wiki/%E8%82%8C%E8%82%89%E8%90%8E%E7%B8%AE%E6%80%A7%E8%84%8A%E9%AB%93%E5%81%B4%E7%B4%A2%E7%A1%AC%E5%8C%96%E7%97%87" title="肌肉萎縮性脊髓側索硬化症 – Cantonese" lang="yue" hreflang="yue" class="interlanguage-link-target"><span>粵語</span></a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E8%82%8C%E8%90%8E%E7%BC%A9%E6%80%A7%E8%84%8A%E9%AB%93%E4%BE%A7%E7%B4%A2%E7%A1%AC%E5%8C%96%E7%97%87" title="肌萎缩性脊髓侧索硬化症 – Chinese" lang="zh" hreflang="zh" class="interlanguage-link-target"><span>中文</span></a></li></ul>
			<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q206901#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
		</div>

	</div>
</div>
				</header>
				<div class="vector-page-toolbar">
					<div class="vector-page-toolbar-container">
						<div id="left-navigation">
							<nav aria-label="Namespaces">
								
<div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/ALS" title="View the content page [c]" accesskey="c" class=""><span>Article</span></a>
</li>
<li id="ca-talk" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Talk:ALS" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t" class=""><span>Talk</span></a>
</li>

		</ul>
		
	</div>
</div>

								

<div id="p-variants" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-variants emptyPortlet"  >
	<input type="checkbox"
		id="p-variants-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-variants"
		class="vector-menu-checkbox"
		aria-label="Change language variant"
		
		
	/>
	<label
		id="p-variants-label"
		for="p-variants-checkbox"
		class="vector-menu-heading "
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">English</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"></ul>
		
	</div>

	</div>
</div>
							</nav>
						</div>
						<div id="right-navigation" class="vector-collapsible">
							<nav aria-label="Views">
								
<div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/ALS" class=""><span>Read</span></a>
</li>
<li id="ca-edit" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=ALS&amp;action=edit" title="Edit this page [e]" accesskey="e" class=""><span>Edit</span></a>
</li>
<li id="ca-history" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=ALS&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class=""><span>View history</span></a>
</li>

		</ul>
		
	</div>
</div>

							</nav>
				
							<nav class="vector-page-tools-landmark" aria-label="More options">
								
<div id="vector-page-tools-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-tools-dropdown"  >
	<input type="checkbox"
		id="vector-page-tools-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-tools-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Tools"
		
	/>
	<label
		id="vector-page-tools-dropdown-label"
		for="vector-page-tools-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet"
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">Tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


									<div id="vector-page-tools-unpinned-container" class="vector-unpinned-container">
						
<div id="vector-page-tools" class="vector-page-tools vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="page-tools-pinned"
	data-pinnable-element-id="vector-page-tools"
	data-pinned-container-id="vector-page-tools-pinned-container"
	data-unpinned-container-id="vector-page-tools-unpinned-container"
>
	<div class="vector-pinnable-header-label">Tools</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button>
</div>

	
<div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items"  title="More options" >
	<div class="vector-menu-heading">
		Actions
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/ALS"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=ALS&amp;action=edit"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=ALS&amp;action=history"><span>View history</span></a></li></ul>
		
	</div>
</div>

<div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb"  >
	<div class="vector-menu-heading">
		General
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/ALS" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/ALS" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=ALS&amp;oldid=1161884281" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=ALS&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=ALS&amp;id=1161884281&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-wikibase" class="mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q206901" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li></ul>
		
	</div>
</div>

<div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export"  >
	<div class="vector-menu-heading">
		Print/export
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=ALS&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=ALS&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li></ul>
		
	</div>
</div>

<div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects"  >
	<div class="vector-menu-heading">
		In other projects
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Amyotrophic_lateral_sclerosis" hreflang="en"><span>Wikimedia Commons</span></a></li></ul>
		
	</div>
</div>

</div>

									</div>
				
	</div>
</div>
							</nav>
						</div>
					</div>
				</div>
				<div class="vector-column-end">
					<nav class="vector-page-tools-landmark vector-sticky-pinned-container" aria-label="More options">
						<div id="vector-page-tools-pinned-container" class="vector-pinned-container">
			
						</div>
	</nav>
				</div>
				<div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container>
					<div class="vector-body-before-content">
							<div class="mw-indicators">
		</div>

						<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
					</div>
					<div id="contentSub"><div id="mw-content-subtitle"><span class="mw-redirectedfrom">(Redirected from <a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;redirect=no" class="mw-redirect" title="Amyotrophic lateral sclerosis">Amyotrophic lateral sclerosis</a>)</span></div></div>
					
					
					<div id="mw-content-text" class="mw-body-content mw-content-ltr" lang="en" dir="ltr"><div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Rare neurodegenerative disease</div>
<style data-mw-deduplicate="TemplateStyles:r1033289096">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role="note" class="hatnote navigation-not-searchable">This article is about the neurodegenerative disease. For other uses, see <a href="/wiki/ALS_(disambiguation)" class="mw-disambig" title="ALS (disambiguation)">ALS (disambiguation)</a>.</div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">"Motor neuron disease" and "Motor neurone disease" redirect here. For a group of muscle-wasting disorders, see <a href="/wiki/Motor_neuron_diseases" title="Motor neuron diseases">Motor neuron diseases</a>.</div>
<p class="mw-empty-elt">
</p>
<div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Medical condition</div><style data-mw-deduplicate="TemplateStyles:r1066479718">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}</style><table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background:#ccc">Amyotrophic lateral sclerosis</th></tr><tr><th scope="row" class="infobox-label">Other names</th><td class="infobox-data"><style data-mw-deduplicate="TemplateStyles:r1126788409">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style><div class="plainlist"><ul><li>Motor neurone disease (MND)</li><li><a href="/wiki/Lou_Gehrig" title="Lou Gehrig">Lou Gehrig</a>'s disease</li><li><a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Charcot</a>'s disease<sup id="cite_ref-Orphanet2009_1-0" class="reference"><a href="#cite_note-Orphanet2009-1">&#91;1&#93;</a></sup></li></ul></div></td></tr><tr><td colspan="2" class="infobox-full-data"><a href="/wiki/File:ALS_Affected_neurons_and_muscles.png" class="image"><img alt="Diagram of a human nervous system highlighting the brain, spinal cord, motor neurons, and muscles of the body affected by ALS" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/16/ALS_Affected_neurons_and_muscles.png/300px-ALS_Affected_neurons_and_muscles.png" decoding="async" width="300" height="266" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/16/ALS_Affected_neurons_and_muscles.png/450px-ALS_Affected_neurons_and_muscles.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/16/ALS_Affected_neurons_and_muscles.png/600px-ALS_Affected_neurons_and_muscles.png 2x" data-file-width="4520" data-file-height="4011" /></a></td></tr><tr><td colspan="2" class="infobox-full-data">Parts of the <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a> affected by ALS, causing progressive symptoms in <a href="/wiki/Skeletal_muscles" class="mw-redirect" title="Skeletal muscles">skeletal muscles</a> throughout the body<sup id="cite_ref-Masrori-2020_2-0" class="reference"><a href="#cite_note-Masrori-2020-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_specialty" title="Medical specialty">Specialty</a></th><td class="infobox-data"><a href="/wiki/Neurology" title="Neurology">Neurology</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Signs_and_symptoms" title="Signs and symptoms">Symptoms</a></th><td class="infobox-data"><b>Early</b>: <a href="/wiki/Spasticity" title="Spasticity">Stiff muscles</a>, <a href="/wiki/Fasciculation" title="Fasciculation">muscle twitches</a>, gradual increasing weakness,<sup id="cite_ref-NINDS2020_3-0" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup><br /> <b>Later</b>: Difficulty in <a href="/wiki/Dysarthria" title="Dysarthria">speaking</a>, <a href="/wiki/Dysphagia" title="Dysphagia">swallowing</a>, and  <a href="/wiki/Shortness_of_breath" title="Shortness of breath">breathing</a>; <a href="/wiki/Respiratory_failure" title="Respiratory failure">respiratory failure</a><sup id="cite_ref-NINDS2020_3-1" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> 10-15% experience <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">frontotemporal dementia</a><sup id="cite_ref-Masrori-2020_2-1" class="reference"><a href="#cite_note-Masrori-2020-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Complication_(medicine)" title="Complication (medicine)">Complications</a></th><td class="infobox-data"><a href="/wiki/Falling_(accident)" title="Falling (accident)">Falling (accident)</a>; <a href="/wiki/Respiratory_failure" title="Respiratory failure">Respiratory failure</a>; <a href="/wiki/Pneumonia" title="Pneumonia">Pneumonia</a>; <a href="/wiki/Malnutrition" title="Malnutrition">Malnutrition</a></td></tr><tr><th scope="row" class="infobox-label">Usual onset</th><td class="infobox-data">45 – 75 years <sup id="cite_ref-Masrori-2020_2-2" class="reference"><a href="#cite_note-Masrori-2020-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Causes</th><td class="infobox-data">Unknown (about 85%), genetic (about 15%)</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Risk_factor" title="Risk factor">Risk factors</a></th><td class="infobox-data">Genetic risk factors; age; <a href="/wiki/Male" title="Male">male sex</a>; heavy metals; organic chemicals; smoking; electric shock; physical exercise; head injury  <sup id="cite_ref-Masrori-2020_2-3" class="reference"><a href="#cite_note-Masrori-2020-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_diagnosis" title="Medical diagnosis">Diagnostic method</a></th><td class="infobox-data">Clinical diagnosis of exclusion based on progressive symptoms of upper and lower motor neuron degeneration in which no other explanation can be found. Supportive evidence from <a href="/wiki/Electromyography" title="Electromyography">electromyography</a>, <a href="/wiki/Genetic_testing" title="Genetic testing">genetic testing</a>, and <a href="/wiki/Neuroimaging" title="Neuroimaging">neuroimaging</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Differential_diagnosis" title="Differential diagnosis">Differential diagnosis</a></th><td class="infobox-data"><a href="/wiki/Multifocal_motor_neuropathy" title="Multifocal motor neuropathy">Multifocal motor neuropathy</a>, <a href="/wiki/Kennedy%27s_disease" class="mw-redirect" title="Kennedy&#39;s disease">Kennedy's disease</a>, <a href="/wiki/Hereditary_spastic_paraplegia" title="Hereditary spastic paraplegia">Hereditary spastic paraplegia</a>, <a href="/wiki/Nerve_compression_syndrome" title="Nerve compression syndrome">Nerve compression syndrome</a>, <a href="/wiki/Diabetic_neuropathy" title="Diabetic neuropathy">Diabetic neuropathy</a>, <a href="/wiki/Post-polio_syndrome" title="Post-polio syndrome">Post-polio syndrome</a>, <a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">Myasthenia gravis</a>, <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a><sup id="cite_ref-4" class="reference"><a href="#cite_note-4">&#91;4&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Treatment</th><td class="infobox-data"><a href="/wiki/Walker_(mobility)" title="Walker (mobility)">Walker (mobility)</a>; <a href="/wiki/Wheelchair" title="Wheelchair">Wheelchair</a>; <a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a>;<sup id="cite_ref-Support2016_5-0" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> <a href="/wiki/Feeding_tube" title="Feeding tube">Feeding tube</a>; <a href="/wiki/Augmentative_and_alternative_communication" title="Augmentative and alternative communication">Augmentative and alternative communication</a>; symptomatic management</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medication" title="Medication">Medication</a></th><td class="infobox-data"><a href="/wiki/Riluzole" title="Riluzole">Riluzole</a>, <a href="/wiki/Edaravone" title="Edaravone">Edaravone</a>, <a href="/wiki/Sodium_phenylbutyrate/ursodoxicoltaurine" title="Sodium phenylbutyrate/ursodoxicoltaurine">Sodium phenylbutyrate/ursodoxicoltaurine</a>, <a href="/wiki/Tofersen" title="Tofersen">Tofersen</a>, <a href="/wiki/Dextromethorphan/quinidine" title="Dextromethorphan/quinidine">Dextromethorphan/quinidine</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Prognosis" title="Prognosis">Prognosis</a></th><td class="infobox-data">Life expectancy highly variable but typically 2–4 years after diagnosis <sup id="cite_ref-Goutman_480–493_6-0" class="reference"><a href="#cite_note-Goutman_480–493-6">&#91;6&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Frequency</th><td class="infobox-data">Incidence: 1.6/100,000 individuals per year;<sup id="cite_ref-Goutman_480–493_6-1" class="reference"><a href="#cite_note-Goutman_480–493-6">&#91;6&#93;</a></sup> Prevalence: 4.4/100,000 living individuals<sup id="cite_ref-Goutman_480–493_6-2" class="reference"><a href="#cite_note-Goutman_480–493-6">&#91;6&#93;</a></sup>
Lifetime risk, 1 in 400 individuals <sup id="cite_ref-7" class="reference"><a href="#cite_note-7">&#91;7&#93;</a></sup></td></tr></tbody></table>
<p><b>Amyotrophic lateral sclerosis</b> (<b>ALS</b>), also known as <b>motor neurone disease</b> (<b>MND</b>) or <b>Lou Gehrig's disease</b>, is a <a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">neurodegenerative disease</a> that results in the progressive loss of <a href="/wiki/Motor_neuron" title="Motor neuron">motor neurons</a> that control <a href="/wiki/Skeletal_muscle" title="Skeletal muscle">voluntary muscles</a>.<sup id="cite_ref-NINDS2020_3-2" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> ALS is the most common form of the <a href="/wiki/Motor_neuron_diseases" title="Motor neuron diseases">motor neuron diseases</a>.<sup id="cite_ref-NIH2020_8-0" class="reference"><a href="#cite_note-NIH2020-8">&#91;8&#93;</a></sup> Early symptoms of ALS include <a href="/wiki/Spasticity" title="Spasticity">stiff muscles</a>, <a href="/wiki/Fasciculation" title="Fasciculation">muscle twitches</a>, and gradual increasing weakness and <a href="/wiki/Muscle_atrophy" title="Muscle atrophy">muscle wasting</a>.<sup id="cite_ref-NINDS2020_3-3" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> <i>Limb-onset ALS</i> begins with weakness in the arms or legs, while <i>bulbar-onset ALS</i> begins with difficulty <a href="/wiki/Dysarthria" title="Dysarthria">speaking</a> or <a href="/wiki/Dysphagia" title="Dysphagia">swallowing</a>.<sup id="cite_ref-Nature2017_9-0" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> Around half of people with ALS develop at least mild difficulties with <a href="/wiki/Cognitive_disorder" title="Cognitive disorder">thinking</a> and behavior, and about 15% develop <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">frontotemporal dementia</a>.<sup id="cite_ref-Lancet2017_10-0" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> Motor neuron loss continues until the ability to eat, speak, move, and finally the ability to breathe is lost.<sup id="cite_ref-NINDS2020_3-4" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup>
</p><p>Most cases of ALS (about 90% to 95%) have no known cause, and are known as <i>sporadic ALS</i>.<sup id="cite_ref-NINDS2020_3-5" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup><sup id="cite_ref-alsa_11-0" class="reference"><a href="#cite_note-alsa-11">&#91;11&#93;</a></sup> However, both <a href="/wiki/Genetics" title="Genetics">genetic</a> and <a href="/wiki/Environmental_factors" class="mw-redirect" title="Environmental factors">environmental factors</a> are believed to be involved.<sup id="cite_ref-Wingo2011_12-0" class="reference"><a href="#cite_note-Wingo2011-12">&#91;12&#93;</a></sup> The remaining 5% to 10% of cases have a genetic cause, often linked to a <a href="/wiki/Family_history_(medicine)" title="Family history (medicine)">history of the disease in the family</a>, and these are known as <i>genetic ALS</i>.<sup id="cite_ref-alsa_11-1" class="reference"><a href="#cite_note-alsa-11">&#91;11&#93;</a></sup><sup id="cite_ref-Lancet2011_13-0" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup> About half of these genetic cases are due to disease-causing variants in one of two specific <a href="/wiki/Gene" title="Gene">genes</a>.<sup id="cite_ref-NINDS2020_3-6" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> The <a href="/wiki/Diagnosis" title="Diagnosis">diagnosis</a> is based on a person's <a href="/wiki/Signs_and_symptoms" title="Signs and symptoms">signs and symptoms</a>, with testing conducted to rule out other potential causes.<sup id="cite_ref-NINDS2020_3-7" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup>
</p><p>There is no known cure for ALS.<sup id="cite_ref-NINDS2020_3-8" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> The goal of treatment is to slow the disease and improve symptoms.<sup id="cite_ref-Lancet2017_10-1" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> Treatments that slow ALS include <a href="/wiki/Riluzole" title="Riluzole">riluzole</a> (extends life by two to three months<sup id="cite_ref-CD001447_14-0" class="reference"><a href="#cite_note-CD001447-14">&#91;14&#93;</a></sup>) and <a href="/wiki/Sodium_phenylbutyrate/ursodoxicoltaurine" title="Sodium phenylbutyrate/ursodoxicoltaurine">sodium phenylbutyrate/ursodoxicoltaurine</a> (extends life by around seven months<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup>). <a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a> may result in both improved quality and length of life.<sup id="cite_ref-Support2016_5-1" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> <a href="/wiki/Mechanical_ventilation" title="Mechanical ventilation">Mechanical ventilation</a> can prolong survival but does not stop disease progression.<sup id="cite_ref-Care2017_16-0" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> A <a href="/wiki/Feeding_tube" title="Feeding tube">feeding tube</a> may help maintain weight and nutrition.<sup id="cite_ref-Conn2015_17-0" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup> Death is usually caused by respiratory failure.<sup id="cite_ref-Lancet2011_13-1" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup> The disease can affect people of any age, but usually starts around the age of 60.<sup id="cite_ref-Lancet2011_13-2" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup> The average survival from onset to death is two to four years, though this can vary, and about 10% of those affected survive longer than ten years.<sup id="cite_ref-Pupillo-2014_18-0" class="reference"><a href="#cite_note-Pupillo-2014-18">&#91;18&#93;</a></sup>
</p><p>Descriptions of the disease date back to at least 1824 by <a href="/wiki/Charles_Bell" title="Charles Bell">Charles Bell</a>.<sup id="cite_ref-Rowland2001_19-0" class="reference"><a href="#cite_note-Rowland2001-19">&#91;19&#93;</a></sup> In 1869, the connection between the symptoms and the underlying neurological problems was first described by French neurologist <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>, who in 1874 began using the term <i>amyotrophic lateral sclerosis</i>.<sup id="cite_ref-Rowland2001_19-1" class="reference"><a href="#cite_note-Rowland2001-19">&#91;19&#93;</a></sup>
</p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc" /></div>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>ALS is a <a href="/wiki/Motor_neuron_diseases" title="Motor neuron diseases">motor neuron disease</a>, which is a group of <a href="/wiki/Neurological_disorder" title="Neurological disorder">neurological disorders</a> that selectively affect <a href="/wiki/Motor_neuron" title="Motor neuron">motor neurons</a>, the cells that control <a href="/wiki/Skeletal_muscle" title="Skeletal muscle">voluntary muscles</a> of the body.<sup id="cite_ref-NINDS2020_3-9" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> Other motor neuron diseases include <a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">primary lateral sclerosis</a> (PLS), <a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">progressive muscular atrophy</a> (PMA), <a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">progressive bulbar palsy</a>, <a href="/wiki/Pseudobulbar_palsy" title="Pseudobulbar palsy">pseudobulbar palsy</a>, and <a href="/wiki/Monomelic_amyotrophy" title="Monomelic amyotrophy">monomelic amyotrophy</a> (MMA).<sup id="cite_ref-20" class="reference"><a href="#cite_note-20">&#91;20&#93;</a></sup>
</p><p>As a disease, ALS itself can be classified in a few different ways: by which part of the motor neurons are affected; by the parts of the body first affected; whether it is genetic; and the age at which it started. Each individual diagnosed with the condition will sit at a unique place at the intersection of these complex and overlapping subtypes, which presents a challenge to diagnosis, understanding, and prognosis.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Subtypes_of_motor_neuron_degeneration">Subtypes of motor neuron degeneration</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=2" title="Edit section: Subtypes of motor neuron degeneration">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Illustration_of_the_motor_neuron_tract_descending_from_primary_motor_cortex,_via_spinal_cord,_to_skeletal_muscle.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Illustration_of_the_motor_neuron_tract_descending_from_primary_motor_cortex%2C_via_spinal_cord%2C_to_skeletal_muscle.jpg/220px-Illustration_of_the_motor_neuron_tract_descending_from_primary_motor_cortex%2C_via_spinal_cord%2C_to_skeletal_muscle.jpg" decoding="async" width="220" height="124" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Illustration_of_the_motor_neuron_tract_descending_from_primary_motor_cortex%2C_via_spinal_cord%2C_to_skeletal_muscle.jpg/330px-Illustration_of_the_motor_neuron_tract_descending_from_primary_motor_cortex%2C_via_spinal_cord%2C_to_skeletal_muscle.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Illustration_of_the_motor_neuron_tract_descending_from_primary_motor_cortex%2C_via_spinal_cord%2C_to_skeletal_muscle.jpg/440px-Illustration_of_the_motor_neuron_tract_descending_from_primary_motor_cortex%2C_via_spinal_cord%2C_to_skeletal_muscle.jpg 2x" data-file-width="8000" data-file-height="4500" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Illustration_of_the_motor_neuron_tract_descending_from_primary_motor_cortex,_via_spinal_cord,_to_skeletal_muscle.jpg" class="internal" title="Enlarge"></a></div>Typical or "classical" ALS involves neurons in the brain and spinal cord (<a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">upper motor neurons</a>, highlighted magenta), as well as the <a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">lower motor neurons</a>, which go from the spinal cord to the muscles, highlighted teal.<sup id="cite_ref-Cold_Spring_Harbor_2017_22-0" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-22">&#91;22&#93;</a></sup></div></div></div>
<p>ALS can be classified by the types of motor neurons that are affected.<sup id="cite_ref-Cold_Spring_Harbor_2017_22-1" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-22">&#91;22&#93;</a></sup> To successfully control any voluntary muscle in the body, a signal must be sent from the <a href="/wiki/Motor_cortex" title="Motor cortex">motor cortex</a> in the brain down the <a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">upper motor neuron</a> as it travels down the spinal cord. There, it connects via a <a href="/wiki/Synapse" title="Synapse">synapse</a> to the <a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">lower motor neuron</a> which connects to the muscle itself. Damage to either the upper or lower motor neuron, as it makes its way from the brain to muscle, causes different types of symptoms.<sup id="cite_ref-Cold_Spring_Harbor_2017_22-2" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-22">&#91;22&#93;</a></sup> Damage to the upper motor neuron typically causes spasticity, stiffness, brisk reflexes, and/or clonus, while damage to the lower motor neuron typically causes weakness, atrophy, and fasciculation.
</p><p>"Typical ALS" or "classical ALS" involves degeneration to both the <a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">upper motor neurons</a> in the brain and the <a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">lower motor neurons</a> in the spinal cord.<sup id="cite_ref-Cold_Spring_Harbor_2017_22-3" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-22">&#91;22&#93;</a></sup> <a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">Primary lateral sclerosis</a> (PLS) involves degeneration of only the upper motor neurons, and <a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">progressive muscular atrophy</a> (PMA) involves only the lower motor neurons. There is debate over whether PLS and PMA are separate diseases or simply variants of ALS.<sup id="cite_ref-Lancet2017_10-2" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup>
</p>
<table class="wikitable">
<caption>
</caption>
<tbody><tr>
<th>Main ALS Subtypes
</th>
<th><a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">Upper motor neuron</a> degeneration
</th>
<th><a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">Lower motor neuron</a> degeneration
</th></tr>
<tr>
<td>Classical ALS
</td>
<td>Yes
</td>
<td>Yes
</td></tr>
<tr>
<td>Primary lateral sclerosis (PLS)
</td>
<td>Yes
</td>
<td>No
</td></tr>
<tr>
<td>Progressive muscular atrophy (PMA)
</td>
<td>No
</td>
<td>Yes
</td></tr></tbody></table>
<p>Classical ALS accounts for about 70% of all cases of ALS and can be subdivided into where symptoms first appear as these are usually focussed to one region of the body at initial presentation before later spread. <i>Limb-onset</i> ALS (also known as spinal-onset) and <i>bulbar-onset</i> ALS.<sup id="cite_ref-Lancet2017_10-3" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> Limb-onset ALS begins with weakness in the hands, arms, feet, and/or legs<sup id="cite_ref-Nature2017_9-1" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> and accounts for about two-thirds of all classical ALS cases.<sup id="cite_ref-Lancet2017_10-4" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> Bulbar-onset ALS begins with weakness in the muscles of speech, chewing, and swallowing<sup id="cite_ref-Cold_Spring_Harbor_2017_22-4" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-22">&#91;22&#93;</a></sup> and accounts for about 25% of classical ALS cases.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup> A rarer type of classical ALS affecting around 3% of patients is respiratory-onset,<sup id="cite_ref-Lancet2017_10-5" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> in which the initial symptoms are difficulty breathing (<a href="/wiki/Dyspnea" class="mw-redirect" title="Dyspnea">dyspnea</a>) upon exertion, at rest, or while lying flat (<a href="/wiki/Orthopnea" title="Orthopnea">orthopnea</a>).<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup> 
</p><p><a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">Primary lateral sclerosis</a> (PLS) is a subtype of the overall ALS category which accounts for about 5% of all cases and affects only affects the upper motor neurons in the arms, legs, and bulbar region.<sup id="cite_ref-Nature2014_25-0" class="reference"><a href="#cite_note-Nature2014-25">&#91;25&#93;</a></sup> However, more than 75% of people with apparent PLS go on to later develop lower motor neuron signs within four years of symptom onset, meaning that a definitive diagnosis of PLS cannot be made until several years have passed.<sup id="cite_ref-Classification2016_26-0" class="reference"><a href="#cite_note-Classification2016-26">&#91;26&#93;</a></sup> PLS has a better prognosis than classical ALS, as it progresses slower, results in less functional decline, does not affect the ability to breathe, and causes less severe weight loss than classical ALS.<sup id="cite_ref-Nature2014_25-1" class="reference"><a href="#cite_note-Nature2014-25">&#91;25&#93;</a></sup>
</p><p><a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">Progressive muscular atrophy</a> (PMA) is another subtype that accounts for about 5% of the overall ALS category and affects lower motor neurons in the arms, legs, and bulbar region.<sup id="cite_ref-Nature2014_25-2" class="reference"><a href="#cite_note-Nature2014-25">&#91;25&#93;</a></sup> While PMA is associated with longer survival on average than classical ALS, it is still progressive over time, eventually leading to respiratory failure and death.<sup id="cite_ref-Lancet2017_10-6" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> As with PLS developing into classical ALS, PMA can also develop into classical ALS over time if the lower motor neuron involvement progresses to include upper motor neurons, in which case the diagnosis might be changed to classic ALS.<sup id="cite_ref-Classification2016_26-1" class="reference"><a href="#cite_note-Classification2016-26">&#91;26&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Rare_isolated_variants_of_ALS">Rare isolated variants of ALS</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=3" title="Edit section: Rare isolated variants of ALS">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Isolated variants of ALS have symptoms that are limited to a single region for at least a year; they progress more slowly than classical ALS and are associated with longer survival.<sup id="cite_ref-Masrori-2020_2-4" class="reference"><a href="#cite_note-Masrori-2020-2">&#91;2&#93;</a></sup> These regional variants of ALS can only be considered as a diagnosis should the initial symptoms fail to spread to other spinal cord regions for an extended period of time (at least 12 months).<sup id="cite_ref-Regional_ALS_Variants_27-0" class="reference"><a href="#cite_note-Regional_ALS_Variants-27">&#91;27&#93;</a></sup> Flail arm syndrome is characterized by lower motor neuron damage affecting the arm muscles, typically starting with the upper arms symmetrically and progressing downwards to the hands.<sup id="cite_ref-Masrori-2020_2-5" class="reference"><a href="#cite_note-Masrori-2020-2">&#91;2&#93;</a></sup> Flail leg syndrome is characterized by lower motor neuron damage leading to asymmetrical weakness and wasting in the legs starting around the feet.<sup id="cite_ref-Masrori-2020_2-6" class="reference"><a href="#cite_note-Masrori-2020-2">&#91;2&#93;</a></sup> Isolated bulbar ALS is characterized by upper or lower motor neuron damage in the bulbar region (in the absence of limb symptoms for at least 20 months<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup>), leading to gradual onset of difficulty with speech (<a href="/wiki/Dysarthria" title="Dysarthria">dysarthria</a>) and swallowing (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>).
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:ALS_subtypes_UMN_LMN_distribution.png" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/ALS_subtypes_UMN_LMN_distribution.png/220px-ALS_subtypes_UMN_LMN_distribution.png" decoding="async" width="220" height="220" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/ALS_subtypes_UMN_LMN_distribution.png/330px-ALS_subtypes_UMN_LMN_distribution.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9c/ALS_subtypes_UMN_LMN_distribution.png/440px-ALS_subtypes_UMN_LMN_distribution.png 2x" data-file-width="8000" data-file-height="8000" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ALS_subtypes_UMN_LMN_distribution.png" class="internal" title="Enlarge"></a></div>Illustration showing the range of upper and lower motor neuron involvement in the two most common types of ALS (top row) and three of the most common rare subtypes of ALS (bottom row)</div></div></div>
<h3><span class="mw-headline" id="Age_of_onset">Age of onset</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=4" title="Edit section: Age of onset">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>ALS can also be classified based on the age of onset. While the peak age of onset is 58 to 63 for sporadic ALS and 47 to 52 for genetic ALS,<sup id="cite_ref-Lancet2011_13-3" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup> about 10% of all cases of ALS begin before age 45 ("young-onset" ALS), and about 1% of all cases begin before age 25 ("juvenile" ALS).<sup id="cite_ref-Cold_Spring_Harbor_2017_22-5" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-22">&#91;22&#93;</a></sup> People who develop young-onset ALS are more likely to be male, less likely to have bulbar onset of symptoms, and more likely to have a slower progression of the disease.<sup id="cite_ref-Classification2016_26-2" class="reference"><a href="#cite_note-Classification2016-26">&#91;26&#93;</a></sup> Juvenile ALS is more likely to be genetic in origin than adult-onset ALS; the most common genes associated with juvenile ALS are <i><a href="/wiki/FUS_(gene)" class="mw-redirect" title="FUS (gene)">FUS</a></i>, <i><a href="/wiki/ALS2" title="ALS2">ALS2</a></i>, and <i><a href="/wiki/SETX" title="SETX">SETX</a></i>.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup> Although most people with juvenile ALS live longer than those with adult-onset ALS, some of them have specific mutations in <a href="/wiki/FUS_(gene)" class="mw-redirect" title="FUS (gene)">FUS</a> and <i><a href="/wiki/SOD1" title="SOD1">SOD1</a></i> that are associated with a poor prognosis.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup> Late onset (after age 65) is generally associated with a more rapid functional decline and shorter survival.<sup id="cite_ref-Clinical_Features_of_ALS_31-0" class="reference"><a href="#cite_note-Clinical_Features_of_ALS-31">&#91;31&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=5" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The disorder causes muscle weakness, <a href="/wiki/Atrophy" title="Atrophy">atrophy</a>, and <a href="/wiki/Spasticity" title="Spasticity">muscle spasms</a> throughout the body due to the degeneration of the upper motor and lower motor neurons.  <a href="/wiki/Sensory_neuron" title="Sensory neuron">Sensory nerves</a> and the <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic nervous system</a> are generally unaffected, meaning the majority of people with ALS maintain <a href="/wiki/Hearing" title="Hearing">hearing</a>, <a href="/wiki/Visual_perception" title="Visual perception">sight</a>, <a href="/wiki/Somatosensory_system" title="Somatosensory system">touch</a>, <a href="/wiki/Olfaction" class="mw-redirect" title="Olfaction">smell</a>, and <a href="/wiki/Taste" title="Taste">taste</a>.<sup id="cite_ref-NINDS2020_3-10" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Initial_symptoms">Initial symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=6" title="Edit section: Initial symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The start of ALS may be so subtle that the symptoms are overlooked.<sup id="cite_ref-NINDS2020_3-11" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> The earliest symptoms of ALS are muscle weakness or muscle atrophy, typically on one side of the body. Other presenting symptoms include trouble swallowing or breathing, cramping, or stiffness of affected muscles; muscle weakness affecting an arm or a leg; or slurred and nasal speech. The parts of the body affected by early symptoms of ALS depend on which motor neurons in the body are damaged first.<sup id="cite_ref-NHS_32-0" class="reference"><a href="#cite_note-NHS-32">&#91;32&#93;</a></sup>
</p><p>In limb-onset ALS, the first symptoms are in the arms or the legs. If the legs are affected first, people may experience awkwardness, tripping, or stumbling when walking or running; this is often marked by walking with a "<a href="/wiki/Foot_drop" title="Foot drop">dropped foot</a>" that drags gently on the ground. If the arms are affected first, they may experience difficulty with tasks requiring manual dexterity, such as buttoning a shirt, writing, or turning a key in a lock.<sup id="cite_ref-NHS_32-1" class="reference"><a href="#cite_note-NHS-32">&#91;32&#93;</a></sup>
</p><p>In bulbar-onset ALS, the first symptoms are difficulty speaking or swallowing. Speech may become slurred, nasal in character, or quieter. There may be difficulty with swallowing and loss of tongue mobility. A smaller proportion of people experience "respiratory-onset" ALS, where the <a href="/wiki/Intercostal_muscle" class="mw-redirect" title="Intercostal muscle">intercostal muscles</a> that support breathing are affected first.<sup id="cite_ref-Lancet2011_13-4" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup>
</p><p>Over time, people experience increasing difficulty moving, swallowing (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>), and speaking or forming words (<a href="/wiki/Dysarthria" title="Dysarthria">dysarthria</a>). Symptoms of upper motor neuron involvement include tight and stiff muscles (<a href="/wiki/Spasticity" title="Spasticity">spasticity</a>) and exaggerated reflexes (<a href="/wiki/Hyperreflexia" title="Hyperreflexia">hyperreflexia</a>), including an overactive gag reflex.<sup id="cite_ref-Cold_Spring_Harbor_20172_33-0" class="reference"><a href="#cite_note-Cold_Spring_Harbor_20172-33">&#91;33&#93;</a></sup> While the disease does not cause pain directly, pain is a symptom experienced by most people with ALS caused by reduced mobility.<sup id="cite_ref-Pain2017_34-0" class="reference"><a href="#cite_note-Pain2017-34">&#91;34&#93;</a></sup> Symptoms of lower motor neuron degeneration include muscle weakness and atrophy, muscle cramps, and fleeting twitches of muscles that can be seen under the skin (<a href="/wiki/Fasciculation" title="Fasciculation">fasciculations</a>).
</p>
<h3><span class="mw-headline" id="Progression">Progression</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=7" title="Edit section: Progression">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Although the initial site of symptoms and subsequent rate of disability progression vary from person to person, the initially affected body region is usually the most affected over time, and symptoms usually spread to a neighbouring body region. For example, symptoms starting in one arm usually spread next to either the opposite arm or to the leg on the same side.<sup id="cite_ref-Cold_Spring_Harbor_2017_22-6" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-22">&#91;22&#93;</a></sup> Bulbar-onset patients most typically get their next symptoms in their arms rather than legs, arm-onset patients typically spreads to the legs before the bulbar region, and leg-onset patients typically spread to the arms rather than the bulbar region.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">&#91;35&#93;</a></sup> Over time, regardless of where symptoms began, most people eventually lose the ability to walk or use their hands and arms independently. Less consistently, they may lose the ability to speak and to swallow food. It is the eventual development of weakness of the respiratory muscles, with the loss of ability to cough and to breathe without support, that is ultimately life-shortening in ALS.<sup id="cite_ref-Support2016_5-2" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup>
</p><p>The rate of progression can be measured using the <a href="/wiki/ALS_Functional_Rating_Scale_-_Revised" title="ALS Functional Rating Scale - Revised">ALS Functional Rating Scale - Revised</a> (ALSFRS-R), a 12-item instrument survey administered as a clinical interview or self-reported questionnaire that produces a score between 48 (normal function) and 0 (severe disability).<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup> The ALSFRS-R is the most frequently used outcome measure in clinical trials<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup> and is used by doctors to track disease progression.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup> Though the degree of variability is high and a small percentage of people have a much slower disorder, on average, people with ALS lose about 1 ALSFRS-R point per month.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">&#91;39&#93;</a></sup> Brief periods of stabilization ("plateaus") and even small reversals in ALSFRS-R score are not uncommon, due to the fact the tool is subjective, can be affected by medication, and different forms of compensation for changes in function.<sup id="cite_ref-Bedlack-2016_40-0" class="reference"><a href="#cite_note-Bedlack-2016-40">&#91;40&#93;</a></sup> However it is rare (&lt;1%) for these improvements to be large (i.e. greater than 4 ALSFRS-R points) or sustained (i.e. greater than 12 months).<sup id="cite_ref-Bedlack-2016_40-1" class="reference"><a href="#cite_note-Bedlack-2016-40">&#91;40&#93;</a></sup> A survey-based study among clinicians showed that they rated a 20% change in the slope of the ALSFRS-R as being clinically meaningful, which is the most common threshold used to determine whether a new treatment is working in clinical trials.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">&#91;41&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Late_stage_disease_management">Late stage disease management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=8" title="Edit section: Late stage disease management">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Difficulties with chewing and swallowing make eating very difficult (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>) and increase the risk of choking or of <a href="/wiki/Pulmonary_aspiration" title="Pulmonary aspiration">aspirating</a> food into the lungs.<sup id="cite_ref-Yunusova-2019_42-0" class="reference"><a href="#cite_note-Yunusova-2019-42">&#91;42&#93;</a></sup> In later stages of the disorder, <a href="/wiki/Aspiration_pneumonia" title="Aspiration pneumonia">aspiration pneumonia</a> can develop, and maintaining a healthy weight can become a significant problem that may require the insertion of a feeding tube.<sup id="cite_ref-Yunusova-2019_42-1" class="reference"><a href="#cite_note-Yunusova-2019-42">&#91;42&#93;</a></sup> As the diaphragm and <a href="/wiki/Intercostal_muscle" class="mw-redirect" title="Intercostal muscle">intercostal muscles</a> of the <a href="/wiki/Rib_cage" title="Rib cage">rib cage</a> that support breathing weaken, measures of <a href="/wiki/Spirometry" title="Spirometry">lung function</a> such as <a href="/wiki/Vital_capacity" title="Vital capacity">vital capacity</a> and inspiratory pressure diminish. In respiratory-onset ALS, this may occur before significant limb weakness is apparent. Individuals affected by the disorder may ultimately lose the ability to initiate and control all voluntary movement,<sup id="cite_ref-Support2016_5-3" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> known as <a href="/wiki/Locked-in_syndrome" title="Locked-in syndrome">locked-in syndrome</a>. Bladder and bowel function is usually spared, meaning <a href="/wiki/Urinary_incontinence" title="Urinary incontinence">urinary</a> and <a href="/wiki/Fecal_incontinence" title="Fecal incontinence">fecal incontinence</a> is uncommon, although trouble getting to the toilet can lead to difficulties. The <a href="/wiki/Extraocular_muscles" title="Extraocular muscles">extraocular muscles</a> responsible for eye movement are usually spared,<sup id="cite_ref-43" class="reference"><a href="#cite_note-43">&#91;43&#93;</a></sup> meaning that the use of <a href="/wiki/Eye_tracking" title="Eye tracking">eye tracking</a> technology to support <a href="/wiki/Augmentative_and_alternative_communication" title="Augmentative and alternative communication">augmentative communication</a> is often feasible, albeit slow, and needs may change over time.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">&#91;44&#93;</a></sup> Despite these challenges, many people in an advanced state of disease report satisfactory wellbeing and quality of life.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">&#91;45&#93;</a></sup>
</p>
<h3><span id="Prognosis.2C_staging.2C_and_survival"></span><span class="mw-headline" id="Prognosis,_staging,_and_survival">Prognosis, staging, and survival</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=9" title="Edit section: Prognosis, staging, and survival">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Although respiratory support using <a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">non-invasive ventilation</a> can ease problems with breathing and prolong survival,<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">&#91;46&#93;</a></sup> it does not affect the progression rate of ALS. Most people with ALS die between two and four years after the diagnosis.<sup id="cite_ref-Support2016_5-4" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> Around 50% of people with ALS die within 30 months of their symptoms beginning, about 20% live between five and ten years,<sup id="cite_ref-Lancet2011_13-5" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup> and about 10% survive for 10 years or longer.<sup id="cite_ref-Pupillo-2014_18-1" class="reference"><a href="#cite_note-Pupillo-2014-18">&#91;18&#93;</a></sup>
</p><p>The most common cause of death among people with ALS is <a href="/wiki/Respiratory_failure" title="Respiratory failure">respiratory failure</a>, often accelerated by <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>.<sup id="cite_ref-Lancet2011_13-6" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup> Most ALS patients die at home after a period of worsening difficulty breathing, a decline in their nutritional status, or a rapid worsening of symptoms.<sup id="cite_ref-Bede-2011_47-0" class="reference"><a href="#cite_note-Bede-2011-47">&#91;47&#93;</a></sup> Sudden death or acute respiratory distress are uncommon.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48">&#91;48&#93;</a></sup> Access to <a href="/wiki/Palliative_care" title="Palliative care">palliative care</a> is recommended from an early stage to explore options, ensure psychosocial support for the patient and caregivers, and to discuss <a href="/wiki/Advance_healthcare_directive" title="Advance healthcare directive">advance healthcare directives</a>.<sup id="cite_ref-Bede-2011_47-1" class="reference"><a href="#cite_note-Bede-2011-47">&#91;47&#93;</a></sup>
</p><p>As with <a href="/wiki/Cancer_staging" title="Cancer staging">cancer staging</a>, ALS has staging systems numbered between 1 and 4 that are used for research purposes in clinical trials.<sup id="cite_ref-Goutman_480–493_6-3" class="reference"><a href="#cite_note-Goutman_480–493-6">&#91;6&#93;</a></sup> Two very similar staging systems emerged around a similar time, the King's staging system and Milano-Torino (MiToS) functional staging.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49">&#91;49&#93;</a></sup> 
</p>
<table class="wikitable">
<caption style="text-align: left;">Comparison of Kings and MiToS ALS staging systems and prognosis at each stage <sup id="cite_ref-Goutman_480–493_6-4" class="reference"><a href="#cite_note-Goutman_480–493-6">&#91;6&#93;</a></sup>
</caption>
<tbody><tr>
<th>
</th>
<th>Stage 0
</th>
<th>Stage 1
</th>
<th>Stage 2
</th>
<th>Stage 3
</th>
<th>Stage 4
</th>
<th>Stage 5
</th></tr>
<tr>
<td>King's Staging System
</td>
<td>Not used
</td>
<td>Symptom onset, involvement of the first region
</td>
<td>2A: Diagnosis
<p>2B: Involvement of the second region
</p>
</td>
<td>Involvement of the third region
</td>
<td>4A: Need for a feeding tube
<p>4B: Need for non-invasive ventilation
</p>
</td>
<td>Not used
</td></tr>
<tr>
<td>Median time to King's stage
</td>
<td>N/A
</td>
<td>13.5 months
</td>
<td>17.7 months
</td>
<td>23.3 months
</td>
<td>4A: 17.7 months
<p>4B: 30.3 months
</p>
</td>
<td>N/A
</td></tr>
<tr>
<td>ALS-MiToS Staging System
</td>
<td>No loss of a functional domain
</td>
<td>Loss of 1 domain
</td>
<td>Loss of 2 domains
</td>
<td>Loss of 3 domains
</td>
<td>Loss of 4 domains
</td>
<td>Death
</td></tr>
<tr>
<td>Probability of death at each MiToS stage
</td>
<td>7%
</td>
<td>26%
</td>
<td>33%
</td>
<td>33%
</td>
<td>86%
</td>
<td>
</td></tr></tbody></table>
<p>Providing individual patients with a precise prognosis is not currently possible, though research is underway to provide statistical models on the basis of prognostic factors including age at onset, progression rate, site of onset, and presence of <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">frontotemporal dementia</a>.<sup id="cite_ref-Goutman_480–493_6-5" class="reference"><a href="#cite_note-Goutman_480–493-6">&#91;6&#93;</a></sup> Those with a bulbar onset have a worse prognosis than limb-onset ALS; a population-based study found that bulbar-onset ALS patients had a median survival of 2.0 years and a 10-year survival rate of 3%, while limb-onset ALS patients had a median survival of 2.6 years and a 10-year survival rate of 13%.<sup id="cite_ref-JNNP_July_2011_50-0" class="reference"><a href="#cite_note-JNNP_July_2011-50">&#91;50&#93;</a></sup> Those with respiratory-onset ALS had a shorter median survival of 1.4 years and 0% survival at 10 years.<sup id="cite_ref-JNNP_July_2011_50-1" class="reference"><a href="#cite_note-JNNP_July_2011-50">&#91;50&#93;</a></sup> While <a href="/wiki/Astrophysics" title="Astrophysics">astrophysicist</a> <a href="/wiki/Stephen_Hawking" title="Stephen Hawking">Stephen Hawking</a> lived for 55 more years following his diagnosis, his was an unusual case.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51">&#91;51&#93;</a></sup>
</p>
<h3><span id="Cognitive.2C_emotional.2C_and_behavioral_symptoms"></span><span class="mw-headline" id="Cognitive,_emotional,_and_behavioral_symptoms">Cognitive, emotional, and behavioral symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=10" title="Edit section: Cognitive, emotional, and behavioral symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Cognitive_disorder" title="Cognitive disorder">Cognitive impairment</a> or behavioral dysfunction is present in 30–50% of individuals with ALS,<sup id="cite_ref-Martin2017_52-0" class="reference"><a href="#cite_note-Martin2017-52">&#91;52&#93;</a></sup> and can appear more frequently in later stages of the disease.<sup id="cite_ref-Crockford-2018_53-0" class="reference"><a href="#cite_note-Crockford-2018-53">&#91;53&#93;</a></sup> <a href="/wiki/Language_disorder" title="Language disorder">Language dysfunction</a>, <a href="/wiki/Executive_dysfunction" title="Executive dysfunction">executive dysfunction</a>, and troubles with <a href="/wiki/Social_cognition" title="Social cognition">social cognition</a> and <a href="/wiki/Verbal_memory" title="Verbal memory">verbal memory</a> are the most commonly reported cognitive symptoms in ALS.<sup id="cite_ref-Crockford-2018_53-1" class="reference"><a href="#cite_note-Crockford-2018-53">&#91;53&#93;</a></sup>  Cognitive impairment is found more frequently in patients with C9orf72 gene repeat expansions, bulbar onset, bulbar symptoms, family history of ALS, and/or a predominantly upper motor neuron phenotype.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">&#91;54&#93;</a></sup>  
</p><p><a href="/wiki/Pseudobulbar_affect" title="Pseudobulbar affect">Emotional lability</a> is a symptom in which patients cry, smile, yawn, or laugh, either in the absence of emotional stimuli, or when they are feeling the opposite emotion to that being expressed;<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">&#91;55&#93;</a></sup> it is experienced by about half of ALS patients and is more common in those with bulbar-onset ALS.<sup id="cite_ref-Support2016_5-5" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> While relatively benign relative to other symptoms, it can cause increased stigma and social isolation as people around the patient struggle to react appropriately to what can be frequent and inappropriate outbursts in public.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup>
</p><p>In addition to mild changes in cognition that may only emerge during neuropsychological testing, around 10–15% of individuals have signs of <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">frontotemporal dementia</a> (FTD).<sup id="cite_ref-Support2016_5-6" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> <a href="/wiki/Perseveration" title="Perseveration">Repeating phrases or gestures</a>, apathy, and <a href="/wiki/Disinhibition" title="Disinhibition">loss of inhibition</a> are the most frequently reported behavioral features of ALS.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57">&#91;57&#93;</a></sup> ALS and <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">frontotemporal dementia</a> (FTD) are now considered to be part of a common disease spectrum (ALS–FTD) because of genetic, clinical, and pathological similarities.<sup id="cite_ref-ALS-FTD_58-0" class="reference"><a href="#cite_note-ALS-FTD-58">&#91;58&#93;</a></sup> Genetically, repeat expansions in the C9orf72 gene account for about 40% of genetic ALS and 25% of genetic FTD.<sup id="cite_ref-Neuroscience2014_59-0" class="reference"><a href="#cite_note-Neuroscience2014-59">&#91;59&#93;</a></sup> 
</p><p>Cognitive and behavioral issues are associated with poorer prognosis as they may reduce adherence to medical advice, as well as increased caregiver burden due to deficits in empathy and social cognition.<sup id="cite_ref-2016cog_60-0" class="reference"><a href="#cite_note-2016cog-60">&#91;60&#93;</a></sup> 
</p>
<h2><span class="mw-headline" id="Cause">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=11" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Nobody knows what causes ALS, hence it is described as an <a href="/wiki/Idiopathic_disease" title="Idiopathic disease">idiopathic disease</a>.<sup id="cite_ref-Lancet2011_13-7" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup> Though its exact cause is unknown, genetic and environmental factors are thought to be of roughly equal importance.<sup id="cite_ref-Wingo2011_12-1" class="reference"><a href="#cite_note-Wingo2011-12">&#91;12&#93;</a></sup> The genetic factors are better understood than the environmental factors; no specific environmental factor has been definitively shown to cause ALS. A multi-step <a href="/wiki/Liability_threshold_model" class="mw-redirect" title="Liability threshold model">liability threshold model</a> for ALS proposes that cellular damage accumulates over time due to genetic factors present at birth and exposure to environmental risks throughout life.<sup id="cite_ref-Conspiracy_61-0" class="reference"><a href="#cite_note-Conspiracy-61">&#91;61&#93;</a></sup> ALS can strike at any age, but its likelihood increases with age.<sup id="cite_ref-Mayo_Clinic_62-0" class="reference"><a href="#cite_note-Mayo_Clinic-62">&#91;62&#93;</a></sup> Most people who develop ALS are between the ages of 40 and 70, with an average age of 55 at the time of diagnosis.<sup id="cite_ref-auto_63-0" class="reference"><a href="#cite_note-auto-63">&#91;63&#93;</a></sup> ALS is 20% more common in men than women,<sup id="cite_ref-auto_63-1" class="reference"><a href="#cite_note-auto-63">&#91;63&#93;</a></sup> but this difference in sex distribution is no longer present in patients with onset after age 70.<sup id="cite_ref-Mayo_Clinic_62-1" class="reference"><a href="#cite_note-Mayo_Clinic-62">&#91;62&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Genetics_and_genetic_testing">Genetics and genetic testing</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=12" title="Edit section: Genetics and genetic testing">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Genetics_of_amyotrophic_lateral_sclerosis" title="Genetics of amyotrophic lateral sclerosis">Genetics of amyotrophic lateral sclerosis</a></div>
<p>While they appear identical clinically and pathologically,<sup id="cite_ref-The_Neuroscientist_2015_64-0" class="reference"><a href="#cite_note-The_Neuroscientist_2015-64">&#91;64&#93;</a></sup> ALS can be classified as being either genetic or sporadic, depending on whether there is a known family history of disease and/or whether an ALS-associated genetic mutation has been identified via genetic testing.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">&#91;65&#93;</a></sup> Genetic ALS is thought to account for 10-15% of cases overall and can include <a href="/wiki/Monogenic_(genetics)" class="mw-redirect" title="Monogenic (genetics)">monogenic</a>, <a href="/wiki/Oligogenic_inheritance" title="Oligogenic inheritance">oligogenic</a>, and <a href="/wiki/Polygenic_inheritance" class="mw-redirect" title="Polygenic inheritance">polygenic</a> modes of inheritance.<sup id="cite_ref-Goutman-2022_66-0" class="reference"><a href="#cite_note-Goutman-2022-66">&#91;66&#93;</a></sup>
</p><p>There is considerable variation among clinicians on how to approach genetic testing in ALS, and only about half discuss the possibility of genetic inheritance with their patients, particularly if there is no discernible family history of the disease.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67">&#91;67&#93;</a></sup> Historically, genetic ALS was most commonly referred to as "familial" ALS and genetic counseling and testing only offered to those with a family history, though again there was a lack of consensus in the field as to what constituted a positive finding.<sup id="cite_ref-Goutman-2022_66-1" class="reference"><a href="#cite_note-Goutman-2022-66">&#91;66&#93;</a></sup>
</p><p>It is increasingly recognized that some people once thought to have sporadic ALS may in fact carry disease-causing mutations such as <a href="/wiki/SOD1" title="SOD1">SOD1</a> or <a href="/wiki/C9orf72" title="C9orf72">C9orf72</a>, due either to <a href="/wiki/De_novo_mutation" title="De novo mutation">de novo mutations</a>,<sup id="cite_ref-68" class="reference"><a href="#cite_note-68">&#91;68&#93;</a></sup> an incomplete family history, or incomplete <a href="/wiki/Penetrance" title="Penetrance">penetrance</a>, meaning that a patient's ancestors carried the gene but did not express the disease in their lifetimes.<sup id="cite_ref-Goutman-2022_66-2" class="reference"><a href="#cite_note-Goutman-2022-66">&#91;66&#93;</a></sup> The lack of positive family history may be caused by lack of historical records, having a smaller family, older generations dying earlier of causes other than ALS, genetic <a href="/wiki/Non-paternity_event" title="Non-paternity event">non-paternity</a>, and uncertainty over whether certain neuropsychiatric conditions (e.g. <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">frontotemporal dementia</a>, other forms of <a href="/wiki/Dementia" title="Dementia">dementia</a>, suicide, psychosis, <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>) should be considered significant when determining a family history.<sup id="cite_ref-Goutman-2022_66-3" class="reference"><a href="#cite_note-Goutman-2022-66">&#91;66&#93;</a></sup> There have been calls in the research community to routinely counsel and test all diagnosed ALS patients for genetic ALS,<sup id="cite_ref-69" class="reference"><a href="#cite_note-69">&#91;69&#93;</a></sup> particularly as there is now a licensed gene therapy (<a href="/wiki/Tofersen" title="Tofersen">tofersen</a>) specifically targeted to carriers of SOD-1 ALS. A shortage of genetic counselors and limited clinical capacity to see such at-risk individuals makes this challenging in practice, as does the unequal access to genetic testing around the world.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70">&#91;70&#93;</a></sup>
</p><p>More than 40 genes have been associated with genetic ALS, of which four account for nearly half of genetic cases and around 5% of sporadic cases:<sup id="cite_ref-Goutman-2022_66-4" class="reference"><a href="#cite_note-Goutman-2022-66">&#91;66&#93;</a></sup> <i><a href="/wiki/C9orf72" title="C9orf72">C9orf72</a></i> (40% of genetic cases, 7% sporadic), <i><a href="/wiki/SOD1" title="SOD1">SOD1</a></i> (12% of genetic cases, 1-2% sporadic), <i><a href="/wiki/FUS_(gene)" class="mw-redirect" title="FUS (gene)">FUS</a></i> (4% of genetic cases, 1% sporadic), and <i><a href="/wiki/TARDBP" class="mw-redirect" title="TARDBP">TARDBP</a></i> (4% of genetic cases, 1% sporadic), with the remaining genes mostly accounting for fewer than 1% of genetic or sporadic cases.<sup id="cite_ref-Goutman-2022_66-5" class="reference"><a href="#cite_note-Goutman-2022-66">&#91;66&#93;</a></sup> ALS genes identified to date explain the cause of about 70% of genetic ALS and about 15% of sporadic ALS.<sup id="cite_ref-Goutman-2022_66-6" class="reference"><a href="#cite_note-Goutman-2022-66">&#91;66&#93;</a></sup> Overall, first-degree relatives of an individual with ALS have a ~1% risk of developing ALS themselves.<sup id="cite_ref-Goutman-2022_66-7" class="reference"><a href="#cite_note-Goutman-2022-66">&#91;66&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Environmental_and_other_factors">Environmental and other factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=13" title="Edit section: Environmental and other factors">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The multi-step hypothesis suggests the disease is caused by some interaction between an individual's genetic risk factors and their cumulative lifetime of exposures to environmental factors.<sup id="cite_ref-71" class="reference"><a href="#cite_note-71">&#91;71&#93;</a></sup> The most consistent lifetime exposures associated with developing ALS (other than genetic mutations) include heavy metals (e.g. <a href="/wiki/Lead" title="Lead">lead</a> and <a href="/wiki/Mercury_(element)" title="Mercury (element)">mercury</a>), organic chemicals (e.g. <a href="/wiki/Pesticide" title="Pesticide">pesticides</a> and <a href="/wiki/Solvent" title="Solvent">solvents</a>), <a href="/wiki/Electrical_injury" title="Electrical injury">electric shock</a>, <a href="/wiki/Injury" title="Injury">physical injury</a> (including <a href="/wiki/Head_injury" title="Head injury">head injury</a>), and <a href="/wiki/Smoking" title="Smoking">smoking</a> (in men more than women).<sup id="cite_ref-:0_72-0" class="reference"><a href="#cite_note-:0-72">&#91;72&#93;</a></sup> Overall these effects are small, with each exposure in isolation only increasing the likelihood of a very rare condition by a small amount. For instance an individual's lifetime risk of developing ALS might go from "1 in 400" without an exposure to between "1 in 300" and "1 in 200" if they were exposed to heavy metals. A range of other exposures have weaker evidence supporting them and include participation in <a href="/wiki/Professional_sports" title="Professional sports">professional sports</a>, having a lower <a href="/wiki/Body_mass_index" title="Body mass index">body mass index</a>, lower <a href="/wiki/Educational_attainment" title="Educational attainment">educational attainment</a>, manual occupations, military service, exposure to <a href="/wiki/Beta-Methylamino-L-alanine" title="Beta-Methylamino-L-alanine">Beta-N-methylamino-L-alanin</a> (BMAA), and viral infections.<sup id="cite_ref-:0_72-1" class="reference"><a href="#cite_note-:0-72">&#91;72&#93;</a></sup>
</p><p>Some personality traits such as <a href="/wiki/Agreeableness" title="Agreeableness">agreeableness</a> and <a href="/wiki/Conscientiousness" title="Conscientiousness">conscientiousness</a> might underlie lifestyle choices that are currently thought to be risk factors for ALS.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73">&#91;73&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=14" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Neuropathology">Neuropathology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=15" title="Edit section: Neuropathology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Upon examination at autopsy, features of the disease that can be <a href="/wiki/Gross_pathology" title="Gross pathology">seen with the naked eye</a> include skeletal muscle atrophy, motor cortex atrophy, sclerosis of the <a href="/wiki/Corticospinal_tract" title="Corticospinal tract">corticospinal</a> and <a href="/wiki/Corticobulbar_tract" title="Corticobulbar tract">corticobulbar tracts</a>, thinning of the <a href="/wiki/Hypoglossal_nerve" title="Hypoglossal nerve">hypoglossal nerves</a> (which control the tongue), and thinning of the <a href="/wiki/Anterior_roots" class="mw-redirect" title="Anterior roots">anterior roots</a> of the spinal cord.<sup id="cite_ref-Nature2017_9-2" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> Aside from the death of motor neurons, two other characteristics common to most ALS variants are focal initial pathology, meaning that symptoms start in a single spinal cord region, and progressive continuous spread, meaning that symptoms spread to additional regions over time.
</p><p>The defining feature of ALS is the death of both upper motor neurons (located in the <a href="/wiki/Motor_cortex" title="Motor cortex">motor cortex</a> of the brain) and lower motor neurons (located in the brainstem and spinal cord).<sup id="cite_ref-74" class="reference"><a href="#cite_note-74">&#91;74&#93;</a></sup> In ALS with frontotemporal dementia, neurons throughout the frontal and temporal lobes of the brain die as well.<sup id="cite_ref-NEJM_2017_75-0" class="reference"><a href="#cite_note-NEJM_2017-75">&#91;75&#93;</a></sup> The pathological hallmark of ALS is the presence of <a href="/wiki/Inclusion_bodies" title="Inclusion bodies">inclusion bodies</a> (abnormal aggregations of protein) known as Bunina bodies in the cytoplasm of motor neurons. In about 97% of people with ALS, the main component of the inclusion bodies is <a href="/wiki/TDP-43" class="mw-redirect" title="TDP-43">TDP-43</a> protein;<sup id="cite_ref-Nature2017_9-3" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> however, in those with <i>SOD1</i> or <i>FUS</i> mutations, the main component of the inclusion bodies<sup id="cite_ref-Okamoto_76-0" class="reference"><a href="#cite_note-Okamoto-76">&#91;76&#93;</a></sup><sup id="cite_ref-White_77-0" class="reference"><a href="#cite_note-White-77">&#91;77&#93;</a></sup> is SOD1 protein or FUS protein, respectively.<sup id="cite_ref-Cold_Spring_Harbor_2017_22-7" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-22">&#91;22&#93;</a></sup>  <a href="/wiki/Prion" title="Prion">Prion</a>-like propagation of misfolded proteins from cell to cell may explain why ALS starts in one area and spreads to others.<sup id="cite_ref-Cold_Spring_Harbor_2017_22-8" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-22">&#91;22&#93;</a></sup> The <a href="/wiki/Glymphatic_system" title="Glymphatic system">glymphatic system</a> may also be involved in the <a href="/wiki/Pathogenesis" title="Pathogenesis">pathogenesis</a> of ALS.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">&#91;78&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Biochemistry">Biochemistry</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=16" title="Edit section: Biochemistry">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/7/76/ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg/290px-ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg" decoding="async" width="290" height="353" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/76/ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg/435px-ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/76/ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg/580px-ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg 2x" data-file-width="1052" data-file-height="1280" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg" class="internal" title="Enlarge"></a></div>This figure shows ten proposed disease mechanisms for ALS and the genes associated with them.<sup id="cite_ref-Modelling_ALS_79-0" class="reference"><a href="#cite_note-Modelling_ALS-79">&#91;79&#93;</a></sup></div></div></div>
<p>It is still not fully understood why neurons die in ALS, but this <a href="/wiki/Neurodegeneration" class="mw-redirect" title="Neurodegeneration">neurodegeneration</a> is thought to involve many different cellular and molecular processes.<sup id="cite_ref-Lancet2017_10-7" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> The genes known to be involved in ALS can be grouped into three general categories based on their normal function: protein degradation, the <a href="/wiki/Cytoskeleton" title="Cytoskeleton">cytoskeleton</a>, and RNA processing. Mutant SOD1 protein forms intracellular aggregations that inhibit protein degradation. Cytoplasmic aggregations of <a href="/wiki/Wild-type" class="mw-redirect" title="Wild-type">wild-type</a> (normal) SOD1 protein are common in sporadic ALS.<sup id="cite_ref-NEJM_2017_75-1" class="reference"><a href="#cite_note-NEJM_2017-75">&#91;75&#93;</a></sup> It is thought that misfolded mutant SOD1 can cause misfolding and aggregation of wild-type SOD1 in neighboring neurons in a prion-like manner.<sup id="cite_ref-Nature2017_9-4" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> Other protein degradation genes that can cause ALS when mutated include <i><a href="/wiki/Valosin-containing_protein" title="Valosin-containing protein">VCP</a></i>, <i><a href="/wiki/Optineurin" title="Optineurin">OPTN</a></i>, <i>TBK1</i>, and <i>SQSTM1</i>. Three genes implicated in ALS that are important for maintaining the cytoskeleton<sup id="cite_ref-NEJM_2017_75-2" class="reference"><a href="#cite_note-NEJM_2017-75">&#91;75&#93;</a></sup> and for axonal transport<sup id="cite_ref-Nature2017_9-5" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> include <i><a href="/wiki/DCTN1" title="DCTN1">DCTN1</a></i>, <i><a href="/wiki/PFN1" class="mw-redirect" title="PFN1">PFN1</a></i>, and <i><a href="/wiki/TUBA4A" title="TUBA4A">TUBA4A</a></i>.<sup id="cite_ref-NEJM_2017_75-3" class="reference"><a href="#cite_note-NEJM_2017-75">&#91;75&#93;</a></sup>
</p><p>There are a number of ALS genes that encode for RNA-binding proteins. The first to be discovered was TDP-43 protein,<sup id="cite_ref-NEJM_2017_75-4" class="reference"><a href="#cite_note-NEJM_2017-75">&#91;75&#93;</a></sup> a nuclear protein that aggregates in the cytoplasm of motor neurons in almost all cases of ALS; however, mutations in <i>TARDBP</i>, the gene that codes for TDP-43, are a rare cause of ALS.<sup id="cite_ref-Nature2017_9-6" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> <i>FUS</i> codes for FUS, another RNA-binding protein with a similar function to TDP-43, which can cause ALS when mutated.<sup id="cite_ref-Neuroscience2014_59-1" class="reference"><a href="#cite_note-Neuroscience2014-59">&#91;59&#93;</a></sup> It is thought that mutations in <i>TARDBP</i> and <i>FUS</i> increase the binding affinity of the low-complexity domain, causing their respective proteins to aggregate in the cytoplasm. Once these mutant RNA-binding proteins are misfolded and aggregated, they may be able to misfold normal proteins both within and between cells in a prion-like manner.<sup id="cite_ref-NEJM_2017_75-5" class="reference"><a href="#cite_note-NEJM_2017-75">&#91;75&#93;</a></sup> This also leads to decreased levels of RNA-binding protein in the nucleus, which may mean that their target RNA transcripts do not undergo normal processing. Other RNA metabolism genes associated with ALS include <i><a href="/wiki/Angiogenin" title="Angiogenin">ANG</a></i>, <i><a href="/wiki/SETX" title="SETX">SETX</a></i>, and <i><a href="/wiki/MATR3" title="MATR3">MATR3</a></i>.<sup id="cite_ref-Nature2017_9-7" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup>
</p><p><i>C9orf72</i> is the most commonly mutated gene in ALS and causes motor neuron death through a number of mechanisms.<sup id="cite_ref-NEJM_2017_75-6" class="reference"><a href="#cite_note-NEJM_2017-75">&#91;75&#93;</a></sup> The pathogenic mutation is a hexanucleotide repeat expansion (a series of six nucleotides repeated over and over);<sup id="cite_ref-Trends_in_Genetics_2018_80-0" class="reference"><a href="#cite_note-Trends_in_Genetics_2018-80">&#91;80&#93;</a></sup> people with up to 30 repeats are considered normal, while people with hundreds or thousands of repeats can have familial ALS, frontotemporal dementia, or sometimes sporadic ALS. The three mechanisms of disease associated with these <i>C9orf72</i> repeats are deposition of RNA transcripts in the nucleus, translation of the RNA into toxic dipeptide repeat proteins in the cytoplasm, and decreased levels of the normal C9orf72 protein.<sup id="cite_ref-NEJM_2017_75-7" class="reference"><a href="#cite_note-NEJM_2017-75">&#91;75&#93;</a></sup> Mitochondrial bioenergetic dysfunction leading to dysfunctional motor neuron axonal homeostasis (reduced axonal length and fast axonal transport of mitochondrial cargo) has been shown to occur in <i>C9orf72</i>-ALS using human <a href="/wiki/Induced_pluripotent_stem_cells" class="mw-redirect" title="Induced pluripotent stem cells">induced pluripotent stem cell</a> (iPSC) technologies coupled with <a href="/wiki/CRISPR/Cas9-mediated_genome_editing" class="mw-redirect" title="CRISPR/Cas9-mediated genome editing">CRISPR/Cas9</a> gene-editing, and human post-mortem spinal cord tissue examination.<sup id="cite_ref-link.springer.com_81-0" class="reference"><a href="#cite_note-link.springer.com-81">&#91;81&#93;</a></sup>
</p><p><a href="/wiki/Excitotoxicity" title="Excitotoxicity">Excitotoxicity</a>, or nerve cell death caused by high levels of intracellular calcium due to excessive stimulation by the excitatory <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> <a href="/wiki/Glutamate" class="mw-redirect" title="Glutamate">glutamate</a>, is a mechanism thought to be common to all forms of ALS. Motor neurons are more sensitive to excitotoxicity than other types of neurons because they have a lower calcium-buffering capacity and a type of glutamate receptor (the <a href="/wiki/AMPA_receptor" title="AMPA receptor">AMPA receptor</a>) that is more permeable to calcium. In ALS, there are decreased levels of excitatory amino acid transporter 2 (<a href="/wiki/EAAT2" class="mw-redirect" title="EAAT2">EAAT2</a>), which is the main transporter that removes glutamate from the synapse; this leads to increased synaptic glutamate levels and excitotoxicity. <a href="/wiki/Riluzole" title="Riluzole">Riluzole</a>, a drug that modestly prolongs survival in ALS, inhibits glutamate release from pre-synaptic neurons; however, it is unclear if this mechanism is responsible for its therapeutic effect.<sup id="cite_ref-Nature2017_9-8" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=17" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:ALS_cross.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6d/ALS_cross.jpg/290px-ALS_cross.jpg" decoding="async" width="290" height="382" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6d/ALS_cross.jpg/435px-ALS_cross.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6d/ALS_cross.jpg/580px-ALS_cross.jpg 2x" data-file-width="713" data-file-height="938" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ALS_cross.jpg" class="internal" title="Enlarge"></a></div>An <a href="/wiki/MRI_of_the_brain" class="mw-redirect" title="MRI of the brain">MRI of the brain</a> (axial <a href="/wiki/Fluid-attenuated_inversion_recovery" title="Fluid-attenuated inversion recovery">FLAIR</a>) looking at a person as if from above that shows increased <a href="/wiki/Spin-spin_relaxation" class="mw-redirect" title="Spin-spin relaxation"><i>T<sub>2</sub></i></a> signal as a small white region within the <a href="/wiki/Internal_capsule#Posterior_limb" title="Internal capsule">posterior part of the internal capsule</a> around the center of the image, consistent with the diagnosis of ALS</div></div></div><p>
No single test can provide a definite diagnosis of ALS.<sup id="cite_ref-NINDS2020_3-12" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> Instead, the diagnosis of ALS is primarily based on the symptoms and signs the <a href="/wiki/Physician" title="Physician">physician</a> observes in the person and a series of tests to rule out other diseases.<sup id="cite_ref-NINDS2020_3-13" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> Physicians obtain the person's full <a href="/wiki/Medical_history" title="Medical history">medical history</a> and usually conduct a neurologic examination at regular intervals to assess whether signs and symptoms such as muscle weakness, atrophy of muscles, <a href="/wiki/Hyperreflexia" title="Hyperreflexia">hyperreflexia</a>, <a href="/wiki/Plantar_reflex" title="Plantar reflex">Babinski's sign</a>, and spasticity are worsening.<sup id="cite_ref-NINDS2020_3-14" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> A number of biomarkers are being studied for the condition, but so far are not in general medical use.<sup id="cite_ref-82" class="reference"><a href="#cite_note-82">&#91;82&#93;</a></sup></p><div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:ALS_Coronal.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/7/75/ALS_Coronal.jpg/220px-ALS_Coronal.jpg" decoding="async" width="220" height="224" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/75/ALS_Coronal.jpg/330px-ALS_Coronal.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/75/ALS_Coronal.jpg/440px-ALS_Coronal.jpg 2x" data-file-width="920" data-file-height="938" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ALS_Coronal.jpg" class="internal" title="Enlarge"></a></div>An <a href="/wiki/MRI_of_the_brain" class="mw-redirect" title="MRI of the brain">MRI of the brain</a> looking at a person from side-on that shows <a href="/wiki/T2-weighted" class="mw-redirect" title="T2-weighted">increased T2 signal</a> as a white region in the posterior part of the <a href="/wiki/Internal_capsule" title="Internal capsule">internal capsule</a> that can be tracked to the <a href="/wiki/Motor_cortex" title="Motor cortex">motor cortex</a>, consistent with the diagnosis of ALS</div></div></div>
<h3><span class="mw-headline" id="Differential_diagnosis">Differential diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=18" title="Edit section: Differential diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Because symptoms of ALS can be similar to those of a wide variety of other, more treatable diseases or disorders, appropriate tests must be conducted to exclude the possibility of other conditions. One of these tests is <a href="/wiki/Electromyography" title="Electromyography">electromyography</a> (EMG), a special recording technique that detects electrical activity in muscles. Certain EMG findings can support the diagnosis of ALS. Another common test measures <a href="/wiki/Nerve_conduction_velocity" title="Nerve conduction velocity">nerve conduction velocity</a> (NCV). Specific abnormalities in the NCV results may suggest, for example, that the person has a form of <a href="/wiki/Peripheral_neuropathy" title="Peripheral neuropathy">peripheral neuropathy</a> (damage to peripheral nerves) or <a href="/wiki/Myopathy" title="Myopathy">myopathy</a> (muscle disease) rather than ALS. While a <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> (MRI) is often normal in people with early-stage ALS, it can reveal evidence of other problems that may be causing the symptoms, such as a spinal cord tumor, <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>, a <a href="/wiki/Herniated_disc" class="mw-redirect" title="Herniated disc">herniated disc</a> in the neck, <a href="/wiki/Syringomyelia" title="Syringomyelia">syringomyelia</a>, or cervical <a href="/wiki/Spondylosis" title="Spondylosis">spondylosis</a>.<sup id="cite_ref-NINDS2020_3-15" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup><sup id="cite_ref-83" class="reference"><a href="#cite_note-83">&#91;83&#93;</a></sup>
</p><p>Based on the person's symptoms and findings from the examination and from these tests, the physician may order tests on blood and <a href="/wiki/Urine" title="Urine">urine</a> samples to eliminate the possibility of other diseases, as well as routine laboratory tests. In some cases, for example, if a physician suspects the person may have a myopathy rather than ALS, a muscle biopsy may be performed.<sup id="cite_ref-NINDS2020_3-16" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup>
</p><p>A number of infectious diseases can sometimes cause ALS-like symptoms,<sup id="cite_ref-NINDS2020_3-17" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup> including human immunodeficiency virus (<a href="/wiki/HIV" title="HIV">HIV</a>), <a href="/wiki/Human_T-lymphotropic_virus" class="mw-redirect" title="Human T-lymphotropic virus">human T-lymphotropic virus</a> (HTLV), <a href="/wiki/Lyme_disease" title="Lyme disease">Lyme disease</a>, and <a href="/wiki/Syphilis" title="Syphilis">syphilis</a>.<sup id="cite_ref-Lancet2017_10-8" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> Neurological disorders such as multiple sclerosis, <a href="/wiki/Post-polio_syndrome" title="Post-polio syndrome">post-polio syndrome</a>, <a href="/wiki/Multifocal_motor_neuropathy" title="Multifocal motor neuropathy">multifocal motor neuropathy</a>, <a href="/wiki/Chronic_inflammatory_demyelinating_polyneuropathy" title="Chronic inflammatory demyelinating polyneuropathy">CIDP</a>, <a href="/wiki/Spinal_muscular_atrophy" title="Spinal muscular atrophy">spinal muscular atrophy</a>, and <a href="/wiki/Spinal_and_bulbar_muscular_atrophy" title="Spinal and bulbar muscular atrophy">spinal and bulbar muscular atrophy</a> can also mimic certain aspects of the disease and should be considered.<sup id="cite_ref-NINDS2020_3-18" class="reference"><a href="#cite_note-NINDS2020-3">&#91;3&#93;</a></sup>
</p><p>ALS must be differentiated from the "ALS mimic syndromes", which are unrelated disorders that may have a similar presentation and clinical features to ALS or its variants.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84">&#91;84&#93;</a></sup> Because the prognosis of ALS and closely related subtypes of motor neuron disease are generally poor, neurologists may carry out investigations to evaluate and exclude other diagnostic possibilities. Disorders of the <a href="/wiki/Neuromuscular_junction" title="Neuromuscular junction">neuromuscular junction</a>, such as <a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">myasthenia gravis</a> (MG) and <a href="/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome" title="Lambert–Eaton myasthenic syndrome">Lambert–Eaton myasthenic syndrome</a>, may also mimic ALS, although this rarely presents diagnostic difficulty over time.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85">&#91;85&#93;</a></sup><sup id="cite_ref-86" class="reference"><a href="#cite_note-86">&#91;86&#93;</a></sup> <a href="/wiki/Benign_fasciculation_syndrome" title="Benign fasciculation syndrome">Benign fasciculation syndrome</a> and <a href="/wiki/Cramp_fasciculation_syndrome" title="Cramp fasciculation syndrome">cramp fasciculation syndrome</a> may also, occasionally, mimic some of the early symptoms of ALS. Nonetheless, the absence of other neurological features that develop inexorably with ALS means that, over time, the distinction will not present any difficulty to the experienced neurologist; where doubt remains, EMG may be helpful.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87">&#91;87&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=19" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is no cure for ALS.<sup id="cite_ref-Lancet2017_10-9" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> Management focuses on treating symptoms and providing supportive care, with the goal of improving quality of life and prolonging survival.<sup id="cite_ref-Lancet2017_10-10" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> This care is best provided by multidisciplinary teams of healthcare professionals; attending a multidisciplinary ALS clinic is associated with longer survival, fewer hospitalizations, and improved quality of life.<sup id="cite_ref-Support2016_5-7" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> Riluzole prolongs survival by about 2–3 months.<sup id="cite_ref-CD001447_14-1" class="reference"><a href="#cite_note-CD001447-14">&#91;14&#93;</a></sup> <a href="/wiki/Edaravone" title="Edaravone">Edaravone</a> slows functional decline slightly in a small number of people with ALS;<sup id="cite_ref-Edaravone_Trial_88-0" class="reference"><a href="#cite_note-Edaravone_Trial-88">&#91;88&#93;</a></sup> it is expensive and must be administered by daily IV infusions that may decrease quality of life.<sup id="cite_ref-Eda2018_89-0" class="reference"><a href="#cite_note-Eda2018-89">&#91;89&#93;</a></sup> Other medications may be used to manage other symptoms.<sup id="cite_ref-British_Medical_Bulletin_90-0" class="reference"><a href="#cite_note-British_Medical_Bulletin-90">&#91;90&#93;</a></sup>
</p><p><a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a> (NIV) is the main treatment for respiratory failure in ALS.<sup id="cite_ref-Nature2017_9-9" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> In people with normal bulbar function, it prolongs survival by about seven months and improves quality of life. One study found that NIV is ineffective for people with poor bulbar function<sup id="cite_ref-Cochrane_NIV_91-0" class="reference"><a href="#cite_note-Cochrane_NIV-91">&#91;91&#93;</a></sup> while another suggested that it may provide a modest survival benefit.<sup id="cite_ref-Lancet2017_10-11" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> Many people with ALS have difficulty tolerating NIV.<sup id="cite_ref-Sleep_Disorders_and_Respiratory_Function_92-0" class="reference"><a href="#cite_note-Sleep_Disorders_and_Respiratory_Function-92">&#91;92&#93;</a></sup> Invasive ventilation is an option for people with advanced ALS when NIV is not enough to manage their symptoms.<sup id="cite_ref-Support2016_5-8" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> While invasive ventilation prolongs survival, disease progression and functional decline continue.<sup id="cite_ref-Care2017_16-1" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> It may decrease the quality of life of people with ALS or their caregivers.<sup id="cite_ref-Conn2015_17-1" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup><sup id="cite_ref-Care2017_16-2" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> Invasive ventilation is more commonly used in Japan than in North America or Europe.<sup id="cite_ref-ALS_Ethics_93-0" class="reference"><a href="#cite_note-ALS_Ethics-93">&#91;93&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Per_Villand.jpg" class="image"><img alt="Person with ALS and their assistive technologies" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Per_Villand.jpg/220px-Per_Villand.jpg" decoding="async" width="220" height="123" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Per_Villand.jpg/330px-Per_Villand.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Per_Villand.jpg/440px-Per_Villand.jpg 2x" data-file-width="980" data-file-height="550" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Per_Villand.jpg" class="internal" title="Enlarge"></a></div>A person with late-stage ALS with a range of assistive technologies to support movement (power wheelchair), breathing (invasive ventilation), and communication (eye tracker and computer)</div></div></div>
<p>Physical therapy can promote functional independence<sup id="cite_ref-Lewis_&amp;_Rushanan_94-0" class="reference"><a href="#cite_note-Lewis_&amp;_Rushanan-94">&#91;94&#93;</a></sup><sup id="cite_ref-asha_95-0" class="reference"><a href="#cite_note-asha-95">&#91;95&#93;</a></sup> through an aerobic, range of motion, and stretching exercises.<sup id="cite_ref-British_Medical_Bulletin_90-1" class="reference"><a href="#cite_note-British_Medical_Bulletin-90">&#91;90&#93;</a></sup> Occupational therapy can assist with activities of daily living through adaptive equipment.<sup id="cite_ref-ajop_96-0" class="reference"><a href="#cite_note-ajop-96">&#91;96&#93;</a></sup> Speech therapy can assist people with ALS who have difficulty speaking.<sup id="cite_ref-asha_95-1" class="reference"><a href="#cite_note-asha-95">&#91;95&#93;</a></sup> Preventing weight loss and malnutrition in people with ALS improves both survival and quality of life.<sup id="cite_ref-Lancet2017_10-12" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> Initially, difficulty swallowing (dysphagia) can be managed by dietary changes and swallowing techniques. A <a href="/wiki/Feeding_tube" title="Feeding tube">feeding tube</a> should be considered if someone with ALS loses 5% or more of their body weight or if they cannot safely swallow food and water.<sup id="cite_ref-Nature2017_9-10" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> The feeding tube is usually inserted by <a href="/wiki/Percutaneous_endoscopic_gastrostomy" title="Percutaneous endoscopic gastrostomy">percutaneous endoscopic gastrostomy</a> (PEG). There is weak evidence that PEG tubes improve survival.<sup id="cite_ref-Cochrane_Tube_Feeding_97-0" class="reference"><a href="#cite_note-Cochrane_Tube_Feeding-97">&#91;97&#93;</a></sup> PEG insertion is usually performed with the intent of improving quality of life.<sup id="cite_ref-Conn2015_17-2" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup>
</p><p><a href="/wiki/Palliative_care" title="Palliative care">Palliative care</a> should begin shortly after someone is diagnosed with ALS.<sup id="cite_ref-EFNS_2012_98-0" class="reference"><a href="#cite_note-EFNS_2012-98">&#91;98&#93;</a></sup> Discussion of end-of-life issues gives people with ALS time to reflect on their preferences for end-of-life care and can help avoid unwanted interventions or procedures. Hospice care can improve symptom management at the end of life and increases the likelihood of a peaceful death.<sup id="cite_ref-Conn2015_17-3" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup> In the final days of life, opioids can be used to treat pain and dyspnea, while benzodiazepines can be used to treat anxiety.<sup id="cite_ref-Care2017_16-3" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Medications">Medications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=20" title="Edit section: Medications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="Disease-slowing_treatments">Disease-slowing treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=21" title="Edit section: Disease-slowing treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Riluzole2DACS.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Riluzole2DACS.svg/290px-Riluzole2DACS.svg.png" decoding="async" width="290" height="96" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Riluzole2DACS.svg/435px-Riluzole2DACS.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Riluzole2DACS.svg/580px-Riluzole2DACS.svg.png 2x" data-file-width="512" data-file-height="169" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Riluzole2DACS.svg" class="internal" title="Enlarge"></a></div>Chemical structure of <a href="/wiki/Riluzole" title="Riluzole">riluzole</a>, a medication that prolongs survival by 2–3 months<sup id="cite_ref-CD001447_14-2" class="reference"><a href="#cite_note-CD001447-14">&#91;14&#93;</a></sup></div></div></div>
<p><a href="/wiki/Riluzole" title="Riluzole">Riluzole</a> has been found to modestly prolong survival by about 2–3 months.<sup id="cite_ref-99" class="reference"><a href="#cite_note-99">&#91;99&#93;</a></sup><sup id="cite_ref-CD001447_14-3" class="reference"><a href="#cite_note-CD001447-14">&#91;14&#93;</a></sup> It may have a greater survival benefit for those with <a href="/wiki/Bulbar-onset_ALS" class="mw-redirect" title="Bulbar-onset ALS">bulbar-onset ALS</a>.<sup id="cite_ref-CD001447_14-4" class="reference"><a href="#cite_note-CD001447-14">&#91;14&#93;</a></sup> It may work by decreasing release of the excitatory <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> <a href="/wiki/Glutamate_(neurotransmitter)" title="Glutamate (neurotransmitter)">glutamate</a> from pre-synaptic neurons.<sup id="cite_ref-Nature2017_9-11" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> The most common side effects are nausea and a lack of energy (<a href="/wiki/Asthenia" class="mw-redirect" title="Asthenia">asthenia</a>).<sup id="cite_ref-CD001447_14-5" class="reference"><a href="#cite_note-CD001447-14">&#91;14&#93;</a></sup> People with ALS should begin treatment with riluzole as soon as possible following their diagnosis.<sup id="cite_ref-EFNS_2012_98-1" class="reference"><a href="#cite_note-EFNS_2012-98">&#91;98&#93;</a></sup> Riluzole is available as a tablet, liquid, or dissolvable oral film.<sup id="cite_ref-100" class="reference"><a href="#cite_note-100">&#91;100&#93;</a></sup>
</p><p><a href="/wiki/Edaravone" title="Edaravone">Edaravone</a> has been shown to modestly slow the decline in function in a small group of people with early-stage ALS.<sup id="cite_ref-Edaravone_Trial_88-1" class="reference"><a href="#cite_note-Edaravone_Trial-88">&#91;88&#93;</a></sup><sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-0" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-101">&#91;101&#93;</a></sup> It may work by protecting motor neurons from <a href="/wiki/Oxidative_stress" title="Oxidative stress">oxidative stress</a>.<sup id="cite_ref-Edaravone&#39;s_Clinical_Development_102-0" class="reference"><a href="#cite_note-Edaravone&#39;s_Clinical_Development-102">&#91;102&#93;</a></sup> The most common side effects are bruising and gait disturbance.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-1" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-101">&#91;101&#93;</a></sup> Edaravone is available as an intravenous infusion or as an oral suspension.<sup id="cite_ref-103" class="reference"><a href="#cite_note-103">&#91;103&#93;</a></sup>
</p><p><a href="/wiki/Sodium_phenylbutyrate/ursodoxicoltaurine" title="Sodium phenylbutyrate/ursodoxicoltaurine">AMX0035</a>, a combination of <a href="/wiki/Sodium_phenylbutyrate" title="Sodium phenylbutyrate">sodium phenylbutyrate</a> and <a href="/wiki/Tauroursodeoxycholic_acid" class="mw-redirect" title="Tauroursodeoxycholic acid">taurursodiol</a>, was shown to prolong the survival of patients by an average of six months.<sup id="cite_ref-104" class="reference"><a href="#cite_note-104">&#91;104&#93;</a></sup>
</p><p><a href="/wiki/Tofersen" title="Tofersen">Tofersen</a> (Qalsody) is an <a href="/wiki/Antisense_oligonucleotide" class="mw-redirect" title="Antisense oligonucleotide">antisense oligonucleotide</a> that was approved for medical use in the United States in April 2023, for the treatment of SOD1-associated ALS.<sup id="cite_ref-FDA_Qalsody_105-0" class="reference"><a href="#cite_note-FDA_Qalsody-105">&#91;105&#93;</a></sup> In a study of 108 patients with SOD1-associated ALS there was a non-significant trend towards a slowing of progression, as well as a 35%+50% reduction in the putative ALS biomarker neurofilament light chain, thought to indicate neuronal damage. A follow-up study and open-label extension suggested that earlier treatment initiation had a beneficial effect on slowing disease progression. Tofersen is available as an intrathecal injection into the <a href="/wiki/Lumbar_cistern" class="mw-redirect" title="Lumbar cistern">lumbar cistern</a>.<sup id="cite_ref-FDA_Qalsody_105-1" class="reference"><a href="#cite_note-FDA_Qalsody-105">&#91;105&#93;</a></sup>
</p>
<h5><span class="mw-headline" id="Symptomatic_treatments">Symptomatic treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=22" title="Edit section: Symptomatic treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h5>
<p>Other medications may be used to help reduce fatigue, ease muscle cramps, control spasticity, and reduce excess saliva and <a href="/wiki/Phlegm" title="Phlegm">phlegm</a>.<sup id="cite_ref-British_Medical_Bulletin_90-2" class="reference"><a href="#cite_note-British_Medical_Bulletin-90">&#91;90&#93;</a></sup> <a href="/wiki/Gabapentin" title="Gabapentin">Gabapentin</a>, <a href="/wiki/Pregabalin" title="Pregabalin">pregabalin</a>, and <a href="/wiki/Tricyclic_antidepressants" class="mw-redirect" title="Tricyclic antidepressants">tricyclic antidepressants</a> (e.g., <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a>) can be used for neuropathic pain, while nonsteroidal anti-inflammatory drugs (<a href="/wiki/NSAIDs" class="mw-redirect" title="NSAIDs">NSAIDs</a>), <a href="/wiki/Acetaminophen" class="mw-redirect" title="Acetaminophen">acetaminophen</a>, and <a href="/wiki/Opioid" title="Opioid">opioids</a> can be used for nociceptive pain.<sup id="cite_ref-Pain2017_34-1" class="reference"><a href="#cite_note-Pain2017-34">&#91;34&#93;</a></sup>
</p><p>Depression can be treated with <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitors</a> (SSRIs) or tricyclic antidepressants,<sup id="cite_ref-Nature2017_9-12" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> while <a href="/wiki/Benzodiazepines" class="mw-redirect" title="Benzodiazepines">benzodiazepines</a> can be used for anxiety.<sup id="cite_ref-Support2016_5-9" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> There are no medications to treat cognitive impairment/frontotemporal dementia (FTD); however, SSRIs and antipsychotics can help treat some of the symptoms of FTD.<sup id="cite_ref-Nature2017_9-13" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> <a href="/wiki/Baclofen" title="Baclofen">Baclofen</a> and <a href="/wiki/Tizanidine" title="Tizanidine">tizanidine</a> are the most commonly used oral drugs for treating spasticity; an <a href="/wiki/Intrathecal" class="mw-redirect" title="Intrathecal">intrathecal</a> baclofen pump can be used for severe spasticity.<sup id="cite_ref-Nature2017_9-14" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> <a href="/wiki/Atropine" title="Atropine">Atropine</a>, <a href="/wiki/Scopolamine" title="Scopolamine">scopolamine</a>, amitriptyline or <a href="/wiki/Glycopyrrolate" class="mw-redirect" title="Glycopyrrolate">glycopyrrolate</a> may be prescribed when people with ALS begin having trouble swallowing their saliva (<a href="/wiki/Sialorrhea" class="mw-redirect" title="Sialorrhea">sialorrhea</a>).<sup id="cite_ref-Nature2017_9-15" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup>
</p><p>A 2017 review concluded that <a href="/wiki/Mexiletine" title="Mexiletine">mexiletine</a> is safe and effective for treating cramps in ALS based on a randomized controlled trial from 2016.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-2" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-101">&#91;101&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Breathing_support">Breathing support</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=23" title="Edit section: Breathing support">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="Non-invasive_ventilation">Non-invasive ventilation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=24" title="Edit section: Non-invasive ventilation">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:BIPAP.JPG" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/0/04/BIPAP.JPG/290px-BIPAP.JPG" decoding="async" width="290" height="226" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/04/BIPAP.JPG/435px-BIPAP.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/04/BIPAP.JPG/580px-BIPAP.JPG 2x" data-file-width="3840" data-file-height="2994" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:BIPAP.JPG" class="internal" title="Enlarge"></a></div><a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a> supports breathing with a face or nasal mask connected to a ventilator.</div></div></div>
<p><a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a> (NIV) is the primary treatment for respiratory failure in ALS<sup id="cite_ref-Nature2017_9-16" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> and was the first treatment shown to improve both survival and quality of life.<sup id="cite_ref-Support2016_5-10" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> NIV uses a face or nasal mask connected to a ventilator that provides intermittent positive pressure to support breathing. Continuous positive pressure is not recommended for people with ALS because it makes breathing more difficult.<sup id="cite_ref-Care2017_16-4" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> Initially, NIV is used only at night<sup id="cite_ref-Support2016_5-11" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> because the first sign of respiratory failure is decreased gas exchange (<a href="/wiki/Hypoventilation" title="Hypoventilation">hypoventilation</a>) during sleep; symptoms associated with this nocturnal hypoventilation include interrupted sleep, anxiety, morning headaches, and daytime fatigue. As the disease progresses, people with ALS develop shortness of breath when lying down, during physical activity or talking, and eventually at rest.<sup id="cite_ref-NeuroRehabilitation_2015_106-0" class="reference"><a href="#cite_note-NeuroRehabilitation_2015-106">&#91;106&#93;</a></sup> Other symptoms include poor concentration, poor memory, confusion, respiratory tract infections, and a weak cough. Respiratory failure is the most common cause of death in ALS.<sup id="cite_ref-Support2016_5-12" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup>
</p><p>It is important to monitor the respiratory function of people with ALS every three months because beginning NIV soon after the start of respiratory symptoms is associated with increased survival. This involves asking the person with ALS if they have any respiratory symptoms and measuring their respiratory function.<sup id="cite_ref-Support2016_5-13" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> The most commonly used measurement is upright <a href="/wiki/Forced_vital_capacity" class="mw-redirect" title="Forced vital capacity">forced vital capacity</a> (FVC), but it is a poor detector of early respiratory failure and is not a good choice for those with bulbar symptoms, as they have difficulty maintaining a tight seal around the mouthpiece. Measuring FVC while the person is lying on their back (supine FVC) is a more accurate measure of diaphragm weakness than upright FVC.<sup id="cite_ref-Sleep_Disorders_and_Respiratory_Function_92-1" class="reference"><a href="#cite_note-Sleep_Disorders_and_Respiratory_Function-92">&#91;92&#93;</a></sup> Sniff nasal inspiratory pressure (SNIP) is a rapid, convenient test of diaphragm strength that is not affected by bulbar muscle weakness.<sup id="cite_ref-Care2017_16-5" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> If someone with ALS has signs and symptoms of respiratory failure, they should undergo daytime <a href="/wiki/Blood_gas_analysis" class="mw-redirect" title="Blood gas analysis">blood gas analysis</a><sup id="cite_ref-Support2016_5-14" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> to look for <a href="/wiki/Hypoxemia" title="Hypoxemia">hypoxemia</a> (low oxygen in the blood) and <a href="/wiki/Hypercapnia" title="Hypercapnia">hypercapnia</a> (too much carbon dioxide in the blood).<sup id="cite_ref-Care2017_16-6" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> If their daytime blood gas analysis is normal, they should then have nocturnal <a href="/wiki/Pulse_oximetry" title="Pulse oximetry">pulse oximetry</a> to look for hypoxemia during sleep.<sup id="cite_ref-Support2016_5-15" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup>
</p><p>Non-invasive ventilation prolongs survival longer than riluzole. A 2006 randomized controlled trial found that NIV prolongs survival by about 48 days and improves the quality of life; however, it also found that some people with ALS benefit more from this intervention than others. For those with normal or only moderately impaired bulbar function, NIV prolongs survival by about seven months and significantly improves the quality of life. For those with poor bulbar function, NIV neither prolongs survival nor improves the quality of life, though it does improve some sleep-related symptoms.<sup id="cite_ref-Cochrane_NIV_91-1" class="reference"><a href="#cite_note-Cochrane_NIV-91">&#91;91&#93;</a></sup> Despite the clear benefits of NIV, about 25–30% of all people with ALS are unable to tolerate it, especially those with cognitive impairment or bulbar dysfunction.<sup id="cite_ref-Sleep_Disorders_and_Respiratory_Function_92-2" class="reference"><a href="#cite_note-Sleep_Disorders_and_Respiratory_Function-92">&#91;92&#93;</a></sup> Results from a large 2015 cohort study suggest that NIV may prolong survival in those with bulbar weakness, so NIV should be offered to all people with ALS, even if it is likely that they will have difficulty tolerating it.<sup id="cite_ref-Lancet2017_10-13" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Invasive_ventilation">Invasive ventilation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=25" title="Edit section: Invasive ventilation">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Invasive ventilation bypasses the nose and mouth (the upper airways) by making a cut in the trachea (<a href="/wiki/Tracheostomy" class="mw-redirect" title="Tracheostomy">tracheostomy</a>) and inserting a <a href="/wiki/Tracheal_tube" title="Tracheal tube">tube</a> connected to a ventilator.<sup id="cite_ref-Care2017_16-7" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> It is an option for people with advanced ALS whose respiratory symptoms are poorly managed despite continuous NIV use.<sup id="cite_ref-Support2016_5-16" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> While invasive ventilation prolongs survival, especially for those younger than 60, it does not treat the underlying neurodegenerative process. The person with ALS will continue to lose motor function, making communication increasingly difficult and sometimes leading to <a href="/wiki/Locked-in_syndrome" title="Locked-in syndrome">locked-in syndrome</a>, in which they are completely paralyzed except for their eye muscles.<sup id="cite_ref-Care2017_16-8" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> About half of the people with ALS who choose to undergo invasive ventilation report a decrease in their quality of life<sup id="cite_ref-Conn2015_17-4" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup> but most still consider it to be satisfactory. However, invasive ventilation imposes a heavy burden on caregivers and may decrease their quality of life.<sup id="cite_ref-Care2017_16-9" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> Attitudes toward invasive ventilation vary from country to country; about 30% of people with ALS in Japan choose invasive ventilation, versus less than 5% in North America and Europe.<sup id="cite_ref-ALS_Ethics_93-1" class="reference"><a href="#cite_note-ALS_Ethics-93">&#91;93&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Therapy">Therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=26" title="Edit section: Therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg" class="image"><img alt="A man with ALS communicates with his wife by pointing to letters and words with a head mounted laser pointer." src="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg/290px-Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg" decoding="async" width="290" height="229" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg/435px-Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/36/Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg/580px-Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg 2x" data-file-width="609" data-file-height="480" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg" class="internal" title="Enlarge"></a></div>A man with ALS communicates by pointing to letters and words using a head-mounted laser pointer.</div></div></div>
<p><a href="/wiki/Physical_therapy" title="Physical therapy">Physical therapy</a> plays a large role in rehabilitation for individuals with ALS. Specifically, physical, occupational, and speech therapists can set goals and promote benefits for individuals with ALS by delaying loss of strength, maintaining endurance, limiting pain, improving speech and swallowing, preventing complications, and promoting functional independence.<sup id="cite_ref-Lewis_&amp;_Rushanan_94-1" class="reference"><a href="#cite_note-Lewis_&amp;_Rushanan-94">&#91;94&#93;</a></sup><sup id="cite_ref-asha_95-2" class="reference"><a href="#cite_note-asha-95">&#91;95&#93;</a></sup>
</p><p>Occupational therapy and special equipment such as <a href="/wiki/Assistive_technology" title="Assistive technology">assistive technology</a> can also enhance people's independence and safety throughout the course of ALS.<sup id="cite_ref-ajop_96-1" class="reference"><a href="#cite_note-ajop-96">&#91;96&#93;</a></sup> Gentle, low-impact <a href="/wiki/Aerobic_exercise" title="Aerobic exercise">aerobic exercise</a> such as performing activities of daily living, walking, swimming, and <a href="/wiki/Stationary_bicycle" title="Stationary bicycle">stationary bicycling</a> can strengthen unaffected muscles, improve cardiovascular health, and help people fight fatigue and depression. Range of motion and stretching exercises can help prevent painful <a href="/wiki/Spasticity" title="Spasticity">spasticity</a> and shortening (contracture) of muscles. Physical and occupational therapists can recommend exercises that provide these benefits without overworking muscles because muscle exhaustion can lead to a worsening of symptoms associated with ALS, rather than providing help to people with ALS.<sup id="cite_ref-British_Medical_Bulletin_90-3" class="reference"><a href="#cite_note-British_Medical_Bulletin-90">&#91;90&#93;</a></sup> They can suggest devices such as ramps, braces, walkers, bathroom equipment (shower chairs, toilet risers, etc.), and wheelchairs that help people remain mobile. Occupational therapists can provide or recommend equipment and adaptations to enable ALS people to retain as much safety and independence in activities of daily living as possible.<sup id="cite_ref-ajop_96-2" class="reference"><a href="#cite_note-ajop-96">&#91;96&#93;</a></sup> Since respiratory insufficiency is the primary cause of mortality, physical therapists can help improve respiratory outcomes in people with ALS by implementing pulmonary physical therapy. This includes inspiratory muscle training, lung volume recruitment training, and manual assisted cough therapy aimed at increasing respiratory muscle strength as well as increasing survival rates.<sup id="cite_ref-107" class="reference"><a href="#cite_note-107">&#91;107&#93;</a></sup>
</p><p>People with ALS who have difficulty speaking or swallowing may benefit from working with a <a href="/wiki/Speech-language_pathology" class="mw-redirect" title="Speech-language pathology">speech-language pathologist</a>.<sup id="cite_ref-asha_95-3" class="reference"><a href="#cite_note-asha-95">&#91;95&#93;</a></sup> These health professionals can teach people adaptive strategies such as techniques to help them speak louder and more clearly. As ALS progresses, speech-language pathologists can recommend the use of <a href="/wiki/Augmentative_and_alternative_communication" title="Augmentative and alternative communication">augmentative and alternative communication</a> such as voice amplifiers, speech-generating devices (or voice output communication devices) or low-tech communication techniques such as head-mounted laser pointers, <a href="/wiki/Letter_board#Communication_Board" title="Letter board">alphabet boards</a> or yes/no signals.<sup id="cite_ref-asha_95-4" class="reference"><a href="#cite_note-asha-95">&#91;95&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Nutrition">Nutrition</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=27" title="Edit section: Nutrition">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Percutaneous_endoscopic_gastrostomy-tube.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/6/62/Percutaneous_endoscopic_gastrostomy-tube.jpg/220px-Percutaneous_endoscopic_gastrostomy-tube.jpg" decoding="async" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/62/Percutaneous_endoscopic_gastrostomy-tube.jpg/330px-Percutaneous_endoscopic_gastrostomy-tube.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/62/Percutaneous_endoscopic_gastrostomy-tube.jpg/440px-Percutaneous_endoscopic_gastrostomy-tube.jpg 2x" data-file-width="1000" data-file-height="750" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Percutaneous_endoscopic_gastrostomy-tube.jpg" class="internal" title="Enlarge"></a></div>A <a href="/wiki/Gastrostomy" title="Gastrostomy">gastrostomy</a> tube is placed through the wall of the abdomen into the stomach.</div></div></div>
<p>Preventing weight loss and malnutrition in people with ALS improves both survival and quality of life.<sup id="cite_ref-Lancet2017_10-14" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> Weight loss in ALS is caused by muscle wasting, increased resting energy expenditure, and decreased food intake. Difficulty swallowing (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>) develops in about 85% of people with ALS at some point over the course of their disease,  leading to malnutrition and weight loss.<sup id="cite_ref-Care2017_16-10" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> It is important to regularly assess the weight and swallowing ability of people with ALS.<sup id="cite_ref-Support2016_5-17" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> Initially, dysphagia may be managed by dietary changes and modified swallowing techniques.<sup id="cite_ref-Nature2017_9-17" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> Difficulty swallowing liquids usually develops first and can be managed by switching to thicker liquids like fruit nectar or smoothies, or by adding fluid thickeners to thin fluids like water and coffee. People with ALS should eat soft, moist foods, which tend to be easier to swallow than dry, crumbly, or chewy foods.<sup id="cite_ref-NeuroRehabilitation_2015_106-1" class="reference"><a href="#cite_note-NeuroRehabilitation_2015-106">&#91;106&#93;</a></sup> They should also be instructed on proper head posture during swallowing, which can make swallowing easier.<sup id="cite_ref-Nature2017_9-18" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> There is tentative evidence that high-calorie diets may prevent further weight loss and improve survival.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-3" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-101">&#91;101&#93;</a></sup>
</p><p>A <a href="/wiki/Feeding_tube" title="Feeding tube">feeding tube</a> should be considered if someone with ALS loses 5% or more of their body weight or if they cannot safely swallow food and water.<sup id="cite_ref-Nature2017_9-19" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> This can take the form of a <a href="/wiki/Gastrostomy" title="Gastrostomy">gastrostomy</a> tube, in which a tube is placed through the wall of the abdomen into the stomach, or (less commonly) a <a href="/wiki/Nasogastric_tube" class="mw-redirect" title="Nasogastric tube">nasogastric tube</a>, in which a tube is placed through the nose and down the esophagus into the stomach.<sup id="cite_ref-Care2017_16-11" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> A gastrostomy tube is more appropriate for long-term use<sup id="cite_ref-Support2016_5-18" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> than a nasogastric tube, which is uncomfortable and can cause esophageal ulcers.<sup id="cite_ref-Care2017_16-12" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup> The feeding tube is usually inserted by a <a href="/wiki/Percutaneous_endoscopic_gastrostomy" title="Percutaneous endoscopic gastrostomy">percutaneous endoscopic gastrostomy</a> procedure (PEG).
</p><p>There is weak evidence that PEG tubes improve survival.<sup id="cite_ref-Cochrane_Tube_Feeding_97-1" class="reference"><a href="#cite_note-Cochrane_Tube_Feeding-97">&#91;97&#93;</a></sup> PEG insertion is usually performed with the intent of improving quality of life<sup id="cite_ref-Conn2015_17-5" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup> by sustaining nutrition and medication intake.<sup id="cite_ref-Support2016_5-19" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> This makes up for reduced oral food intake,<sup id="cite_ref-Support2016_5-20" class="reference"><a href="#cite_note-Support2016-5">&#91;5&#93;</a></sup> decreases risk of weight loss and dehydration, and can decrease anxiety by shortening what can become extended time taken to eat at mealtimes.<sup id="cite_ref-Conn2015_17-6" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup> 
</p>
<h3><span class="mw-headline" id="End-of-life_care">End-of-life care</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=28" title="Edit section: End-of-life care">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Palliative_care" title="Palliative care">Palliative care</a>, which relieves symptoms and improves the quality of life without treating the underlying disease, should begin shortly after someone is diagnosed with ALS.<sup id="cite_ref-EFNS_2012_98-2" class="reference"><a href="#cite_note-EFNS_2012-98">&#91;98&#93;</a></sup> Early discussion of end-of-life issues gives people with ALS time to reflect on their preferences for end-of-life care and can help avoid unwanted interventions or procedures.<sup id="cite_ref-Conn2015_17-7" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup> Once they have been fully informed about all aspects of various life-prolonging measures, they can fill out <a href="/wiki/Advance_directive" class="mw-redirect" title="Advance directive">advance directives</a> indicating their attitude toward noninvasive ventilation, invasive ventilation, and feeding tubes.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-4" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-101">&#91;101&#93;</a></sup> Late in the disease course, difficulty speaking due to muscle weakness (<a href="/wiki/Dysarthria" title="Dysarthria">dysarthria</a>) and cognitive dysfunction may impair their ability to communicate their wishes regarding care.<sup id="cite_ref-Nature2017_9-20" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> Continued failure to solicit the preferences of the person with ALS may lead to unplanned and potentially unwanted emergency interventions, such as invasive ventilation. If people with ALS or their family members are reluctant to discuss end-of-life issues, it may be useful to use the introduction of gastrostomy or noninvasive ventilation as an opportunity to bring up the subject.<sup id="cite_ref-Conn2015_17-8" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup>
</p><p><a href="/wiki/Hospice_care" class="mw-redirect" title="Hospice care">Hospice care</a>, or palliative care at the end of life, is especially important in ALS because it helps to optimize the management of symptoms and increases the likelihood of a peaceful death.<sup id="cite_ref-Conn2015_17-9" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup> It is unclear exactly when the end-of-life phase begins in ALS, but it is associated with significant difficulty moving, communicating, and, in some cases, thinking.<sup id="cite_ref-Nature2017_9-21" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> Although many people with ALS fear choking to death (suffocating),<sup id="cite_ref-Conn2015_17-10" class="reference"><a href="#cite_note-Conn2015-17">&#91;17&#93;</a></sup> they can be reassured that this occurs rarely, about 0–3% of the time. About 90% of people with ALS die peacefully.<sup id="cite_ref-108" class="reference"><a href="#cite_note-108">&#91;108&#93;</a></sup> In the final days of life, opioids can be used to treat pain and <a href="/wiki/Dyspnea" class="mw-redirect" title="Dyspnea">dyspnea</a>, while <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepines</a> can be used to treat anxiety.<sup id="cite_ref-Care2017_16-13" class="reference"><a href="#cite_note-Care2017-16">&#91;16&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=29" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>ALS is the most common <a href="/wiki/Motor_neuron_diseases" title="Motor neuron diseases">motor neuron disease</a> in adults and the third most common <a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">neurodegenerative disease</a><sup id="cite_ref-Neuroscience2014_59-2" class="reference"><a href="#cite_note-Neuroscience2014-59">&#91;59&#93;</a></sup> after <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's disease</a> and <a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">Parkinson's disease</a>.<sup id="cite_ref-109" class="reference"><a href="#cite_note-109">&#91;109&#93;</a></sup> Worldwide the number of people who develop ALS yearly is estimated to be 1.9 people per 100,000 per year, while the number of people who have ALS at any given time is estimated to be about 4.5 people per 100,000.<sup id="cite_ref-Global_Epidemiology_110-0" class="reference"><a href="#cite_note-Global_Epidemiology-110">&#91;110&#93;</a></sup> In Europe, the number of new cases a year is about 2.6 people per 100,000, while the number affected is 7–9 people per 100,000.<sup id="cite_ref-Har2017_111-0" class="reference"><a href="#cite_note-Har2017-111">&#91;111&#93;</a></sup> The lifetime risk of developing ALS is 1:350 for European men and 1:400 for European women. Men have a higher risk mainly because spinal-onset ALS is more common in men than women.<sup id="cite_ref-Conspiracy_61-1" class="reference"><a href="#cite_note-Conspiracy-61">&#91;61&#93;</a></sup> The number of those with ALS in the United States in 2015 was 5.2 people per 100,000, and was higher in whites, males, and people over 60 years old.<sup id="cite_ref-MMWR_2015_112-0" class="reference"><a href="#cite_note-MMWR_2015-112">&#91;112&#93;</a></sup> The number of new cases is about 0.8 people per 100,000 per year in east Asia and about 0.7 people per 100,000 per year in south Asia. About 80% of ALS epidemiology studies have been conducted in Europe and the United States, mostly in people of northern European descent.<sup id="cite_ref-Nature2017_9-22" class="reference"><a href="#cite_note-Nature2017-9">&#91;9&#93;</a></sup> There is not enough information to determine the rates of ALS in much of the world, including Africa, parts of Asia, India, Russia, and South America.<sup id="cite_ref-Conspiracy_61-2" class="reference"><a href="#cite_note-Conspiracy-61">&#91;61&#93;</a></sup> There are several geographic clusters in the Western Pacific where the prevalence of ALS was reported to be 50–100 times higher than the rest of the world, including Guam, the <a href="/wiki/Kii_Peninsula" title="Kii Peninsula">Kii Peninsula</a> of Japan, and <a href="/wiki/Western_New_Guinea" title="Western New Guinea">Western New Guinea</a>. The incidence in these areas has decreased since the 1960s;<sup id="cite_ref-Orphanet2009_1-1" class="reference"><a href="#cite_note-Orphanet2009-1">&#91;1&#93;</a></sup> the cause remains unknown.<sup id="cite_ref-Conspiracy_61-3" class="reference"><a href="#cite_note-Conspiracy-61">&#91;61&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:332px;"><a href="/wiki/File:Prevalence_of_ALS_in_the_United_States_by_age_group,_2012-2015.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/c/ca/Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg/330px-Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg" decoding="async" width="330" height="215" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/ca/Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg/495px-Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/ca/Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg/660px-Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg 2x" data-file-width="1191" data-file-height="777" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Prevalence_of_ALS_in_the_United_States_by_age_group,_2012-2015.jpg" class="internal" title="Enlarge"></a></div>Estimated prevalence of ALS in the United States by age group, 2012–2015<sup id="cite_ref-MMWR_2015_112-1" class="reference"><a href="#cite_note-MMWR_2015-112">&#91;112&#93;</a></sup></div></div></div>
<p>People of all races and ethnic backgrounds may be affected by ALS,<sup id="cite_ref-MMWR_2015_112-2" class="reference"><a href="#cite_note-MMWR_2015-112">&#91;112&#93;</a></sup> but it is more common in whites than in Africans, Asians, or Hispanics.<sup id="cite_ref-Projected2016_113-0" class="reference"><a href="#cite_note-Projected2016-113">&#91;113&#93;</a></sup> In the United States in 2015, the prevalence of ALS in whites was 5.4 people per 100,000, while the prevalence in blacks was 2.3 people per 100,000. The Midwest had the highest prevalence of the four US Census regions with 5.5 people per 100,000, followed by the Northeast (5.1), the South (4.7), and the West (4.4). The Midwest and Northeast likely had a higher prevalence of ALS because they have a higher proportion of whites than the South and West.<sup id="cite_ref-MMWR_2015_112-3" class="reference"><a href="#cite_note-MMWR_2015-112">&#91;112&#93;</a></sup> Ethnically mixed populations may be at a lower risk of developing ALS; a study in Cuba found that people of mixed ancestry were less likely to die from ALS than whites or blacks.<sup id="cite_ref-Current_Issues_in_ALS_Epidemiology_114-0" class="reference"><a href="#cite_note-Current_Issues_in_ALS_Epidemiology-114">&#91;114&#93;</a></sup> There are also differences in the genetics of ALS between different ethnic groups; the most common ALS gene in Europe is <i>C9orf72</i>, followed by <i>SOD1</i>, <i>TARDBP</i>, and <i>FUS</i>, while the most common ALS gene in Asia is <i>SOD1</i>, followed by <i>FUS</i>, <i>C9orf72</i>, and <i>TARDBP</i>.<sup id="cite_ref-115" class="reference"><a href="#cite_note-115">&#91;115&#93;</a></sup>
</p><p>ALS can affect people at any age,<sup id="cite_ref-Martin2017_52-1" class="reference"><a href="#cite_note-Martin2017-52">&#91;52&#93;</a></sup> but the peak incidence is between 50 and 75 years<sup id="cite_ref-Lancet2017_10-15" class="reference"><a href="#cite_note-Lancet2017-10">&#91;10&#93;</a></sup> and decreases dramatically after 80 years.<sup id="cite_ref-Lancet2011_13-8" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup> The reason for the decreased incidence in the elderly is unclear. One thought is that people who survive into their 80s may not be genetically susceptible to developing ALS; alternatively, ALS in the elderly might go undiagnosed because of <a href="/wiki/Comorbidities" class="mw-redirect" title="Comorbidities">comorbidities</a> (other diseases they have), difficulty seeing a neurologist, or dying quickly from an aggressive form of ALS.<sup id="cite_ref-Current_Issues_in_ALS_Epidemiology_114-1" class="reference"><a href="#cite_note-Current_Issues_in_ALS_Epidemiology-114">&#91;114&#93;</a></sup> In the United States in 2015, the lowest prevalence was in the 18–39 age group, while the highest prevalence was in the 70–79 age group.<sup id="cite_ref-MMWR_2015_112-4" class="reference"><a href="#cite_note-MMWR_2015-112">&#91;112&#93;</a></sup> Sporadic ALS usually starts around the ages of 58 to 63 years, while genetic ALS starts earlier, usually around 47 to 52 years.<sup id="cite_ref-Lancet2011_13-9" class="reference"><a href="#cite_note-Lancet2011-13">&#91;13&#93;</a></sup> The number of ALS cases worldwide is projected to increase from 222,801 in 2015 to 376,674 in 2040, an increase of 69%. This will largely be due to the aging of the world's population, especially in developing countries.<sup id="cite_ref-Projected2016_113-1" class="reference"><a href="#cite_note-Projected2016-113">&#91;113&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=30" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Jean-Martin_Charcot.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6a/Jean-Martin_Charcot.jpg/170px-Jean-Martin_Charcot.jpg" decoding="async" width="170" height="225" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6a/Jean-Martin_Charcot.jpg/255px-Jean-Martin_Charcot.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6a/Jean-Martin_Charcot.jpg/340px-Jean-Martin_Charcot.jpg 2x" data-file-width="457" data-file-height="604" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Jean-Martin_Charcot.jpg" class="internal" title="Enlarge"></a></div>The French neurologist <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a> coined the term <i>amyotrophic lateral sclerosis</i> in 1874.<sup id="cite_ref-Rowland2001_19-2" class="reference"><a href="#cite_note-Rowland2001-19">&#91;19&#93;</a></sup></div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:1923_Lou_Gehrig.png" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/1923_Lou_Gehrig.png/170px-1923_Lou_Gehrig.png" decoding="async" width="170" height="226" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/1923_Lou_Gehrig.png/255px-1923_Lou_Gehrig.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fb/1923_Lou_Gehrig.png/340px-1923_Lou_Gehrig.png 2x" data-file-width="719" data-file-height="957" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:1923_Lou_Gehrig.png" class="internal" title="Enlarge"></a></div>American baseball player <a href="/wiki/Lou_Gehrig" title="Lou Gehrig">Lou Gehrig</a>. In some countries, especially the United States, ALS is called "Lou Gehrig's disease."<sup id="cite_ref-What&#39;s_in_a_name?_116-0" class="reference"><a href="#cite_note-What&#39;s_in_a_name?-116">&#91;116&#93;</a></sup></div></div></div>
<p>Descriptions of the disease date back to at least 1824 by <a href="/wiki/Charles_Bell" title="Charles Bell">Charles Bell</a>.<sup id="cite_ref-Rowland2001_19-3" class="reference"><a href="#cite_note-Rowland2001-19">&#91;19&#93;</a></sup> In 1850, <a href="/wiki/Fran%C3%A7ois-Amilcar_Aran" title="François-Amilcar Aran">François-Amilcar Aran</a> was the first to describe a disorder he named "progressive muscular atrophy", a form of ALS in which only the lower motor neurons are affected.<sup id="cite_ref-117" class="reference"><a href="#cite_note-117">&#91;117&#93;</a></sup> In 1869, the connection between the symptoms and the underlying neurological problems were first described by <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>, who initially introduced the term <i>amyotrophic lateral sclerosis</i> in his 1874 paper.<sup id="cite_ref-Rowland2001_19-4" class="reference"><a href="#cite_note-Rowland2001-19">&#91;19&#93;</a></sup> Flail arm syndrome, a regional variant of ALS, was first described by <a href="/wiki/Alfred_Vulpian" title="Alfred Vulpian">Alfred Vulpian</a> in 1886. Flail leg syndrome, another regional variant of ALS, was first described by <a href="/wiki/Pierre_Marie" title="Pierre Marie">Pierre Marie</a> and his student Patrikios in 1918.<sup id="cite_ref-118" class="reference"><a href="#cite_note-118">&#91;118&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Diagnostic_criteria">Diagnostic criteria</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=31" title="Edit section: Diagnostic criteria">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In the 1950s, <a href="/wiki/Electrodiagnostic_testing" class="mw-redirect" title="Electrodiagnostic testing">electrodiagnostic testing</a> (EMG and NCV) began to be used to evaluate clinically suspected ALS. In 1969 <a href="/wiki/Electromyography#History" title="Electromyography">Edward H. Lambert</a> published the first EMG/NCS diagnostic criteria for ALS, consisting of four findings he considered to strongly support the diagnosis.<sup id="cite_ref-119" class="reference"><a href="#cite_note-119">&#91;119&#93;</a></sup> Since then a number of diagnostic criteria have been developed, which are mostly in use for research purposes for inclusion/exclusion criteria, and to stratify patients for analysis in trials. Research diagnostic criteria for ALS include the "El Escorial" in 1994,<sup id="cite_ref-120" class="reference"><a href="#cite_note-120">&#91;120&#93;</a></sup> revised in 1998.<sup id="cite_ref-121" class="reference"><a href="#cite_note-121">&#91;121&#93;</a></sup> In 2006,  the "Awaji" criteria proposed using EMG and NCV tests to help diagnose ALS earlier,<sup id="cite_ref-Awaji_Criteria_2008_122-0" class="reference"><a href="#cite_note-Awaji_Criteria_2008-122">&#91;122&#93;</a></sup> and most recently the "Gold Coast" criteria (2019).<sup id="cite_ref-123" class="reference"><a href="#cite_note-123">&#91;123&#93;</a></sup> 
</p>
<h3><span class="mw-headline" id="Name">Name</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=32" title="Edit section: Name">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Motor_neuron_diseases" title="Motor neuron diseases">Motor neuron diseases</a></div>
<p><i>Amyotrophic</i> comes from <a href="/wiki/Greek_language" title="Greek language">Greek</a>: <i>a-</i> means "no", <i>myo-</i> (from <i>mûs</i>) refers to "muscle", and <i>trophḗ</i> means "nourishment". Therefore, <i><a href="/wiki/Amyotrophy" title="Amyotrophy">amyotrophy</a></i> means "muscle malnourishment"<sup id="cite_ref-What_is_ALS?_124-0" class="reference"><a href="#cite_note-What_is_ALS?-124">&#91;124&#93;</a></sup> or the wasting of muscle tissue.<sup id="cite_ref-125" class="reference"><a href="#cite_note-125">&#91;125&#93;</a></sup> <i>Lateral</i> identifies the areas in a person's spinal cord where the affected motor neurons that control muscle are located. <i><a href="/wiki/Sclerosis_(medicine)" title="Sclerosis (medicine)">Sclerosis</a></i> means "scarring" or "hardening" and refers to the death of the motor neurons in the spinal cord.<sup id="cite_ref-What_is_ALS?_124-1" class="reference"><a href="#cite_note-What_is_ALS?-124">&#91;124&#93;</a></sup>
</p><p>ALS is sometimes referred to as <i>Charcot's disease</i> (not to be confused with <a href="/wiki/Charcot%E2%80%93Marie%E2%80%93Tooth_disease" title="Charcot–Marie–Tooth disease">Charcot–Marie–Tooth disease</a> or <a href="/wiki/Charcot_joint_disease" class="mw-redirect" title="Charcot joint disease">Charcot joint disease</a>), because <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a> was the first to connect the clinical symptoms with the pathology seen at autopsy.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126">&#91;126&#93;</a></sup> The British neurologist <a href="/wiki/Russell_Brain" class="mw-redirect" title="Russell Brain">Russell Brain</a> coined the term <i>motor neurone disease</i> in 1933 to reflect his belief that ALS, progressive bulbar palsy, and progressive muscular atrophy were all different forms of the same disease.<sup id="cite_ref-127" class="reference"><a href="#cite_note-127">&#91;127&#93;</a></sup> In some countries, especially the United States, ALS is called <i>Lou Gehrig's disease</i><sup id="cite_ref-What&#39;s_in_a_name?_116-1" class="reference"><a href="#cite_note-What&#39;s_in_a_name?-116">&#91;116&#93;</a></sup> after the American <a href="/wiki/Baseball" title="Baseball">baseball</a> player <a href="/wiki/Lou_Gehrig" title="Lou Gehrig">Lou Gehrig</a>, who developed ALS in 1938.<sup id="cite_ref-128" class="reference"><a href="#cite_note-128">&#91;128&#93;</a></sup>
</p><p>In the United States and continental Europe, the term <i>ALS</i> (as well as <i>Lou Gehrig's disease</i> in the US) refers to all forms of the disease, including "classical" ALS, <a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">progressive bulbar palsy</a>, <a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">progressive muscular atrophy</a>, and <a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">primary lateral sclerosis</a>.<sup id="cite_ref-UMN_Assessment_129-0" class="reference"><a href="#cite_note-UMN_Assessment-129">&#91;129&#93;</a></sup><sup id="cite_ref-Clinical_Features_of_ALS_31-1" class="reference"><a href="#cite_note-Clinical_Features_of_ALS-31">&#91;31&#93;</a></sup> In the United Kingdom and Australia, the term <i>motor neurone disease</i> refers to all forms of the disease while <i>ALS</i> only refers to "classical" ALS, meaning the form with both upper and lower motor neuron involvement.<sup id="cite_ref-UMN_Assessment_129-1" class="reference"><a href="#cite_note-UMN_Assessment-129">&#91;129&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=33" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
 <div class="thumb tleft"><div class="thumbinner" style="width:292px;"><video id="mwe_player_0" poster="//upload.wikimedia.org/wikipedia/commons/thumb/d/d2/ALS_Ice_Bucket_Challenge.ogv/290px--ALS_Ice_Bucket_Challenge.ogv.jpg" controls="" preload="none" class="thumbimage" width="290" height="163" data-durationhint="23" data-mwtitle="ALS_Ice_Bucket_Challenge.ogv" data-mwprovider="wikimediacommons"><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.480p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="SD WebM (480P)" data-shorttitle="WebM 480P" data-transcodekey="480p.webm" data-width="854" data-height="480" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.480p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="SD VP9 (480P)" data-shorttitle="VP9 480P" data-transcodekey="480p.vp9.webm" data-width="854" data-height="480" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.720p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="HD WebM (720P)" data-shorttitle="WebM 720P" data-transcodekey="720p.webm" data-width="1280" data-height="720" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.720p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="HD VP9 (720P)" data-shorttitle="VP9 720P" data-transcodekey="720p.vp9.webm" data-width="1280" data-height="720" /><source src="//upload.wikimedia.org/wikipedia/commons/d/d2/ALS_Ice_Bucket_Challenge.ogv" type="video/ogg; codecs=&quot;theora, vorbis&quot;" data-title="Original Ogg file, 1,280 × 720 (6.53 Mbps)" data-shorttitle="Ogg source" data-width="1280" data-height="720" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.120p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="Lowest bandwidth VP9 (120P)" data-shorttitle="VP9 120P" data-transcodekey="120p.vp9.webm" data-width="214" data-height="120" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.160p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="Low bandwidth WebM (160P)" data-shorttitle="WebM 160P" data-transcodekey="160p.webm" data-width="284" data-height="160" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.180p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="Low bandwidth VP9 (180P)" data-shorttitle="VP9 180P" data-transcodekey="180p.vp9.webm" data-width="320" data-height="180" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.240p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="Small WebM (240P)" data-shorttitle="WebM 240P" data-transcodekey="240p.webm" data-width="426" data-height="240" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.240p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="Small VP9 (240P)" data-shorttitle="VP9 240P" data-transcodekey="240p.vp9.webm" data-width="426" data-height="240" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.360p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="WebM (360P)" data-shorttitle="WebM 360P" data-transcodekey="360p.webm" data-width="640" data-height="360" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.360p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="VP9 (360P)" data-shorttitle="VP9 360P" data-transcodekey="360p.vp9.webm" data-width="640" data-height="360" /></video>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ALS_Ice_Bucket_Challenge.ogv" class="internal" title="Enlarge"></a></div>A student demonstrating the ice bucket challenge</div></div></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/List_of_people_with_motor_neuron_disease" title="List of people with motor neuron disease">List of people with motor neuron disease</a></div><p>People with ALS have been featured in high-profile works such as the memoir <i><a href="/wiki/Tuesdays_with_Morrie" title="Tuesdays with Morrie">Tuesdays with Morrie</a></i> and the critically acclaimed motion picture <i><a href="/wiki/The_Theory_of_Everything_(2014_film)" title="The Theory of Everything (2014 film)">The Theory of Everything</a></i>. 
</p><p>In August 2014 the "<a href="/wiki/Ice_Bucket_Challenge" title="Ice Bucket Challenge">ALS Ice Bucket Challenge</a>" went <a href="/wiki/Viral_phenomenon" title="Viral phenomenon">viral</a> online.<sup id="cite_ref-bush_130-0" class="reference"><a href="#cite_note-bush-130">&#91;130&#93;</a></sup> Contestants filled a bucket full of ice and water, stated who nominated them to do the challenge, and nominated three other individuals. The contestants then poured the buckets of ice and water onto themselves. Many contestants then donated to ALS research at the <a href="/wiki/ALS_Association" title="ALS Association">ALS Association</a>, the <a href="/wiki/ALS_Therapy_Development_Institute" title="ALS Therapy Development Institute">ALS Therapy Development Institute</a>, <a href="/wiki/ALS_Society_of_Canada" title="ALS Society of Canada">ALS Society of Canada</a>, or <a href="/wiki/Motor_Neurone_Disease_Association" title="Motor Neurone Disease Association">Motor Neurone Disease Association</a> in the UK.<sup id="cite_ref-131" class="reference"><a href="#cite_note-131">&#91;131&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=34" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-Orphanet2009-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Orphanet2009_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Orphanet2009_1-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1133582631">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFWijesekeraLeigh2009" class="citation journal cs1">Wijesekera LC, Leigh PN (February 2009). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656493">"Amyotrophic lateral sclerosis"</a>. <i>Orphanet Journal of Rare Diseases</i>. <b>4</b> (4): 3. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2F1750-1172-4-3">10.1186/1750-1172-4-3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656493">2656493</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19192301">19192301</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Orphanet+Journal+of+Rare+Diseases&amp;rft.atitle=Amyotrophic+lateral+sclerosis&amp;rft.volume=4&amp;rft.issue=4&amp;rft.pages=3&amp;rft.date=2009-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2656493%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19192301&amp;rft_id=info%3Adoi%2F10.1186%2F1750-1172-4-3&amp;rft.aulast=Wijesekera&amp;rft.aufirst=LC&amp;rft.au=Leigh%2C+PN&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2656493&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Masrori-2020-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Masrori-2020_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Masrori-2020_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Masrori-2020_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Masrori-2020_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Masrori-2020_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Masrori-2020_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Masrori-2020_2-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMasroriVan_Damme2020" class="citation journal cs1">Masrori P, Van Damme P (October 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540334">"Amyotrophic lateral sclerosis: a clinical review"</a>. <i>European Journal of Neurology</i>. <b>27</b> (10): 1918–1929. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fene.14393">10.1111/ene.14393</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540334">7540334</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32526057">32526057</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Neurology&amp;rft.atitle=Amyotrophic+lateral+sclerosis%3A+a+clinical+review&amp;rft.volume=27&amp;rft.issue=10&amp;rft.pages=1918-1929&amp;rft.date=2020-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7540334%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32526057&amp;rft_id=info%3Adoi%2F10.1111%2Fene.14393&amp;rft.aulast=Masrori&amp;rft.aufirst=P&amp;rft.au=Van+Damme%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7540334&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-NINDS2020-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-NINDS2020_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-NINDS2020_3-18"><sup><i><b>s</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Amyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet">"Amyotrophic Lateral Sclerosis (ALS) Fact Sheet | National Institute of Neurological Disorders and Stroke"</a>. <i>www.ninds.nih.gov</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170105002627/http://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Amyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet">Archived</a> from the original on 5 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">22 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.ninds.nih.gov&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis+%28ALS%29+Fact+Sheet+%7C+National+Institute+of+Neurological+Disorders+and+Stroke&amp;rft_id=https%3A%2F%2Fwww.ninds.nih.gov%2FDisorders%2FPatient-Caregiver-Education%2FFact-Sheets%2FAmyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKwanVullaganti2022" class="citation journal cs1">Kwan J, Vullaganti M (September 2022). "Amyotrophic lateral sclerosis mimics". <i>Muscle &amp; Nerve</i>. <b>66</b> (3): 240–252. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmus.27567">10.1002/mus.27567</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35607838">35607838</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:249014375">249014375</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Muscle+%26+Nerve&amp;rft.atitle=Amyotrophic+lateral+sclerosis+mimics&amp;rft.volume=66&amp;rft.issue=3&amp;rft.pages=240-252&amp;rft.date=2022-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A249014375%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F35607838&amp;rft_id=info%3Adoi%2F10.1002%2Fmus.27567&amp;rft.aulast=Kwan&amp;rft.aufirst=J&amp;rft.au=Vullaganti%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Support2016-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Support2016_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Support2016_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Support2016_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Support2016_5-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Support2016_5-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Support2016_5-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Support2016_5-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Support2016_5-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Support2016_5-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Support2016_5-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Support2016_5-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Support2016_5-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Support2016_5-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Support2016_5-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Support2016_5-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Support2016_5-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Support2016_5-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Support2016_5-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Support2016_5-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Support2016_5-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Support2016_5-20"><sup><i><b>u</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHobsonMcDermott2016" class="citation journal cs1">Hobson EV, McDermott CJ (September 2016). <a rel="nofollow" class="external text" href="http://eprints.whiterose.ac.uk/104445/1/16.pdf">"Supportive and symptomatic management of amyotrophic lateral sclerosis"</a> <span class="cs1-format">(PDF)</span>. <i>Nature Reviews. Neurology</i>. <b>12</b> (9): 526–538. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2016.111">10.1038/nrneurol.2016.111</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27514291">27514291</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8547381">8547381</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201201183335/http://eprints.whiterose.ac.uk/104445/1/16.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 1 December 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">20 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=Supportive+and+symptomatic+management+of+amyotrophic+lateral+sclerosis&amp;rft.volume=12&amp;rft.issue=9&amp;rft.pages=526-538&amp;rft.date=2016-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8547381%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27514291&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneurol.2016.111&amp;rft.aulast=Hobson&amp;rft.aufirst=EV&amp;rft.au=McDermott%2C+CJ&amp;rft_id=http%3A%2F%2Feprints.whiterose.ac.uk%2F104445%2F1%2F16.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Goutman_480–493-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-Goutman_480–493_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Goutman_480–493_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Goutman_480–493_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Goutman_480–493_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Goutman_480–493_6-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Goutman_480–493_6-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGoutmanHardimanAl-ChalabiChió2022" class="citation journal cs1">Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, Feldman EL (May 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513753">"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis"</a>. <i>The Lancet. Neurology</i>. <b>21</b> (5): 480–493. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2821%2900465-8">10.1016/S1474-4422(21)00465-8</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513753">9513753</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35334233">35334233</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Recent+advances+in+the+diagnosis+and+prognosis+of+amyotrophic+lateral+sclerosis&amp;rft.volume=21&amp;rft.issue=5&amp;rft.pages=480-493&amp;rft.date=2022-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9513753%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35334233&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2821%2900465-8&amp;rft.aulast=Goutman&amp;rft.aufirst=SA&amp;rft.au=Hardiman%2C+O&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Chi%C3%B3%2C+A&amp;rft.au=Savelieff%2C+MG&amp;rft.au=Kiernan%2C+MC&amp;rft.au=Feldman%2C+EL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9513753&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRyanHeverinMcLaughlinHardiman2019" class="citation journal cs1">Ryan M, Heverin M, McLaughlin RL, Hardiman O (November 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646974">"Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis"</a>. <i>JAMA Neurology</i>. <b>76</b> (11): 1367–1374. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamaneurol.2019.2044">10.1001/jamaneurol.2019.2044</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646974">6646974</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31329211">31329211</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA+Neurology&amp;rft.atitle=Lifetime+Risk+and+Heritability+of+Amyotrophic+Lateral+Sclerosis&amp;rft.volume=76&amp;rft.issue=11&amp;rft.pages=1367-1374&amp;rft.date=2019-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6646974%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31329211&amp;rft_id=info%3Adoi%2F10.1001%2Fjamaneurol.2019.2044&amp;rft.aulast=Ryan&amp;rft.aufirst=M&amp;rft.au=Heverin%2C+M&amp;rft.au=McLaughlin%2C+RL&amp;rft.au=Hardiman%2C+O&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6646974&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-NIH2020-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-NIH2020_8-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ninds.nih.gov/disorders/patient-caregiver-education/fact-sheets/motor-neuron-diseases-fact-sheet">"Motor Neuron Diseases Fact Sheet | National Institute of Neurological Disorders and Stroke"</a>. <i>www.ninds.nih.gov</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201010105651/https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Motor-Neuron-Diseases-Fact-Sheet">Archived</a> from the original on 10 October 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.ninds.nih.gov&amp;rft.atitle=Motor+Neuron+Diseases+Fact+Sheet+%7C+National+Institute+of+Neurological+Disorders+and+Stroke&amp;rft_id=https%3A%2F%2Fwww.ninds.nih.gov%2Fdisorders%2Fpatient-caregiver-education%2Ffact-sheets%2Fmotor-neuron-diseases-fact-sheet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Nature2017-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nature2017_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nature2017_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nature2017_9-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nature2017_9-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nature2017_9-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Nature2017_9-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Nature2017_9-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Nature2017_9-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Nature2017_9-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Nature2017_9-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Nature2017_9-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Nature2017_9-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Nature2017_9-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Nature2017_9-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Nature2017_9-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Nature2017_9-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Nature2017_9-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Nature2017_9-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Nature2017_9-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Nature2017_9-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Nature2017_9-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Nature2017_9-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Nature2017_9-22"><sup><i><b>w</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHardimanAl-ChalabiChioCorr2017" class="citation journal cs1">Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W,  et&#160;al. (October 2017). <a rel="nofollow" class="external text" href="http://eprints.whiterose.ac.uk/122838/1/WR_ALS-Hardiman_V3_EDITED_FOR_AUTHOR_APPROVAL_FINAL_APPROVED-1.pdf">"Amyotrophic lateral sclerosis"</a> <span class="cs1-format">(PDF)</span>. <i>Nature Reviews. Disease Primers</i>. <b>3</b> (17071): 17071. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrdp.2017.71">10.1038/nrdp.2017.71</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28980624">28980624</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:1002680">1002680</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201201185718/http://eprints.whiterose.ac.uk/122838/1/WR_ALS-Hardiman_V3_EDITED_FOR_AUTHOR_APPROVAL_FINAL_APPROVED-1.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 1 December 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">20 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Disease+Primers&amp;rft.atitle=Amyotrophic+lateral+sclerosis&amp;rft.volume=3&amp;rft.issue=17071&amp;rft.pages=17071&amp;rft.date=2017-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A1002680%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28980624&amp;rft_id=info%3Adoi%2F10.1038%2Fnrdp.2017.71&amp;rft.aulast=Hardiman&amp;rft.aufirst=O&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Chio%2C+A&amp;rft.au=Corr%2C+EM&amp;rft.au=Logroscino%2C+G&amp;rft.au=Robberecht%2C+W&amp;rft.au=Shaw%2C+PJ&amp;rft.au=Simmons%2C+Z&amp;rft.au=van+den+Berg%2C+LH&amp;rft_id=http%3A%2F%2Feprints.whiterose.ac.uk%2F122838%2F1%2FWR_ALS-Hardiman_V3_EDITED_FOR_AUTHOR_APPROVAL_FINAL_APPROVED-1.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Lancet2017-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lancet2017_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Lancet2017_10-15"><sup><i><b>p</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFvan_EsHardimanChioAl-Chalabi2017" class="citation journal cs1">van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH (November 2017). "Amyotrophic lateral sclerosis". <i>Lancet</i>. <b>390</b> (10107): 2084–2098. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2817%2931287-4">10.1016/S0140-6736(17)31287-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28552366">28552366</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24483077">24483077</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Amyotrophic+lateral+sclerosis&amp;rft.volume=390&amp;rft.issue=10107&amp;rft.pages=2084-2098&amp;rft.date=2017-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24483077%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28552366&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2817%2931287-4&amp;rft.aulast=van+Es&amp;rft.aufirst=MA&amp;rft.au=Hardiman%2C+O&amp;rft.au=Chio%2C+A&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Pasterkamp%2C+RJ&amp;rft.au=Veldink%2C+JH&amp;rft.au=van+den+Berg%2C+LH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-alsa-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-alsa_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-alsa_11-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.als.org/understanding-als">"Understanding ALS"</a>. <i>The ALS Association</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201026133033/https://www.als.org/understanding-als">Archived</a> from the original on 26 October 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">28 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+ALS+Association&amp;rft.atitle=Understanding+ALS&amp;rft_id=https%3A%2F%2Fwww.als.org%2Funderstanding-als&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Wingo2011-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wingo2011_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wingo2011_12-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWingoCutlerYarabKelly2011" class="citation journal cs1">Wingo TS, Cutler DJ, Yarab N, Kelly CM, Glass JD (2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222666">"The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry"</a>. <i>PLOS ONE</i>. <b>6</b> (11): e27985. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2011PLoSO...627985W">2011PLoSO...627985W</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0027985">10.1371/journal.pone.0027985</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222666">3222666</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22132186">22132186</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=The+heritability+of+amyotrophic+lateral+sclerosis+in+a+clinically+ascertained+United+States+research+registry&amp;rft.volume=6&amp;rft.issue=11&amp;rft.pages=e27985&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3222666%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22132186&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0027985&amp;rft_id=info%3Abibcode%2F2011PLoSO...627985W&amp;rft.aulast=Wingo&amp;rft.aufirst=TS&amp;rft.au=Cutler%2C+DJ&amp;rft.au=Yarab%2C+N&amp;rft.au=Kelly%2C+CM&amp;rft.au=Glass%2C+JD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3222666&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Lancet2011-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lancet2011_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lancet2011_13-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lancet2011_13-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Lancet2011_13-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Lancet2011_13-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Lancet2011_13-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Lancet2011_13-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Lancet2011_13-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Lancet2011_13-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Lancet2011_13-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKiernanVucicCheahTurner2011" class="citation journal cs1">Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (March 2011). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0140-6736%2810%2961156-7">"Amyotrophic lateral sclerosis"</a>. <i>Lancet</i>. <b>377</b> (9769): 942–955. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0140-6736%2810%2961156-7">10.1016/s0140-6736(10)61156-7</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21296405">21296405</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Amyotrophic+lateral+sclerosis&amp;rft.volume=377&amp;rft.issue=9769&amp;rft.pages=942-955&amp;rft.date=2011-03&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2810%2961156-7&amp;rft_id=info%3Apmid%2F21296405&amp;rft.aulast=Kiernan&amp;rft.aufirst=MC&amp;rft.au=Vucic%2C+S&amp;rft.au=Cheah%2C+BC&amp;rft.au=Turner%2C+MR&amp;rft.au=Eisen%2C+A&amp;rft.au=Hardiman%2C+O&amp;rft.au=Burrell%2C+JR&amp;rft.au=Zoing%2C+MC&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fs0140-6736%252810%252961156-7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-CD001447-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-CD001447_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CD001447_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-CD001447_14-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-CD001447_14-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-CD001447_14-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-CD001447_14-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMillerMitchellMoore2012" class="citation journal cs1">Miller RG, Mitchell JD, Moore DH (March 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055506">"Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2012</b> (3): CD001447. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD001447.pub3">10.1002/14651858.CD001447.pub3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055506">7055506</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22419278">22419278</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Riluzole+for+amyotrophic+lateral+sclerosis+%28ALS%29%2Fmotor+neuron+disease+%28MND%29&amp;rft.volume=2012&amp;rft.issue=3&amp;rft.pages=CD001447&amp;rft.date=2012-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7055506%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22419278&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD001447.pub3&amp;rft.aulast=Miller&amp;rft.aufirst=RG&amp;rft.au=Mitchell%2C+JD&amp;rft.au=Moore%2C+DH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7055506&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHeo2022" class="citation journal cs1">Heo YA (September 2022). <a rel="nofollow" class="external text" href="https://figshare.com/articles/online_resource/Sodium_Phenylbutyrate_and_Ursodoxicoltaurine_First_Approval/20327265">"Sodium Phenylbutyrate and Ursodoxicoltaurine: First Approval"</a>. <i>CNS Drugs</i>. <b>36</b> (9): 1007–1013. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-022-00945-x">10.1007/s40263-022-00945-x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35907175">35907175</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:251162676">251162676</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Sodium+Phenylbutyrate+and+Ursodoxicoltaurine%3A+First+Approval&amp;rft.volume=36&amp;rft.issue=9&amp;rft.pages=1007-1013&amp;rft.date=2022-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A251162676%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F35907175&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-022-00945-x&amp;rft.aulast=Heo&amp;rft.aufirst=YA&amp;rft_id=https%3A%2F%2Ffigshare.com%2Farticles%2Fonline_resource%2FSodium_Phenylbutyrate_and_Ursodoxicoltaurine_First_Approval%2F20327265&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Care2017-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-Care2017_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Care2017_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Care2017_16-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Care2017_16-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Care2017_16-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Care2017_16-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Care2017_16-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Care2017_16-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Care2017_16-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Care2017_16-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Care2017_16-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Care2017_16-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Care2017_16-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Care2017_16-13"><sup><i><b>n</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSorianiDesnuelle2017" class="citation journal cs1">Soriani MH, Desnuelle C (May 2017). "Care management in amyotrophic lateral sclerosis". <i>Revue Neurologique</i>. <b>173</b> (5): 288–299. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.031">10.1016/j.neurol.2017.03.031</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28461024">28461024</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Care+management+in+amyotrophic+lateral+sclerosis&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=288-299&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.031&amp;rft_id=info%3Apmid%2F28461024&amp;rft.aulast=Soriani&amp;rft.aufirst=MH&amp;rft.au=Desnuelle%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Conn2015-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Conn2015_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Conn2015_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Conn2015_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Conn2015_17-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Conn2015_17-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Conn2015_17-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Conn2015_17-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Conn2015_17-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Conn2015_17-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Conn2015_17-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Conn2015_17-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFConnollyGalvinHardiman2015" class="citation journal cs1">Connolly S, Galvin M, Hardiman O (April 2015). "End-of-life management in patients with amyotrophic lateral sclerosis". <i>The Lancet. Neurology</i>. <b>14</b> (4): 435–442. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2814%2970221-2">10.1016/S1474-4422(14)70221-2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25728958">25728958</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34109901">34109901</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=End-of-life+management+in+patients+with+amyotrophic+lateral+sclerosis&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=435-442&amp;rft.date=2015-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34109901%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25728958&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2814%2970221-2&amp;rft.aulast=Connolly&amp;rft.aufirst=S&amp;rft.au=Galvin%2C+M&amp;rft.au=Hardiman%2C+O&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Pupillo-2014-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pupillo-2014_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pupillo-2014_18-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPupilloMessinaLogroscinoBeghi2014" class="citation journal cs1">Pupillo E, Messina P, Logroscino G, Beghi E (February 2014). "Long-term survival in amyotrophic lateral sclerosis: a population-based study". <i>Annals of Neurology</i>. <b>75</b> (2): 287–297. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.24096">10.1002/ana.24096</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24382602">24382602</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205345019">205345019</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Long-term+survival+in+amyotrophic+lateral+sclerosis%3A+a+population-based+study&amp;rft.volume=75&amp;rft.issue=2&amp;rft.pages=287-297&amp;rft.date=2014-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205345019%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24382602&amp;rft_id=info%3Adoi%2F10.1002%2Fana.24096&amp;rft.aulast=Pupillo&amp;rft.aufirst=E&amp;rft.au=Messina%2C+P&amp;rft.au=Logroscino%2C+G&amp;rft.au=Beghi%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Rowland2001-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rowland2001_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rowland2001_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rowland2001_19-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Rowland2001_19-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Rowland2001_19-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRowland2001" class="citation journal cs1">Rowland LP (March 2001). "How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot". <i>Archives of Neurology</i>. <b>58</b> (3): 512–515. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneur.58.3.512">10.1001/archneur.58.3.512</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11255459">11255459</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Neurology&amp;rft.atitle=How+amyotrophic+lateral+sclerosis+got+its+name%3A+the+clinical-pathologic+genius+of+Jean-Martin+Charcot&amp;rft.volume=58&amp;rft.issue=3&amp;rft.pages=512-515&amp;rft.date=2001-03&amp;rft_id=info%3Adoi%2F10.1001%2Farchneur.58.3.512&amp;rft_id=info%3Apmid%2F11255459&amp;rft.aulast=Rowland&amp;rft.aufirst=LP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/661720689">"8B60 Motor neuron disease"</a>. <i>ICD-11 for Mortality and Morbidity Statistics</i>. World Health Organization. <a rel="nofollow" class="external text" href="https://archive.today/20180801205234/https://icd.who.int/browse11/l-m/en%23/http://id.who.int/icd/entity/294762853#/http://id.who.int/icd/entity/661720689">Archived</a> from the original on 1 August 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">24 January</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ICD-11+for+Mortality+and+Morbidity+Statistics&amp;rft.atitle=8B60+Motor+neuron+disease&amp;rft_id=https%3A%2F%2Ficd.who.int%2Fbrowse11%2Fl-m%2Fen%23%2Fhttp%3A%2F%2Fid.who.int%2Ficd%2Fentity%2F661720689&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFvan_EenennaamKoppenolKruithofKruitwagen-van_Reenen2021" class="citation journal cs1">van Eenennaam RM, Koppenol LS, Kruithof WJ, Kruitwagen-van Reenen ET, Pieters S, van Es MA,  et&#160;al. (November 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699408">"Discussing Personalized Prognosis Empowers Patients with Amyotrophic Lateral Sclerosis to Regain Control over Their Future: A Qualitative Study"</a>. <i>Brain Sciences</i>. <b>11</b> (12): 1597. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fbrainsci11121597">10.3390/brainsci11121597</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699408">8699408</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34942899">34942899</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Sciences&amp;rft.atitle=Discussing+Personalized+Prognosis+Empowers+Patients+with+Amyotrophic+Lateral+Sclerosis+to+Regain+Control+over+Their+Future%3A+A+Qualitative+Study&amp;rft.volume=11&amp;rft.issue=12&amp;rft.pages=1597&amp;rft.date=2021-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8699408%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34942899&amp;rft_id=info%3Adoi%2F10.3390%2Fbrainsci11121597&amp;rft.aulast=van+Eenennaam&amp;rft.aufirst=RM&amp;rft.au=Koppenol%2C+LS&amp;rft.au=Kruithof%2C+WJ&amp;rft.au=Kruitwagen-van+Reenen%2C+ET&amp;rft.au=Pieters%2C+S&amp;rft.au=van+Es%2C+MA&amp;rft.au=van+den+Berg%2C+LH&amp;rft.au=Visser-Meily%2C+JM&amp;rft.au=Beelen%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8699408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Cold_Spring_Harbor_2017-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cold_Spring_Harbor_2017_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_22-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_22-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_22-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_22-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_22-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_22-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_22-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGradRouleauRavitsCashman2017" class="citation journal cs1">Grad LI, Rouleau GA, Ravits J, Cashman NR (August 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538408">"Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS)"</a>. <i>Cold Spring Harbor Perspectives in Medicine</i>. <b>7</b> (8): a024117. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1101%2Fcshperspect.a024117">10.1101/cshperspect.a024117</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538408">5538408</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28003278">28003278</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cold+Spring+Harbor+Perspectives+in+Medicine&amp;rft.atitle=Clinical+Spectrum+of+Amyotrophic+Lateral+Sclerosis+%28ALS%29&amp;rft.volume=7&amp;rft.issue=8&amp;rft.pages=a024117&amp;rft.date=2017-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5538408%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28003278&amp;rft_id=info%3Adoi%2F10.1101%2Fcshperspect.a024117&amp;rft.aulast=Grad&amp;rft.aufirst=LI&amp;rft.au=Rouleau%2C+GA&amp;rft.au=Ravits%2C+J&amp;rft.au=Cashman%2C+NR&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5538408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGoutmanHardimanAl-ChalabiChió2022" class="citation journal cs1">Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, Feldman EL (May 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513753">"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis"</a>. <i>The Lancet. Neurology</i>. <b>21</b> (5): 480–493. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2821%2900465-8">10.1016/S1474-4422(21)00465-8</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513753">9513753</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35334233">35334233</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Recent+advances+in+the+diagnosis+and+prognosis+of+amyotrophic+lateral+sclerosis&amp;rft.volume=21&amp;rft.issue=5&amp;rft.pages=480-493&amp;rft.date=2022-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9513753%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35334233&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2821%2900465-8&amp;rft.aulast=Goutman&amp;rft.aufirst=SA&amp;rft.au=Hardiman%2C+O&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Chi%C3%B3%2C+A&amp;rft.au=Savelieff%2C+MG&amp;rft.au=Kiernan%2C+MC&amp;rft.au=Feldman%2C+EL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9513753&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGautierVerschuerenMonnierAttarian2010" class="citation journal cs1">Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J (August 2010). "ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis". <i>Amyotrophic Lateral Sclerosis</i>. <b>11</b> (4): 379–382. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F17482960903426543">10.3109/17482960903426543</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20001486">20001486</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:27672209">27672209</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=ALS+with+respiratory+onset%3A+clinical+features+and+effects+of+non-invasive+ventilation+on+the+prognosis&amp;rft.volume=11&amp;rft.issue=4&amp;rft.pages=379-382&amp;rft.date=2010-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A27672209%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20001486&amp;rft_id=info%3Adoi%2F10.3109%2F17482960903426543&amp;rft.aulast=Gautier&amp;rft.aufirst=G&amp;rft.au=Verschueren%2C+A&amp;rft.au=Monnier%2C+A&amp;rft.au=Attarian%2C+S&amp;rft.au=Salort-Campana%2C+E&amp;rft.au=Pouget%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Nature2014-25"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nature2014_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nature2014_25-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nature2014_25-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSwinnenRobberecht2014" class="citation journal cs1">Swinnen B, Robberecht W (November 2014). <a rel="nofollow" class="external text" href="https://lirias.kuleuven.be/handle/123456789/469667">"The phenotypic variability of amyotrophic lateral sclerosis"</a>. <i>Nature Reviews. Neurology</i>. <b>10</b> (11): 661–670. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2014.184">10.1038/nrneurol.2014.184</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25311585">25311585</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205516010">205516010</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20181231043137/https://limo.libis.be/primo-explore/fulldisplay?docid=LIRIAS548693&amp;context=L&amp;vid=Lirias&amp;search_scope=Lirias&amp;tab=default_tab&amp;lang=en_US&amp;fromSitemap=1">Archived</a> from the original on 31 December 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">22 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=The+phenotypic+variability+of+amyotrophic+lateral+sclerosis&amp;rft.volume=10&amp;rft.issue=11&amp;rft.pages=661-670&amp;rft.date=2014-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205516010%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25311585&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneurol.2014.184&amp;rft.aulast=Swinnen&amp;rft.aufirst=B&amp;rft.au=Robberecht%2C+W&amp;rft_id=https%3A%2F%2Flirias.kuleuven.be%2Fhandle%2F123456789%2F469667&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Classification2016-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-Classification2016_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Classification2016_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Classification2016_26-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAl-ChalabiHardimanKiernanChiò2016" class="citation journal cs1">Al-Chalabi A, Hardiman O, Kiernan MC, Chiò A, Rix-Brooks B, van den Berg LH (October 2016). "Amyotrophic lateral sclerosis: moving towards a new classification system". <i>The Lancet. Neurology</i>. <b>15</b> (11): 1182–1194. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2816%2930199-5">10.1016/S1474-4422(16)30199-5</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2318%2F1636249">2318/1636249</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27647646">27647646</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:45285510">45285510</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Amyotrophic+lateral+sclerosis%3A+moving+towards+a+new+classification+system&amp;rft.volume=15&amp;rft.issue=11&amp;rft.pages=1182-1194&amp;rft.date=2016-10&amp;rft_id=info%3Ahdl%2F2318%2F1636249&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A45285510%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27647646&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2816%2930199-5&amp;rft.aulast=Al-Chalabi&amp;rft.aufirst=A&amp;rft.au=Hardiman%2C+O&amp;rft.au=Kiernan%2C+MC&amp;rft.au=Chi%C3%B2%2C+A&amp;rft.au=Rix-Brooks%2C+B&amp;rft.au=van+den+Berg%2C+LH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Regional_ALS_Variants-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-Regional_ALS_Variants_27-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFJawdatStatlandBarohnKatz2015" class="citation journal cs1">Jawdat O, Statland JM, Barohn RJ, Katz JS, Dimachkie MM (November 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629514">"Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis)"</a>. <i>Neurologic Clinics</i>. <b>33</b> (4): 775–785. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ncl.2015.07.003">10.1016/j.ncl.2015.07.003</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629514">4629514</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26515621">26515621</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurologic+Clinics&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis+Regional+Variants+%28Brachial+Amyotrophic+Diplegia%2C+Leg+Amyotrophic+Diplegia%2C+and+Isolated+Bulbar+Amyotrophic+Lateral+Sclerosis%29&amp;rft.volume=33&amp;rft.issue=4&amp;rft.pages=775-785&amp;rft.date=2015-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4629514%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26515621&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ncl.2015.07.003&amp;rft.aulast=Jawdat&amp;rft.aufirst=O&amp;rft.au=Statland%2C+JM&amp;rft.au=Barohn%2C+RJ&amp;rft.au=Katz%2C+JS&amp;rft.au=Dimachkie%2C+MM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4629514&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFZhangChenTianFan2021" class="citation journal cs1">Zhang H, Chen L, Tian J, Fan D (October 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532334">"Disease duration of progression is helpful in identifying isolated bulbar palsy of amyotrophic lateral sclerosis"</a>. <i>BMC Neurology</i>. <b>21</b> (1): 405. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs12883-021-02438-8">10.1186/s12883-021-02438-8</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532334">8532334</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34686150">34686150</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Neurology&amp;rft.atitle=Disease+duration+of+progression+is+helpful+in+identifying+isolated+bulbar+palsy+of+amyotrophic+lateral+sclerosis&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=405&amp;rft.date=2021-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8532334%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34686150&amp;rft_id=info%3Adoi%2F10.1186%2Fs12883-021-02438-8&amp;rft.aulast=Zhang&amp;rft.aufirst=H&amp;rft.au=Chen%2C+L&amp;rft.au=Tian%2C+J&amp;rft.au=Fan%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8532334&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLehkyGrunseich2021" class="citation journal cs1">Lehky T, Grunseich C (November 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701111">"Juvenile Amyotrophic Lateral Sclerosis: A Review"</a>. <i>Genes</i>. <b>12</b> (12): 1935. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fgenes12121935">10.3390/genes12121935</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701111">8701111</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34946884">34946884</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes&amp;rft.atitle=Juvenile+Amyotrophic+Lateral+Sclerosis%3A+A+Review&amp;rft.volume=12&amp;rft.issue=12&amp;rft.pages=1935&amp;rft.date=2021-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8701111%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34946884&amp;rft_id=info%3Adoi%2F10.3390%2Fgenes12121935&amp;rft.aulast=Lehky&amp;rft.aufirst=T&amp;rft.au=Grunseich%2C+C&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8701111&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTeohCareySampaioMowat2017" class="citation journal cs1">Teoh HL, Carey K, Sampaio H, Mowat D, Roscioli T, Farrar M (2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467325">"Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy"</a>. <i>Neural Plasticity</i>. <b>2017</b>: 6509493. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1155%2F2017%2F6509493">10.1155/2017/6509493</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467325">5467325</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28634552">28634552</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neural+Plasticity&amp;rft.atitle=Inherited+Paediatric+Motor+Neuron+Disorders%3A+Beyond+Spinal+Muscular+Atrophy&amp;rft.volume=2017&amp;rft.pages=6509493&amp;rft.date=2017&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5467325%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28634552&amp;rft_id=info%3Adoi%2F10.1155%2F2017%2F6509493&amp;rft.aulast=Teoh&amp;rft.aufirst=HL&amp;rft.au=Carey%2C+K&amp;rft.au=Sampaio%2C+H&amp;rft.au=Mowat%2C+D&amp;rft.au=Roscioli%2C+T&amp;rft.au=Farrar%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5467325&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Clinical_Features_of_ALS-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-Clinical_Features_of_ALS_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Clinical_Features_of_ALS_31-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTardDefebvreMoreauDevos2017" class="citation journal cs1">Tard C, Defebvre L, Moreau C, Devos D, Danel-Brunaud V (May 2017). "Clinical features of amyotrophic lateral sclerosis and their prognostic value". <i>Revue Neurologique</i>. <b>173</b> (5): 263–272. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.029">10.1016/j.neurol.2017.03.029</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28477850">28477850</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Clinical+features+of+amyotrophic+lateral+sclerosis+and+their+prognostic+value&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=263-272&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.029&amp;rft_id=info%3Apmid%2F28477850&amp;rft.aulast=Tard&amp;rft.aufirst=C&amp;rft.au=Defebvre%2C+L&amp;rft.au=Moreau%2C+C&amp;rft.au=Devos%2C+D&amp;rft.au=Danel-Brunaud%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-NHS-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-NHS_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NHS_32-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nhs.uk/conditions/motor-neurone-disease/">"Motor neurone disease"</a>. UK: National Health Service. 15 January 2018. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20141229064258/http://www.nhs.uk/conditions/Motor-neurone-disease/Pages/Introduction.aspx">Archived</a> from the original on 29 December 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Motor+neurone+disease&amp;rft.place=UK&amp;rft.pub=National+Health+Service&amp;rft.date=2018-01-15&amp;rft_id=https%3A%2F%2Fwww.nhs.uk%2Fconditions%2Fmotor-neurone-disease%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Cold_Spring_Harbor_20172-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-Cold_Spring_Harbor_20172_33-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGradRouleauRavitsCashman2017" class="citation journal cs1">Grad LI, Rouleau GA, Ravits J, Cashman NR (August 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538408">"Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS)"</a>. <i>Cold Spring Harbor Perspectives in Medicine</i>. <b>7</b> (8): a024117. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1101%2Fcshperspect.a024117">10.1101/cshperspect.a024117</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538408">5538408</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28003278">28003278</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cold+Spring+Harbor+Perspectives+in+Medicine&amp;rft.atitle=Clinical+Spectrum+of+Amyotrophic+Lateral+Sclerosis+%28ALS%29&amp;rft.volume=7&amp;rft.issue=8&amp;rft.pages=a024117&amp;rft.date=2017-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5538408%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28003278&amp;rft_id=info%3Adoi%2F10.1101%2Fcshperspect.a024117&amp;rft.aulast=Grad&amp;rft.aufirst=LI&amp;rft.au=Rouleau%2C+GA&amp;rft.au=Ravits%2C+J&amp;rft.au=Cashman%2C+NR&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5538408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Pain2017-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pain2017_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pain2017_34-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChiòMoraLauria2017" class="citation journal cs1">Chiò A, Mora G, Lauria G (February 2017). "Pain in amyotrophic lateral sclerosis". <i>The Lancet. Neurology</i>. <b>16</b> (2): 144–157. <a href="/wiki/ArXiv_(identifier)" class="mw-redirect" title="ArXiv (identifier)">arXiv</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://arxiv.org/abs/1607.02870">1607.02870</a></span>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2816%2930358-1">10.1016/S1474-4422(16)30358-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27964824">27964824</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:38905437">38905437</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Pain+in+amyotrophic+lateral+sclerosis&amp;rft.volume=16&amp;rft.issue=2&amp;rft.pages=144-157&amp;rft.date=2017-02&amp;rft_id=info%3Aarxiv%2F1607.02870&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A38905437%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27964824&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2816%2930358-1&amp;rft.aulast=Chi%C3%B2&amp;rft.aufirst=A&amp;rft.au=Mora%2C+G&amp;rft.au=Lauria%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGromichoFigueiralUysalGrosskreutz2020" class="citation journal cs1">Gromicho M, Figueiral M, Uysal H, Grosskreutz J, Kuzma-Kozakiewicz M, Pinto S,  et&#160;al. (July 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359118">"Spreading in ALS: The relative impact of upper and lower motor neuron involvement"</a>. <i>Annals of Clinical and Translational Neurology</i>. <b>7</b> (7): 1181–1192. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Facn3.51098">10.1002/acn3.51098</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359118">7359118</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32558369">32558369</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Clinical+and+Translational+Neurology&amp;rft.atitle=Spreading+in+ALS%3A+The+relative+impact+of+upper+and+lower+motor+neuron+involvement&amp;rft.volume=7&amp;rft.issue=7&amp;rft.pages=1181-1192&amp;rft.date=2020-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7359118%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32558369&amp;rft_id=info%3Adoi%2F10.1002%2Facn3.51098&amp;rft.aulast=Gromicho&amp;rft.aufirst=M&amp;rft.au=Figueiral%2C+M&amp;rft.au=Uysal%2C+H&amp;rft.au=Grosskreutz%2C+J&amp;rft.au=Kuzma-Kozakiewicz%2C+M&amp;rft.au=Pinto%2C+S&amp;rft.au=Petri%2C+S&amp;rft.au=Madeira%2C+S&amp;rft.au=Swash%2C+M&amp;rft.au=de+Carvalho%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7359118&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCedarbaumStamblerMaltaFuller1999" class="citation journal cs1">Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (October 1999). "The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)". <i>Journal of the Neurological Sciences</i>. <b>169</b> (1–2): 13–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0022-510x%2899%2900210-5">10.1016/s0022-510x(99)00210-5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10540002">10540002</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7057926">7057926</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=The+ALSFRS-R%3A+a+revised+ALS+functional+rating+scale+that+incorporates+assessments+of+respiratory+function.+BDNF+ALS+Study+Group+%28Phase+III%29&amp;rft.volume=169&amp;rft.issue=1%E2%80%932&amp;rft.pages=13-21&amp;rft.date=1999-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7057926%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10540002&amp;rft_id=info%3Adoi%2F10.1016%2Fs0022-510x%2899%2900210-5&amp;rft.aulast=Cedarbaum&amp;rft.aufirst=JM&amp;rft.au=Stambler%2C+N&amp;rft.au=Malta%2C+E&amp;rft.au=Fuller%2C+C&amp;rft.au=Hilt%2C+D&amp;rft.au=Thurmond%2C+B&amp;rft.au=Nakanishi%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWongStavrouElliottGregory2021" class="citation journal cs1">Wong C, Stavrou M, Elliott E, Gregory JM, Leigh N, Pinto AA,  et&#160;al. (2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659356">"Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective"</a>. <i>Brain Communications</i>. <b>3</b> (4): fcab242. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbraincomms%2Ffcab242">10.1093/braincomms/fcab242</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659356">8659356</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34901853">34901853</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Communications&amp;rft.atitle=Clinical+trials+in+amyotrophic+lateral+sclerosis%3A+a+systematic+review+and+perspective&amp;rft.volume=3&amp;rft.issue=4&amp;rft.pages=fcab242&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8659356%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34901853&amp;rft_id=info%3Adoi%2F10.1093%2Fbraincomms%2Ffcab242&amp;rft.aulast=Wong&amp;rft.aufirst=C&amp;rft.au=Stavrou%2C+M&amp;rft.au=Elliott%2C+E&amp;rft.au=Gregory%2C+JM&amp;rft.au=Leigh%2C+N&amp;rft.au=Pinto%2C+AA&amp;rft.au=Williams%2C+TL&amp;rft.au=Chataway%2C+J&amp;rft.au=Swingler%2C+R&amp;rft.au=Parmar%2C+MK&amp;rft.au=Stallard%2C+N&amp;rft.au=Weir%2C+CJ&amp;rft.au=Parker%2C+RA&amp;rft.au=Chaouch%2C+A&amp;rft.au=Hamdalla%2C+H&amp;rft.au=Ealing%2C+J&amp;rft.au=Gorrie%2C+G&amp;rft.au=Morrison%2C+I&amp;rft.au=Duncan%2C+C&amp;rft.au=Connelly%2C+P&amp;rft.au=Carod-Artal%2C+FJ&amp;rft.au=Davenport%2C+R&amp;rft.au=Reitboeck%2C+PG&amp;rft.au=Radunovic%2C+A&amp;rft.au=Srinivasan%2C+V&amp;rft.au=Preston%2C+J&amp;rft.au=Mehta%2C+AR&amp;rft.au=Leighton%2C+D&amp;rft.au=Glasmacher%2C+S&amp;rft.au=Beswick%2C+E&amp;rft.au=Williamson%2C+J&amp;rft.au=Stenson%2C+A&amp;rft.au=Weaver%2C+C&amp;rft.au=Newton%2C+J&amp;rft.au=Lyle%2C+D&amp;rft.au=Dakin%2C+R&amp;rft.au=Macleod%2C+M&amp;rft.au=Pal%2C+S&amp;rft.au=Chandran%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8659356&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCreemersGrupstraNolletvan_den_Berg2015" class="citation journal cs1">Creemers H, Grupstra H, Nollet F, van den Berg LH, Beelen A (June 2015). "Prognostic factors for the course of functional status of patients with ALS: a systematic review". <i>Journal of Neurology</i>. <b>262</b> (6): 1407–1423. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00415-014-7564-8">10.1007/s00415-014-7564-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25385051">25385051</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:31734765">31734765</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology&amp;rft.atitle=Prognostic+factors+for+the+course+of+functional+status+of+patients+with+ALS%3A+a+systematic+review&amp;rft.volume=262&amp;rft.issue=6&amp;rft.pages=1407-1423&amp;rft.date=2015-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31734765%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25385051&amp;rft_id=info%3Adoi%2F10.1007%2Fs00415-014-7564-8&amp;rft.aulast=Creemers&amp;rft.aufirst=H&amp;rft.au=Grupstra%2C+H&amp;rft.au=Nollet%2C+F&amp;rft.au=van+den+Berg%2C+LH&amp;rft.au=Beelen%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAtassiBerryShuiZach2014" class="citation journal cs1">Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E,  et&#160;al. (November 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239834">"The PRO-ACT database: design, initial analyses, and predictive features"</a>. <i>Neurology</i>. <b>83</b> (19): 1719–1725. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000000951">10.1212/WNL.0000000000000951</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239834">4239834</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25298304">25298304</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=The+PRO-ACT+database%3A+design%2C+initial+analyses%2C+and+predictive+features&amp;rft.volume=83&amp;rft.issue=19&amp;rft.pages=1719-1725&amp;rft.date=2014-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4239834%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25298304&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000000951&amp;rft.aulast=Atassi&amp;rft.aufirst=N&amp;rft.au=Berry%2C+J&amp;rft.au=Shui%2C+A&amp;rft.au=Zach%2C+N&amp;rft.au=Sherman%2C+A&amp;rft.au=Sinani%2C+E&amp;rft.au=Walker%2C+J&amp;rft.au=Katsovskiy%2C+I&amp;rft.au=Schoenfeld%2C+D&amp;rft.au=Cudkowicz%2C+M&amp;rft.au=Leitner%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4239834&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Bedlack-2016-40"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bedlack-2016_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bedlack-2016_40-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBedlackVaughanWicksHeywood2016" class="citation journal cs1">Bedlack RS, Vaughan T, Wicks P, Heywood J, Sinani E, Selsov R,  et&#160;al. (March 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793781">"How common are ALS plateaus and reversals?"</a>. <i>Neurology</i>. <b>86</b> (9): 808–812. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000002251">10.1212/WNL.0000000000002251</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793781">4793781</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26658909">26658909</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=How+common+are+ALS+plateaus+and+reversals%3F&amp;rft.volume=86&amp;rft.issue=9&amp;rft.pages=808-812&amp;rft.date=2016-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4793781%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26658909&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000002251&amp;rft.aulast=Bedlack&amp;rft.aufirst=RS&amp;rft.au=Vaughan%2C+T&amp;rft.au=Wicks%2C+P&amp;rft.au=Heywood%2C+J&amp;rft.au=Sinani%2C+E&amp;rft.au=Selsov%2C+R&amp;rft.au=Macklin%2C+EA&amp;rft.au=Schoenfeld%2C+D&amp;rft.au=Cudkowicz%2C+M&amp;rft.au=Sherman%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4793781&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCastrillo-VigueraGrassoSimpsonShefner2010" class="citation journal cs1">Castrillo-Viguera C, Grasso DL, Simpson E, Shefner J, Cudkowicz ME (2010). "Clinical significance in the change of decline in ALSFRS-R". <i>Amyotrophic Lateral Sclerosis</i> (Journal Article). <b>11</b> (1–2): 178–180. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F17482960903093710">10.3109/17482960903093710</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19634063">19634063</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207619689">207619689</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=Clinical+significance+in+the+change+of+decline+in+ALSFRS-R&amp;rft.volume=11&amp;rft.issue=1%E2%80%932&amp;rft.pages=178-180&amp;rft.date=2010&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207619689%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19634063&amp;rft_id=info%3Adoi%2F10.3109%2F17482960903093710&amp;rft.aulast=Castrillo-Viguera&amp;rft.aufirst=C&amp;rft.au=Grasso%2C+DL&amp;rft.au=Simpson%2C+E&amp;rft.au=Shefner%2C+J&amp;rft.au=Cudkowicz%2C+ME&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Yunusova-2019-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-Yunusova-2019_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Yunusova-2019_42-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYunusovaPlowmanGreenBarnett2019" class="citation journal cs1">Yunusova Y, Plowman EK, Green JR, Barnett C, Bede P (2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389633">"Clinical Measures of Bulbar Dysfunction in ALS"</a>. <i>Frontiers in Neurology</i>. <b>10</b>: 106. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffneur.2019.00106">10.3389/fneur.2019.00106</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389633">6389633</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30837936">30837936</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neurology&amp;rft.atitle=Clinical+Measures+of+Bulbar+Dysfunction+in+ALS&amp;rft.volume=10&amp;rft.pages=106&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6389633%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30837936&amp;rft_id=info%3Adoi%2F10.3389%2Ffneur.2019.00106&amp;rft.aulast=Yunusova&amp;rft.aufirst=Y&amp;rft.au=Plowman%2C+EK&amp;rft.au=Green%2C+JR&amp;rft.au=Barnett%2C+C&amp;rft.au=Bede%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6389633&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLuiByl2009" class="citation journal cs1">Lui AJ, Byl NN (June 2009). "A systematic review of the effect of moderate intensity exercise on function and disease progression in amyotrophic lateral sclerosis". <i>Journal of Neurologic Physical Therapy</i>. <b>33</b> (2): 68–87. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FNPT.0b013e31819912d0">10.1097/NPT.0b013e31819912d0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19556916">19556916</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7650356">7650356</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurologic+Physical+Therapy&amp;rft.atitle=A+systematic+review+of+the+effect+of+moderate+intensity+exercise+on+function+and+disease+progression+in+amyotrophic+lateral+sclerosis&amp;rft.volume=33&amp;rft.issue=2&amp;rft.pages=68-87&amp;rft.date=2009-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7650356%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19556916&amp;rft_id=info%3Adoi%2F10.1097%2FNPT.0b013e31819912d0&amp;rft.aulast=Lui&amp;rft.aufirst=AJ&amp;rft.au=Byl%2C+NN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBeukelmanFagerNordness2011" class="citation journal cs1">Beukelman D, Fager S, Nordness A (2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096454">"Communication Support for People with ALS"</a>. <i>Neurology Research International</i>. <b>2011</b>: 714693. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1155%2F2011%2F714693">10.1155/2011/714693</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096454">3096454</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21603029">21603029</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology+Research+International&amp;rft.atitle=Communication+Support+for+People+with+ALS&amp;rft.volume=2011&amp;rft.pages=714693&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3096454%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21603029&amp;rft_id=info%3Adoi%2F10.1155%2F2011%2F714693&amp;rft.aulast=Beukelman&amp;rft.aufirst=D&amp;rft.au=Fager%2C+S&amp;rft.au=Nordness%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3096454&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKuzma-KozakiewiczAndersenCiecwierskaVázquez2019" class="citation journal cs1">Kuzma-Kozakiewicz M, Andersen PM, Ciecwierska K, Vázquez C, Helczyk O, Loose M,  et&#160;al. (September 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745736">"An observational study on quality of life and preferences to sustain life in locked-in state"</a>. <i>Neurology</i>. <b>93</b> (10): e938–e945. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000008064">10.1212/WNL.0000000000008064</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745736">6745736</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31391247">31391247</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=An+observational+study+on+quality+of+life+and+preferences+to+sustain+life+in+locked-in+state&amp;rft.volume=93&amp;rft.issue=10&amp;rft.pages=e938-e945&amp;rft.date=2019-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6745736%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31391247&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000008064&amp;rft.aulast=Kuzma-Kozakiewicz&amp;rft.aufirst=M&amp;rft.au=Andersen%2C+PM&amp;rft.au=Ciecwierska%2C+K&amp;rft.au=V%C3%A1zquez%2C+C&amp;rft.au=Helczyk%2C+O&amp;rft.au=Loose%2C+M&amp;rft.au=Uttner%2C+I&amp;rft.au=Ludolph%2C+AC&amp;rft.au=Lul%C3%A9%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6745736&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFO&#39;BrienStavroulakisBaxterNorman2019" class="citation journal cs1">O'Brien D, Stavroulakis T, Baxter S, Norman P, Bianchi S, Elliott M,  et&#160;al. (September 2019). "The optimisation of noninvasive ventilation in amyotrophic lateral sclerosis: a systematic review". <i>The European Respiratory Journal</i>. <b>54</b> (3): 1900261. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1183%2F13993003.00261-2019">10.1183/13993003.00261-2019</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31273038">31273038</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:195805546">195805546</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+European+Respiratory+Journal&amp;rft.atitle=The+optimisation+of+noninvasive+ventilation+in+amyotrophic+lateral+sclerosis%3A+a+systematic+review&amp;rft.volume=54&amp;rft.issue=3&amp;rft.pages=1900261&amp;rft.date=2019-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A195805546%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31273038&amp;rft_id=info%3Adoi%2F10.1183%2F13993003.00261-2019&amp;rft.aulast=O%27Brien&amp;rft.aufirst=D&amp;rft.au=Stavroulakis%2C+T&amp;rft.au=Baxter%2C+S&amp;rft.au=Norman%2C+P&amp;rft.au=Bianchi%2C+S&amp;rft.au=Elliott%2C+M&amp;rft.au=Johnson%2C+M&amp;rft.au=Clowes%2C+M&amp;rft.au=Garcia-S%C3%A1nchez%2C+A&amp;rft.au=Hobson%2C+E&amp;rft.au=McDermott%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Bede-2011-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bede-2011_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bede-2011_47-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBedeOliverStodartvan_den_Berg2011" class="citation journal cs1">Bede P, Oliver D, Stodart J, van den Berg L, Simmons Z, O Brannagáin D,  et&#160;al. (April 2011). <a rel="nofollow" class="external text" href="https://epub.ub.uni-muenchen.de/21892/">"Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>82</b> (4): 413–418. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.2010.232637">10.1136/jnnp.2010.232637</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21297150">21297150</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7043837">7043837</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230528133749/https://epub.ub.uni-muenchen.de/21892/">Archived</a> from the original on 28 May 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">30 April</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Palliative+care+in+amyotrophic+lateral+sclerosis%3A+a+review+of+current+international+guidelines+and+initiatives&amp;rft.volume=82&amp;rft.issue=4&amp;rft.pages=413-418&amp;rft.date=2011-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7043837%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21297150&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2010.232637&amp;rft.aulast=Bede&amp;rft.aufirst=P&amp;rft.au=Oliver%2C+D&amp;rft.au=Stodart%2C+J&amp;rft.au=van+den+Berg%2C+L&amp;rft.au=Simmons%2C+Z&amp;rft.au=O+Brannag%C3%A1in%2C+D&amp;rft.au=Borasio%2C+GD&amp;rft.au=Hardiman%2C+O&amp;rft_id=https%3A%2F%2Fepub.ub.uni-muenchen.de%2F21892%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCorciaPradatSalachasBruneteau2008" class="citation journal cs1">Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D,  et&#160;al. (1 January 2008). "Causes of death in a post-mortem series of ALS patients". <i>Amyotrophic Lateral Sclerosis</i>. <b>9</b> (1): 59–62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F17482960701656940">10.1080/17482960701656940</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17924236">17924236</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:40367873">40367873</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=Causes+of+death+in+a+post-mortem+series+of+ALS+patients&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=59-62&amp;rft.date=2008-01-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A40367873%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17924236&amp;rft_id=info%3Adoi%2F10.1080%2F17482960701656940&amp;rft.aulast=Corcia&amp;rft.aufirst=P&amp;rft.au=Pradat%2C+PF&amp;rft.au=Salachas%2C+F&amp;rft.au=Bruneteau%2C+G&amp;rft.au=Forestier%2C+N&amp;rft.au=Seilhean%2C+D&amp;rft.au=Hauw%2C+JJ&amp;rft.au=Meininger%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFangAl_KhleifatStahlLazo_La_Torre2017" class="citation journal cs1">Fang T, Al Khleifat A, Stahl DR, Lazo La Torre C, Murphy C, Young C,  et&#160;al. (May 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425622">"Comparison of the King's and MiToS staging systems for ALS"</a>. <i>Amyotrophic Lateral Sclerosis &amp; Frontotemporal Degeneration</i>. <b>18</b> (3–4): 227–232. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21678421.2016.1265565">10.1080/21678421.2016.1265565</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425622">5425622</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28054828">28054828</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+%26+Frontotemporal+Degeneration&amp;rft.atitle=Comparison+of+the+King%27s+and+MiToS+staging+systems+for+ALS&amp;rft.volume=18&amp;rft.issue=3%E2%80%934&amp;rft.pages=227-232&amp;rft.date=2017-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5425622%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28054828&amp;rft_id=info%3Adoi%2F10.1080%2F21678421.2016.1265565&amp;rft.aulast=Fang&amp;rft.aufirst=T&amp;rft.au=Al+Khleifat%2C+A&amp;rft.au=Stahl%2C+DR&amp;rft.au=Lazo+La+Torre%2C+C&amp;rft.au=Murphy%2C+C&amp;rft.au=Young%2C+C&amp;rft.au=Shaw%2C+PJ&amp;rft.au=Leigh%2C+PN&amp;rft.au=Al-Chalabi%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5425622&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-JNNP_July_2011-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-JNNP_July_2011_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-JNNP_July_2011_50-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChiòCalvoMogliaMazzini2011" class="citation journal cs1">Chiò A, Calvo A, Moglia C, Mazzini L, Mora G (July 2011). <a rel="nofollow" class="external text" href="https://hal.archives-ouvertes.fr/hal-00623289/file/PEER_stage2_10.1136%252Fjnnp.2010.235952.pdf">"Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population-based study"</a> <span class="cs1-format">(PDF)</span>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>82</b> (7): 740–746. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.2010.235952">10.1136/jnnp.2010.235952</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21402743">21402743</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13416164">13416164</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221124232146/https://hal.archives-ouvertes.fr/hal-00623289/file/PEER_stage2_10.1136%2Fjnnp.2010.235952.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 24 November 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">4 August</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Phenotypic+heterogeneity+of+amyotrophic+lateral+sclerosis%3A+a+population-based+study&amp;rft.volume=82&amp;rft.issue=7&amp;rft.pages=740-746&amp;rft.date=2011-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13416164%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21402743&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2010.235952&amp;rft.aulast=Chi%C3%B2&amp;rft.aufirst=A&amp;rft.au=Calvo%2C+A&amp;rft.au=Moglia%2C+C&amp;rft.au=Mazzini%2C+L&amp;rft.au=Mora%2C+G&amp;rft_id=https%3A%2F%2Fhal.archives-ouvertes.fr%2Fhal-00623289%2Ffile%2FPEER_stage2_10.1136%25252Fjnnp.2010.235952.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLandau2009" class="citation web cs1">Landau E (20 September 2009). <a rel="nofollow" class="external text" href="http://www.cnn.com/2009/HEALTH/04/20/hawking.als/index.html">"Stephen Hawking serves as role model for ALS patients"</a>. CNN. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160815000537/http://www.cnn.com/2009/HEALTH/04/20/hawking.als/index.html">Archived</a> from the original on 15 August 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Stephen+Hawking+serves+as+role+model+for+ALS+patients&amp;rft.pub=CNN&amp;rft.date=2009-09-20&amp;rft.aulast=Landau&amp;rft.aufirst=E&amp;rft_id=http%3A%2F%2Fwww.cnn.com%2F2009%2FHEALTH%2F04%2F20%2Fhawking.als%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Martin2017-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-Martin2017_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Martin2017_52-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMartinAl_KhleifatAl-Chalabi2017" class="citation journal cs1">Martin S, Al Khleifat A, Al-Chalabi A (2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373425">"What causes amyotrophic lateral sclerosis?"</a>. <i>F1000Research</i>. <b>6</b>: 371. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.12688%2Ff1000research.10476.1">10.12688/f1000research.10476.1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373425">5373425</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28408982">28408982</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=F1000Research&amp;rft.atitle=What+causes+amyotrophic+lateral+sclerosis%3F&amp;rft.volume=6&amp;rft.pages=371&amp;rft.date=2017&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5373425%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28408982&amp;rft_id=info%3Adoi%2F10.12688%2Ff1000research.10476.1&amp;rft.aulast=Martin&amp;rft.aufirst=S&amp;rft.au=Al+Khleifat%2C+A&amp;rft.au=Al-Chalabi%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5373425&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Crockford-2018-53"><span class="mw-cite-backlink">^ <a href="#cite_ref-Crockford-2018_53-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Crockford-2018_53-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCrockfordNewtonLonerganChiwera2018" class="citation journal cs1">Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S,  et&#160;al. (October 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177274">"ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS"</a>. <i>Neurology</i>. <b>91</b> (15): e1370–e1380. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000006317">10.1212/WNL.0000000000006317</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177274">6177274</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30209236">30209236</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=ALS-specific+cognitive+and+behavior+changes+associated+with+advancing+disease+stage+in+ALS&amp;rft.volume=91&amp;rft.issue=15&amp;rft.pages=e1370-e1380&amp;rft.date=2018-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6177274%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30209236&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000006317&amp;rft.aulast=Crockford&amp;rft.aufirst=C&amp;rft.au=Newton%2C+J&amp;rft.au=Lonergan%2C+K&amp;rft.au=Chiwera%2C+T&amp;rft.au=Booth%2C+T&amp;rft.au=Chandran%2C+S&amp;rft.au=Colville%2C+S&amp;rft.au=Heverin%2C+M&amp;rft.au=Mays%2C+I&amp;rft.au=Pal%2C+S&amp;rft.au=Pender%2C+N&amp;rft.au=Pinto-Grau%2C+M&amp;rft.au=Radakovic%2C+R&amp;rft.au=Shaw%2C+CE&amp;rft.au=Stephenson%2C+L&amp;rft.au=Swingler%2C+R&amp;rft.au=Vajda%2C+A&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Hardiman%2C+O&amp;rft.au=Abrahams%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6177274&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYangHouLiCao2021" class="citation journal cs1">Yang T, Hou Y, Li C, Cao B, Cheng Y, Wei Q,  et&#160;al. (July 2021). "Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis". <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>92</b> (7): 688–693. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2020-325701">10.1136/jnnp-2020-325701</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33563800">33563800</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:231858696">231858696</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Risk+factors+for+cognitive+impairment+in+amyotrophic+lateral+sclerosis%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=92&amp;rft.issue=7&amp;rft.pages=688-693&amp;rft.date=2021-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A231858696%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33563800&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2020-325701&amp;rft.aulast=Yang&amp;rft.aufirst=T&amp;rft.au=Hou%2C+Y&amp;rft.au=Li%2C+C&amp;rft.au=Cao%2C+B&amp;rft.au=Cheng%2C+Y&amp;rft.au=Wei%2C+Q&amp;rft.au=Zhang%2C+L&amp;rft.au=Shang%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWicks2007" class="citation journal cs1">Wicks P (July 2007). "Excessive yawning is common in the bulbar-onset form of ALS". <i>Acta Psychiatrica Scandinavica</i>. <b>116</b> (1): 76, author reply 76-76, author reply 77. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1600-0447.2007.01025.x">10.1111/j.1600-0447.2007.01025.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17559605">17559605</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:12807996">12807996</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Psychiatrica+Scandinavica&amp;rft.atitle=Excessive+yawning+is+common+in+the+bulbar-onset+form+of+ALS&amp;rft.volume=116&amp;rft.issue=1&amp;rft.pages=76%2C+author+reply+76-76%2C+author+reply+77&amp;rft.date=2007-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A12807996%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17559605&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.2007.01025.x&amp;rft.aulast=Wicks&amp;rft.aufirst=P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSauvé2016" class="citation journal cs1">Sauvé WM (December 2016). "Recognizing and treating pseudobulbar affect". <i>CNS Spectrums</i>. <b>21</b> (S1): 34–44. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FS1092852916000791">10.1017/S1092852916000791</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28044945">28044945</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:21066800">21066800</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Spectrums&amp;rft.atitle=Recognizing+and+treating+pseudobulbar+affect&amp;rft.volume=21&amp;rft.issue=S1&amp;rft.pages=34-44&amp;rft.date=2016-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21066800%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28044945&amp;rft_id=info%3Adoi%2F10.1017%2FS1092852916000791&amp;rft.aulast=Sauv%C3%A9&amp;rft.aufirst=WM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRaaphorstBeeldmanDe_VisserDe_Haan2012" class="citation journal cs1">Raaphorst J, Beeldman E, De Visser M, De Haan RJ, Schmand B (October 2012). "A systematic review of behavioural changes in motor neuron disease". <i>Amyotrophic Lateral Sclerosis</i>. <b>13</b> (6): 493–501. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F17482968.2012.656652">10.3109/17482968.2012.656652</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22424127">22424127</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22224140">22224140</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=A+systematic+review+of+behavioural+changes+in+motor+neuron+disease&amp;rft.volume=13&amp;rft.issue=6&amp;rft.pages=493-501&amp;rft.date=2012-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22224140%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22424127&amp;rft_id=info%3Adoi%2F10.3109%2F17482968.2012.656652&amp;rft.aulast=Raaphorst&amp;rft.aufirst=J&amp;rft.au=Beeldman%2C+E&amp;rft.au=De+Visser%2C+M&amp;rft.au=De+Haan%2C+RJ&amp;rft.au=Schmand%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-ALS-FTD-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-ALS-FTD_58-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCouratierCorciaLautretteNicol2017" class="citation journal cs1">Couratier P, Corcia P, Lautrette G, Nicol M, Marin B (May 2017). "ALS and frontotemporal dementia belong to a common disease spectrum". <i>Revue Neurologique</i>. <b>173</b> (5): 273–279. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.04.001">10.1016/j.neurol.2017.04.001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28449882">28449882</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=ALS+and+frontotemporal+dementia+belong+to+a+common+disease+spectrum&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=273-279&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.04.001&amp;rft_id=info%3Apmid%2F28449882&amp;rft.aulast=Couratier&amp;rft.aufirst=P&amp;rft.au=Corcia%2C+P&amp;rft.au=Lautrette%2C+G&amp;rft.au=Nicol%2C+M&amp;rft.au=Marin%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Neuroscience2014-59"><span class="mw-cite-backlink">^ <a href="#cite_ref-Neuroscience2014_59-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Neuroscience2014_59-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Neuroscience2014_59-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRentonChiòTraynor2014" class="citation journal cs1">Renton AE, Chiò A, Traynor BJ (January 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544832">"State of play in amyotrophic lateral sclerosis genetics"</a>. <i>Nature Neuroscience</i>. <b>17</b> (1): 17–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnn.3584">10.1038/nn.3584</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="https://hdl.handle.net/2318%2F156177">2318/156177</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544832">4544832</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24369373">24369373</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Neuroscience&amp;rft.atitle=State+of+play+in+amyotrophic+lateral+sclerosis+genetics&amp;rft.volume=17&amp;rft.issue=1&amp;rft.pages=17-23&amp;rft.date=2014-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4544832%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24369373&amp;rft_id=info%3Ahdl%2F2318%2F156177&amp;rft_id=info%3Adoi%2F10.1038%2Fnn.3584&amp;rft.aulast=Renton&amp;rft.aufirst=AE&amp;rft.au=Chi%C3%B2%2C+A&amp;rft.au=Traynor%2C+BJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4544832&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-2016cog-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-2016cog_60-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBeeldmanRaaphorstKlein_Twennaarde_Visser2016" class="citation journal cs1">Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, de Haan RJ (June 2016). "The cognitive profile of ALS: a systematic review and meta-analysis update". <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>87</b> (6): 611–619. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2015-310734">10.1136/jnnp-2015-310734</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26283685">26283685</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22082109">22082109</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=The+cognitive+profile+of+ALS%3A+a+systematic+review+and+meta-analysis+update&amp;rft.volume=87&amp;rft.issue=6&amp;rft.pages=611-619&amp;rft.date=2016-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22082109%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26283685&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2015-310734&amp;rft.aulast=Beeldman&amp;rft.aufirst=E&amp;rft.au=Raaphorst%2C+J&amp;rft.au=Klein+Twennaar%2C+M&amp;rft.au=de+Visser%2C+M&amp;rft.au=Schmand%2C+BA&amp;rft.au=de+Haan%2C+RJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Conspiracy-61"><span class="mw-cite-backlink">^ <a href="#cite_ref-Conspiracy_61-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Conspiracy_61-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Conspiracy_61-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Conspiracy_61-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAl-ChalabiHardiman2013" class="citation journal cs1">Al-Chalabi A, Hardiman O (November 2013). "The epidemiology of ALS: a conspiracy of genes, environment and time". <i>Nature Reviews. Neurology</i>. <b>9</b> (11): 617–628. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2013.203">10.1038/nrneurol.2013.203</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24126629">24126629</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25040863">25040863</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=The+epidemiology+of+ALS%3A+a+conspiracy+of+genes%2C+environment+and+time&amp;rft.volume=9&amp;rft.issue=11&amp;rft.pages=617-628&amp;rft.date=2013-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25040863%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24126629&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneurol.2013.203&amp;rft.aulast=Al-Chalabi&amp;rft.aufirst=A&amp;rft.au=Hardiman%2C+O&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Mayo_Clinic-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mayo_Clinic_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mayo_Clinic_62-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.mayoclinic.org/diseases-conditions/amyotrophic-lateral-sclerosis/symptoms-causes/syc-20354022">"Amyotrophic lateral sclerosis (ALS) - Symptoms and causes"</a>. <i>Mayo Clinic</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220406073949/https://www.mayoclinic.org/diseases-conditions/amyotrophic-lateral-sclerosis/symptoms-causes/syc-20354022">Archived</a> from the original on 6 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Mayo+Clinic&amp;rft.atitle=Amyotrophic+lateral+sclerosis+%28ALS%29+-+Symptoms+and+causes&amp;rft_id=https%3A%2F%2Fwww.mayoclinic.org%2Fdiseases-conditions%2Famyotrophic-lateral-sclerosis%2Fsymptoms-causes%2Fsyc-20354022&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-auto-63"><span class="mw-cite-backlink">^ <a href="#cite_ref-auto_63-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-auto_63-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.als.org/understanding-als/who-gets-als">"Who Gets ALS?"</a>. <i>The ALS Association</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220406153827/https://www.als.org/understanding-als/who-gets-als">Archived</a> from the original on 6 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+ALS+Association&amp;rft.atitle=Who+Gets+ALS%3F&amp;rft_id=https%3A%2F%2Fwww.als.org%2Funderstanding-als%2Fwho-gets-als&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-The_Neuroscientist_2015-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-The_Neuroscientist_2015_64-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHeMangelsdorfFanBartlett2015" class="citation journal cs1">He J, Mangelsdorf M, Fan D, Bartlett P, Brown MA (December 2015). <a rel="nofollow" class="external text" href="https://eprints.qut.edu.au/110861/2/UQ351652_OA.pdf">"Amyotrophic Lateral Sclerosis Genetic Studies: From Genome-wide Association Mapping to Genome Sequencing"</a> <span class="cs1-format">(PDF)</span>. <i>The Neuroscientist</i>. <b>21</b> (6): 599–615. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1073858414555404">10.1177/1073858414555404</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25378359">25378359</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3437565">3437565</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200507233727/https://eprints.qut.edu.au/110861/2/UQ351652_OA.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 7 May 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">20 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Neuroscientist&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis+Genetic+Studies%3A+From+Genome-wide+Association+Mapping+to+Genome+Sequencing&amp;rft.volume=21&amp;rft.issue=6&amp;rft.pages=599-615&amp;rft.date=2015-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3437565%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25378359&amp;rft_id=info%3Adoi%2F10.1177%2F1073858414555404&amp;rft.aulast=He&amp;rft.aufirst=J&amp;rft.au=Mangelsdorf%2C+M&amp;rft.au=Fan%2C+D&amp;rft.au=Bartlett%2C+P&amp;rft.au=Brown%2C+MA&amp;rft_id=https%3A%2F%2Feprints.qut.edu.au%2F110861%2F2%2FUQ351652_OA.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMcNeillAmadorBekkerClarke2022" class="citation journal cs1">McNeill A, Amador MD, Bekker H, Clarke A, Crook A, Cummings C,  et&#160;al. (June 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177585">"Predictive genetic testing for Motor neuron disease: time for a guideline?"</a>. <i>European Journal of Human Genetics</i>. <b>30</b> (6): 635–636. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41431-022-01093-y">10.1038/s41431-022-01093-y</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177585">9177585</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35379930">35379930</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Human+Genetics&amp;rft.atitle=Predictive+genetic+testing+for+Motor+neuron+disease%3A+time+for+a+guideline%3F&amp;rft.volume=30&amp;rft.issue=6&amp;rft.pages=635-636&amp;rft.date=2022-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9177585%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35379930&amp;rft_id=info%3Adoi%2F10.1038%2Fs41431-022-01093-y&amp;rft.aulast=McNeill&amp;rft.aufirst=A&amp;rft.au=Amador%2C+MD&amp;rft.au=Bekker%2C+H&amp;rft.au=Clarke%2C+A&amp;rft.au=Crook%2C+A&amp;rft.au=Cummings%2C+C&amp;rft.au=McEwen%2C+A&amp;rft.au=McDermott%2C+C&amp;rft.au=Quarrell%2C+O&amp;rft.au=Renieri%2C+A&amp;rft.au=Roggenbuck%2C+J&amp;rft.au=Salmon%2C+K&amp;rft.au=Volk%2C+A&amp;rft.au=Weishaupt%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9177585&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Goutman-2022-66"><span class="mw-cite-backlink">^ <a href="#cite_ref-Goutman-2022_66-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Goutman-2022_66-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Goutman-2022_66-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Goutman-2022_66-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Goutman-2022_66-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Goutman-2022_66-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Goutman-2022_66-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Goutman-2022_66-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGoutmanHardimanAl-ChalabiChió2022" class="citation journal cs1">Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, Feldman EL (May 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513754">"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis"</a>. <i>The Lancet. Neurology</i>. <b>21</b> (5): 465–479. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2821%2900414-2">10.1016/S1474-4422(21)00414-2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513754">9513754</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35334234">35334234</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Emerging+insights+into+the+complex+genetics+and+pathophysiology+of+amyotrophic+lateral+sclerosis&amp;rft.volume=21&amp;rft.issue=5&amp;rft.pages=465-479&amp;rft.date=2022-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9513754%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35334234&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2821%2900414-2&amp;rft.aulast=Goutman&amp;rft.aufirst=SA&amp;rft.au=Hardiman%2C+O&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Chi%C3%B3%2C+A&amp;rft.au=Savelieff%2C+MG&amp;rft.au=Kiernan%2C+MC&amp;rft.au=Feldman%2C+EL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9513754&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDe_OliveiraSomaBakerTurner2022" class="citation journal cs1">De Oliveira HM, Soma A, Baker MR, Turner MR, Talbot K, Williams TL (December 2022). "A survey of current practice in genetic testing in amyotrophic lateral sclerosis in the UK and Republic of Ireland: implications for future planning". <i>Amyotrophic Lateral Sclerosis &amp; Frontotemporal Degeneration</i>: 1–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21678421.2022.2150556">10.1080/21678421.2022.2150556</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/36458618">36458618</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:254150195">254150195</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+%26+Frontotemporal+Degeneration&amp;rft.atitle=A+survey+of+current+practice+in+genetic+testing+in+amyotrophic+lateral+sclerosis+in+the+UK+and+Republic+of+Ireland%3A+implications+for+future+planning&amp;rft.pages=1-9&amp;rft.date=2022-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A254150195%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F36458618&amp;rft_id=info%3Adoi%2F10.1080%2F21678421.2022.2150556&amp;rft.aulast=De+Oliveira&amp;rft.aufirst=HM&amp;rft.au=Soma%2C+A&amp;rft.au=Baker%2C+MR&amp;rft.au=Turner%2C+MR&amp;rft.au=Talbot%2C+K&amp;rft.au=Williams%2C+TL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMüllerOhNordinPanthi2022" class="citation journal cs1">Müller K, Oh KW, Nordin A, Panthi S, Kim SH, Nordin F,  et&#160;al. (February 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784989">"De novo mutations in <i>SOD1</i> are a cause of ALS"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>93</b> (2): 201–206. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2021-327520">10.1136/jnnp-2021-327520</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784989">8784989</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34518333">34518333</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=De+novo+mutations+in+%3Ci%3ESOD1%3C%2Fi%3E+are+a+cause+of+ALS&amp;rft.volume=93&amp;rft.issue=2&amp;rft.pages=201-206&amp;rft.date=2022-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8784989%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34518333&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2021-327520&amp;rft.aulast=M%C3%BCller&amp;rft.aufirst=K&amp;rft.au=Oh%2C+KW&amp;rft.au=Nordin%2C+A&amp;rft.au=Panthi%2C+S&amp;rft.au=Kim%2C+SH&amp;rft.au=Nordin%2C+F&amp;rft.au=Freischmidt%2C+A&amp;rft.au=Ludolph%2C+AC&amp;rft.au=Ki%2C+CS&amp;rft.au=Forsberg%2C+K&amp;rft.au=Weishaupt%2C+J&amp;rft.au=Kim%2C+YE&amp;rft.au=Andersen%2C+PM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8784989&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMcNeillAmadorBekkerClarke2022" class="citation journal cs1">McNeill A, Amador MD, Bekker H, Clarke A, Crook A, Cummings C,  et&#160;al. (International Alliance of ALS/MND Associations) (June 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177585">"Predictive genetic testing for Motor neuron disease: time for a guideline?"</a>. <i>European Journal of Human Genetics</i>. <b>30</b> (6): 635–636. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41431-022-01093-y">10.1038/s41431-022-01093-y</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177585">9177585</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35379930">35379930</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Human+Genetics&amp;rft.atitle=Predictive+genetic+testing+for+Motor+neuron+disease%3A+time+for+a+guideline%3F&amp;rft.volume=30&amp;rft.issue=6&amp;rft.pages=635-636&amp;rft.date=2022-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9177585%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35379930&amp;rft_id=info%3Adoi%2F10.1038%2Fs41431-022-01093-y&amp;rft.aulast=McNeill&amp;rft.aufirst=A&amp;rft.au=Amador%2C+MD&amp;rft.au=Bekker%2C+H&amp;rft.au=Clarke%2C+A&amp;rft.au=Crook%2C+A&amp;rft.au=Cummings%2C+C&amp;rft.au=McEwen%2C+A&amp;rft.au=McDermott%2C+C&amp;rft.au=Quarrell%2C+O&amp;rft.au=Renieri%2C+A&amp;rft.au=Roggenbuck%2C+J&amp;rft.au=Salmon%2C+K&amp;rft.au=Volk%2C+A&amp;rft.au=Weishaupt%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9177585&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSalmonKiernanKimAndersen2022" class="citation journal cs1">Salmon K, Kiernan MC, Kim SH, Andersen PM, Chio A, van den Berg LH,  et&#160;al. (May 2022). <a rel="nofollow" class="external text" href="https://academic.oup.com/brain/article/145/4/1207/6501632">"The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis"</a>. <i>Brain</i>. <b>145</b> (4): 1207–1210. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Fawab472">10.1093/brain/awab472</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129091">9129091</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35020823">35020823</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230527172816/https://academic.oup.com/brain/article/145/4/1207/6501632">Archived</a> from the original on 27 May 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">27 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain&amp;rft.atitle=The+importance+of+offering+early+genetic+testing+in+everyone+with+amyotrophic+lateral+sclerosis&amp;rft.volume=145&amp;rft.issue=4&amp;rft.pages=1207-1210&amp;rft.date=2022-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9129091%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35020823&amp;rft_id=info%3Adoi%2F10.1093%2Fbrain%2Fawab472&amp;rft.aulast=Salmon&amp;rft.aufirst=K&amp;rft.au=Kiernan%2C+MC&amp;rft.au=Kim%2C+SH&amp;rft.au=Andersen%2C+PM&amp;rft.au=Chio%2C+A&amp;rft.au=van+den+Berg%2C+LH&amp;rft.au=Van+Damme%2C+P&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Lillo%2C+P&amp;rft.au=Andrews%2C+JA&amp;rft.au=Genge%2C+A&amp;rft_id=https%3A%2F%2Facademic.oup.com%2Fbrain%2Farticle%2F145%2F4%2F1207%2F6501632&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGoutmanHardimanAl-ChalabiChió2022" class="citation journal cs1">Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, Feldman EL (May 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513754">"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis"</a>. <i>The Lancet. Neurology</i>. <b>21</b> (5): 465–479. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2821%2900414-2">10.1016/S1474-4422(21)00414-2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513754">9513754</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35334234">35334234</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Emerging+insights+into+the+complex+genetics+and+pathophysiology+of+amyotrophic+lateral+sclerosis&amp;rft.volume=21&amp;rft.issue=5&amp;rft.pages=465-479&amp;rft.date=2022-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9513754%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35334234&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2821%2900414-2&amp;rft.aulast=Goutman&amp;rft.aufirst=SA&amp;rft.au=Hardiman%2C+O&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Chi%C3%B3%2C+A&amp;rft.au=Savelieff%2C+MG&amp;rft.au=Kiernan%2C+MC&amp;rft.au=Feldman%2C+EL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9513754&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-:0-72"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_72-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_72-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWangLittleGomesCashman2017" class="citation journal cs1">Wang MD, Little J, Gomes J, Cashman NR, Krewski D (July 2017). <a rel="nofollow" class="external text" href="https://linkinghub.elsevier.com/retrieve/pii/S0161813X16301164">"Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis"</a>. <i>Neurotoxicology</i>. <b>61</b>: 101–130. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuro.2016.06.015">10.1016/j.neuro.2016.06.015</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27377857">27377857</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:33604904">33604904</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221117202809/https://linkinghub.elsevier.com/retrieve/pii/S0161813X16301164">Archived</a> from the original on 17 November 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">27 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurotoxicology&amp;rft.atitle=Identification+of+risk+factors+associated+with+onset+and+progression+of+amyotrophic+lateral+sclerosis+using+systematic+review+and+meta-analysis&amp;rft.volume=61&amp;rft.pages=101-130&amp;rft.date=2017-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A33604904%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27377857&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuro.2016.06.015&amp;rft.aulast=Wang&amp;rft.aufirst=MD&amp;rft.au=Little%2C+J&amp;rft.au=Gomes%2C+J&amp;rft.au=Cashman%2C+NR&amp;rft.au=Krewski%2C+D&amp;rft_id=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0161813X16301164&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFJ.A._Parkin_Kullmann,_Susan_Hayes_and_Roger_Pamphlett2018" class="citation journal cs1">J.A. Parkin Kullmann, Susan Hayes and Roger Pamphlett (2018). "Are people with amyotrophic lateral sclerosis (ALS) particularly nice? An international online case–control study of the Big Five personality factors". <i>Brain and Behavior</i>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fbrb3.1119">10.1002/brb3.1119</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+and+Behavior&amp;rft.atitle=Are+people+with+amyotrophic+lateral+sclerosis+%28ALS%29+particularly+nice%3F+An+international+online+case%E2%80%93control+study+of+the+Big+Five+personality+factors&amp;rft.date=2018&amp;rft_id=info%3Adoi%2F10.1002%2Fbrb3.1119&amp;rft.au=J.A.+Parkin+Kullmann%2C+Susan+Hayes+and+Roger+Pamphlett&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRobberechtPhilips2013" class="citation journal cs1">Robberecht W, Philips T (April 2013). "The changing scene of amyotrophic lateral sclerosis". <i>Nature Reviews. Neuroscience</i>. <b>14</b> (4): 248–264. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrn3430">10.1038/nrn3430</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23463272">23463272</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:208941">208941</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neuroscience&amp;rft.atitle=The+changing+scene+of+amyotrophic+lateral+sclerosis&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=248-264&amp;rft.date=2013-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A208941%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23463272&amp;rft_id=info%3Adoi%2F10.1038%2Fnrn3430&amp;rft.aulast=Robberecht&amp;rft.aufirst=W&amp;rft.au=Philips%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-NEJM_2017-75"><span class="mw-cite-backlink">^ <a href="#cite_ref-NEJM_2017_75-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NEJM_2017_75-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NEJM_2017_75-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NEJM_2017_75-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NEJM_2017_75-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NEJM_2017_75-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NEJM_2017_75-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NEJM_2017_75-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBrownAl-Chalabi2017" class="citation journal cs1">Brown RH, Al-Chalabi A (July 2017). <a rel="nofollow" class="external text" href="https://kclpure.kcl.ac.uk/portal/en/publications/amyotrophic-lateral-sclerosis(70a10b6b-0121-46ae-896b-7108a6666dcb).html">"Amyotrophic Lateral Sclerosis"</a>. <i>The New England Journal of Medicine</i>. <b>377</b> (2): 162–172. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMra1603471">10.1056/NEJMra1603471</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28700839">28700839</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205117619">205117619</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210225022352/https://kclpure.kcl.ac.uk/portal/en/publications/amyotrophic-lateral-sclerosis(70a10b6b-0121-46ae-896b-7108a6666dcb).html">Archived</a> from the original on 25 February 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">20 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis&amp;rft.volume=377&amp;rft.issue=2&amp;rft.pages=162-172&amp;rft.date=2017-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205117619%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28700839&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra1603471&amp;rft.aulast=Brown&amp;rft.aufirst=RH&amp;rft.au=Al-Chalabi%2C+A&amp;rft_id=https%3A%2F%2Fkclpure.kcl.ac.uk%2Fportal%2Fen%2Fpublications%2Famyotrophic-lateral-sclerosis%2870a10b6b-0121-46ae-896b-7108a6666dcb%29.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Okamoto-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-Okamoto_76-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFOkamotoMizunoFujita2008" class="citation journal cs1">Okamoto K, Mizuno Y, Fujita Y (April 2008). "Bunina bodies in amyotrophic lateral sclerosis". <i>Neuropathology</i>. <b>28</b> (2): 109–115. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1440-1789.2007.00873.x">10.1111/j.1440-1789.2007.00873.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18069968">18069968</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34398467">34398467</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropathology&amp;rft.atitle=Bunina+bodies+in+amyotrophic+lateral+sclerosis&amp;rft.volume=28&amp;rft.issue=2&amp;rft.pages=109-115&amp;rft.date=2008-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34398467%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18069968&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1440-1789.2007.00873.x&amp;rft.aulast=Okamoto&amp;rft.aufirst=K&amp;rft.au=Mizuno%2C+Y&amp;rft.au=Fujita%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-White-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-White_77-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWhiteBanerjeeGunawardena2016" class="citation journal cs1">White JA, Banerjee R, Gunawardena S (May 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882576">"Axonal Transport and Neurodegeneration: How Marine Drugs Can Be Used for the Development of Therapeutics"</a>. <i>Marine Drugs</i>. <b>14</b> (5): 102. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fmd14050102">10.3390/md14050102</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882576">4882576</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27213408">27213408</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Marine+Drugs&amp;rft.atitle=Axonal+Transport+and+Neurodegeneration%3A+How+Marine+Drugs+Can+Be+Used+for+the+Development+of+Therapeutics&amp;rft.volume=14&amp;rft.issue=5&amp;rft.pages=102&amp;rft.date=2016-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4882576%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27213408&amp;rft_id=info%3Adoi%2F10.3390%2Fmd14050102&amp;rft.aulast=White&amp;rft.aufirst=JA&amp;rft.au=Banerjee%2C+R&amp;rft.au=Gunawardena%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4882576&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFNg_Kee_KwongMehtaNedergaardChandran2020" class="citation journal cs1">Ng Kee Kwong KC, Mehta AR, Nedergaard M, Chandran S (August 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439665">"Defining novel functions for cerebrospinal fluid in ALS pathophysiology"</a>. <i>Acta Neuropathologica Communications</i>. <b>8</b> (1): 140. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs40478-020-01018-0">10.1186/s40478-020-01018-0</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439665">7439665</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32819425">32819425</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Neuropathologica+Communications&amp;rft.atitle=Defining+novel+functions+for+cerebrospinal+fluid+in+ALS+pathophysiology&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=140&amp;rft.date=2020-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7439665%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32819425&amp;rft_id=info%3Adoi%2F10.1186%2Fs40478-020-01018-0&amp;rft.aulast=Ng+Kee+Kwong&amp;rft.aufirst=KC&amp;rft.au=Mehta%2C+AR&amp;rft.au=Nedergaard%2C+M&amp;rft.au=Chandran%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7439665&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Modelling_ALS-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-Modelling_ALS_79-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPhilip_Van_DammeRobberechtVan_Den_Bosch2017" class="citation journal cs1">Philip Van Damme P, Robberecht W, Van Den Bosch L (May 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451175">"Modelling amyotrophic lateral sclerosis: progress and possibilities"</a>. <i>Disease Models and Mechanisms</i>. <b>10</b> (5): 537–549. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1242%2Fdmm.029058">10.1242/dmm.029058</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451175">5451175</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28468939">28468939</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Disease+Models+and+Mechanisms&amp;rft.atitle=Modelling+amyotrophic+lateral+sclerosis%3A+progress+and+possibilities&amp;rft.volume=10&amp;rft.issue=5&amp;rft.pages=537-549&amp;rft.date=2017-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5451175%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28468939&amp;rft_id=info%3Adoi%2F10.1242%2Fdmm.029058&amp;rft.aulast=Philip+Van+Damme&amp;rft.aufirst=P&amp;rft.au=Robberecht%2C+W&amp;rft.au=Van+Den+Bosch%2C+L&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5451175&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Trends_in_Genetics_2018-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-Trends_in_Genetics_2018_80-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFNguyenVan_Broeckhovenvan_der_Zee2018" class="citation journal cs1">Nguyen HP, Van Broeckhoven C, van der Zee J (June 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tig.2018.03.001">"ALS Genes in the Genomic Era and their Implications for FTD"</a>. <i>Trends in Genetics</i>. <b>34</b> (6): 404–423. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tig.2018.03.001">10.1016/j.tig.2018.03.001</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29605155">29605155</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Genetics&amp;rft.atitle=ALS+Genes+in+the+Genomic+Era+and+their+Implications+for+FTD&amp;rft.volume=34&amp;rft.issue=6&amp;rft.pages=404-423&amp;rft.date=2018-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tig.2018.03.001&amp;rft_id=info%3Apmid%2F29605155&amp;rft.aulast=Nguyen&amp;rft.aufirst=HP&amp;rft.au=Van+Broeckhoven%2C+C&amp;rft.au=van+der+Zee%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.tig.2018.03.001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-link.springer.com-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-link.springer.com_81-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMehtaGregoryDandoCarter2021" class="citation journal cs1">Mehta AR, Gregory JM, Dando O, Carter RN, Burr K, Nanda J,  et&#160;al. (February 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847443">"Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis"</a>. <i>Acta Neuropathologica</i>. <b>141</b> (2): 257–279. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00401-020-02252-5">10.1007/s00401-020-02252-5</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847443">7847443</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33398403">33398403</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Neuropathologica&amp;rft.atitle=Mitochondrial+bioenergetic+deficits+in+C9orf72+amyotrophic+lateral+sclerosis+motor+neurons+cause+dysfunctional+axonal+homeostasis&amp;rft.volume=141&amp;rft.issue=2&amp;rft.pages=257-279&amp;rft.date=2021-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7847443%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33398403&amp;rft_id=info%3Adoi%2F10.1007%2Fs00401-020-02252-5&amp;rft.aulast=Mehta&amp;rft.aufirst=AR&amp;rft.au=Gregory%2C+JM&amp;rft.au=Dando%2C+O&amp;rft.au=Carter%2C+RN&amp;rft.au=Burr%2C+K&amp;rft.au=Nanda%2C+J&amp;rft.au=Story%2C+D&amp;rft.au=McDade%2C+K&amp;rft.au=Smith%2C+C&amp;rft.au=Morton%2C+NM&amp;rft.au=Mahad%2C+DJ&amp;rft.au=Hardingham%2C+GE&amp;rft.au=Chandran%2C+S&amp;rft.au=Selvaraj%2C+BT&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7847443&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFVerberShepheardSassaniMcDonough2019" class="citation journal cs1">Verber NS, Shepheard SR, Sassani M, McDonough HE, Moore SA, Alix JJ,  et&#160;al. (2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456669">"Biomarkers in Motor Neuron Disease: A State of the Art Review"</a>. <i>Frontiers in Neurology</i>. <b>10</b>: 291. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffneur.2019.00291">10.3389/fneur.2019.00291</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456669">6456669</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31001186">31001186</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neurology&amp;rft.atitle=Biomarkers+in+Motor+Neuron+Disease%3A+A+State+of+the+Art+Review&amp;rft.volume=10&amp;rft.pages=291&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6456669%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31001186&amp;rft_id=info%3Adoi%2F10.3389%2Ffneur.2019.00291&amp;rft.aulast=Verber&amp;rft.aufirst=NS&amp;rft.au=Shepheard%2C+SR&amp;rft.au=Sassani%2C+M&amp;rft.au=McDonough%2C+HE&amp;rft.au=Moore%2C+SA&amp;rft.au=Alix%2C+JJ&amp;rft.au=Wilkinson%2C+ID&amp;rft.au=Jenkins%2C+TM&amp;rft.au=Shaw%2C+PJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6456669&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRissardoCaprara2019" class="citation journal cs1">Rissardo JP, Caprara AL (2019). <a rel="nofollow" class="external text" href="http://www.cmijournal.org/text.asp?2019/17/4/155/272798">"Mimicking amyotrophic lateral sclerosis: Cervical spondylotic myelopathy"</a>. <i>Current Medical Issues</i>. <b>17</b> (4): 155. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4103%2Fcmi.cmi_36_19">10.4103/cmi.cmi_36_19</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/0973-4651">0973-4651</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:209377175">209377175</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220125123901/https://www.cmijournal.org/text.asp?2019%2F17%2F4%2F155%2F272798">Archived</a> from the original on 25 January 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">25 January</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Medical+Issues&amp;rft.atitle=Mimicking+amyotrophic+lateral+sclerosis%3A+Cervical+spondylotic+myelopathy&amp;rft.volume=17&amp;rft.issue=4&amp;rft.pages=155&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A209377175%23id-name%3DS2CID&amp;rft.issn=0973-4651&amp;rft_id=info%3Adoi%2F10.4103%2Fcmi.cmi_36_19&amp;rft.aulast=Rissardo&amp;rft.aufirst=JP&amp;rft.au=Caprara%2C+AL&amp;rft_id=http%3A%2F%2Fwww.cmijournal.org%2Ftext.asp%3F2019%2F17%2F4%2F155%2F272798&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSilaniMessinaPolettiMorelli2011" class="citation journal cs1">Silani V, Messina S, Poletti B, Morelli C, Doretti A, Ticozzi N, Maderna L (March 2011). "The diagnosis of Amyotrophic lateral sclerosis in 2010". <i>Archives Italiennes de Biologie</i>. <b>149</b> (1): 5–27. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4449%2Faib.v149i1.1260">10.4449/aib.v149i1.1260</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21412713">21412713</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+Italiennes+de+Biologie&amp;rft.atitle=The+diagnosis+of+Amyotrophic+lateral+sclerosis+in+2010&amp;rft.volume=149&amp;rft.issue=1&amp;rft.pages=5-27&amp;rft.date=2011-03&amp;rft_id=info%3Adoi%2F10.4449%2Faib.v149i1.1260&amp;rft_id=info%3Apmid%2F21412713&amp;rft.aulast=Silani&amp;rft.aufirst=V&amp;rft.au=Messina%2C+S&amp;rft.au=Poletti%2C+B&amp;rft.au=Morelli%2C+C&amp;rft.au=Doretti%2C+A&amp;rft.au=Ticozzi%2C+N&amp;rft.au=Maderna%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFStickler" class="citation web cs1">Stickler DE.  Lorenzo N (ed.). <a rel="nofollow" class="external text" href="http://misc.medscape.com/pi/android/medscapeapp/html/A1170810-business.html">"Lambert-Eaton Myasthenic Syndrome (LEMS)"</a>. Misc.medscape.com. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130514014534/http://misc.medscape.com/pi/android/medscapeapp/html/A1170810-business.html">Archived</a> from the original on 14 May 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">18 April</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lambert-Eaton+Myasthenic+Syndrome+%28LEMS%29&amp;rft.pub=Misc.medscape.com&amp;rft.aulast=Stickler&amp;rft.aufirst=DE&amp;rft_id=http%3A%2F%2Fmisc.medscape.com%2Fpi%2Fandroid%2Fmedscapeapp%2Fhtml%2FA1170810-business.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130120025113/http://www.lems.com/what_is_lems">"Lambert-Eaton Myasthenic Syndrome: About"</a>. <i>LEMS.com</i>. BioMarin Pharmaceutical Inc. Archived from <a rel="nofollow" class="external text" href="http://www.lems.com/what_is_lems">the original</a> on 20 January 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">18 April</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=LEMS.com&amp;rft.atitle=Lambert-Eaton+Myasthenic+Syndrome%3A+About&amp;rft_id=http%3A%2F%2Fwww.lems.com%2Fwhat_is_lems&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMills2010" class="citation journal cs1">Mills KR (November 2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Fawq290">"Characteristics of fasciculations in amyotrophic lateral sclerosis and the benign fasciculation syndrome"</a>. <i>Brain</i>. <b>133</b> (11): 3458–3469. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Fawq290">10.1093/brain/awq290</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20959307">20959307</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain&amp;rft.atitle=Characteristics+of+fasciculations+in+amyotrophic+lateral+sclerosis+and+the+benign+fasciculation+syndrome&amp;rft.volume=133&amp;rft.issue=11&amp;rft.pages=3458-3469&amp;rft.date=2010-11&amp;rft_id=info%3Adoi%2F10.1093%2Fbrain%2Fawq290&amp;rft_id=info%3Apmid%2F20959307&amp;rft.aulast=Mills&amp;rft.aufirst=KR&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fbrain%252Fawq290&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Edaravone_Trial-88"><span class="mw-cite-backlink">^ <a href="#cite_ref-Edaravone_Trial_88-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Edaravone_Trial_88-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAbeMasashiTsujiItoyama2017" class="citation journal cs1">Abe K, Masashi A, Tsuji S, Itoyama Y, Sobue G, Togo M,  et&#160;al. (July 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2817%2930115-1">"Safety and efficacy of edaravone in well-defined patients with amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial"</a>. <i>The Lancet. Neurology</i>. <b>16</b> (7): 505–512. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2817%2930115-1">10.1016/S1474-4422(17)30115-1</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28522181">28522181</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Safety+and+efficacy+of+edaravone+in+well-defined+patients+with+amyotrophic+lateral+sclerosis%3A+a+randomized%2C+double-blind%2C+placebo-controlled+trial.&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=505-512&amp;rft.date=2017-07&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2817%2930115-1&amp;rft_id=info%3Apmid%2F28522181&amp;rft.aulast=Abe&amp;rft.aufirst=K&amp;rft.au=Masashi%2C+A&amp;rft.au=Tsuji%2C+S&amp;rft.au=Itoyama%2C+Y&amp;rft.au=Sobue%2C+G&amp;rft.au=Togo%2C+M&amp;rft.au=Hamada%2C+C&amp;rft.au=Tanaka%2C+M&amp;rft.au=Akimoto%2C+M&amp;rft.au=Nakamura%2C+K&amp;rft.au=Takahashi%2C+F&amp;rft.au=Kondo%2C+K&amp;rft.au=Yoshino%2C+H&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS1474-4422%252817%252930115-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Eda2018-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-Eda2018_89-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYeoSimmons2018" class="citation journal cs1">Yeo CJ, Simmons Z (May 2018). "Discussing edaravone with the ALS patient: an ethical framework from a U.S. perspective". <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>. <b>19</b> (3–4): 167–172. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21678421.2018.1425455">10.1080/21678421.2018.1425455</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29334251">29334251</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4627647">4627647</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+and+Frontotemporal+Degeneration&amp;rft.atitle=Discussing+edaravone+with+the+ALS+patient%3A+an+ethical+framework+from+a+U.S.+perspective&amp;rft.volume=19&amp;rft.issue=3%E2%80%934&amp;rft.pages=167-172&amp;rft.date=2018-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4627647%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29334251&amp;rft_id=info%3Adoi%2F10.1080%2F21678421.2018.1425455&amp;rft.aulast=Yeo&amp;rft.aufirst=CJ&amp;rft.au=Simmons%2C+Z&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-British_Medical_Bulletin-90"><span class="mw-cite-backlink">^ <a href="#cite_ref-British_Medical_Bulletin_90-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-British_Medical_Bulletin_90-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-British_Medical_Bulletin_90-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-British_Medical_Bulletin_90-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFOrrell2010" class="citation journal cs1">Orrell RW (2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbmb%2Fldp049">"Motor neuron disease: systematic reviews of treatment for ALS and SMA"</a>. <i>British Medical Bulletin</i>. <b>93</b>: 145–159. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbmb%2Fldp049">10.1093/bmb/ldp049</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20015852">20015852</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Bulletin&amp;rft.atitle=Motor+neuron+disease%3A+systematic+reviews+of+treatment+for+ALS+and+SMA&amp;rft.volume=93&amp;rft.pages=145-159&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1093%2Fbmb%2Fldp049&amp;rft_id=info%3Apmid%2F20015852&amp;rft.aulast=Orrell&amp;rft.aufirst=RW&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fbmb%252Fldp049&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Cochrane_NIV-91"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cochrane_NIV_91-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cochrane_NIV_91-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRadunovicAnnaneRafiqBrassington2017" class="citation journal cs1">Radunovic A, Annane D, Rafiq M, Brassington R, Mustfa N (6 October 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485636">"Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>10</b> (10): CD004427. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD004427.pub4">10.1002/14651858.CD004427.pub4</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485636">6485636</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28982219">28982219</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Mechanical+ventilation+for+amyotrophic+lateral+sclerosis%2Fmotor+neuron+disease&amp;rft.volume=10&amp;rft.issue=10&amp;rft.pages=CD004427&amp;rft.date=2017-10-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6485636%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28982219&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004427.pub4&amp;rft.aulast=Radunovic&amp;rft.aufirst=A&amp;rft.au=Annane%2C+D&amp;rft.au=Rafiq%2C+M&amp;rft.au=Brassington%2C+R&amp;rft.au=Mustfa%2C+N&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6485636&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Sleep_Disorders_and_Respiratory_Function-92"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sleep_Disorders_and_Respiratory_Function_92-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sleep_Disorders_and_Respiratory_Function_92-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sleep_Disorders_and_Respiratory_Function_92-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAhmedNewcombePiperLewis2016" class="citation journal cs1">Ahmed R, Newcombe R, Piper A, Lewis S, Yee B, Kiernan M, Grunstein R (April 2016). "Sleep disorders and respiratory function in amyotrophic lateral sclerosis". <i>Sleep Medicine Reviews</i>. <b>26</b>: 33–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.smrv.2015.05.007">10.1016/j.smrv.2015.05.007</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26166297">26166297</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sleep+Medicine+Reviews&amp;rft.atitle=Sleep+disorders+and+respiratory+function+in+amyotrophic+lateral+sclerosis&amp;rft.volume=26&amp;rft.pages=33-42&amp;rft.date=2016-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.smrv.2015.05.007&amp;rft_id=info%3Apmid%2F26166297&amp;rft.aulast=Ahmed&amp;rft.aufirst=R&amp;rft.au=Newcombe%2C+R&amp;rft.au=Piper%2C+A&amp;rft.au=Lewis%2C+S&amp;rft.au=Yee%2C+B&amp;rft.au=Kiernan%2C+M&amp;rft.au=Grunstein%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-ALS_Ethics-93"><span class="mw-cite-backlink">^ <a href="#cite_ref-ALS_Ethics_93-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ALS_Ethics_93-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFEisenKrieger2013" class="citation journal cs1">Eisen A, Krieger C (November 2013). "Ethical considerations in the management of amyotrophic lateral sclerosis". <i>Progress in Neurobiology</i>. <b>110</b>: 45–53. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.pneurobio.2013.05.001">10.1016/j.pneurobio.2013.05.001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23735671">23735671</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:26282198">26282198</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Neurobiology&amp;rft.atitle=Ethical+considerations+in+the+management+of+amyotrophic+lateral+sclerosis&amp;rft.volume=110&amp;rft.pages=45-53&amp;rft.date=2013-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A26282198%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23735671&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pneurobio.2013.05.001&amp;rft.aulast=Eisen&amp;rft.aufirst=A&amp;rft.au=Krieger%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Lewis_&amp;_Rushanan-94"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lewis_&amp;_Rushanan_94-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lewis_&amp;_Rushanan_94-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLewisRushanan2007" class="citation journal cs1">Lewis M, Rushanan S (2007). "The role of physical therapy and occupational therapy in the treatment of amyotrophic lateral sclerosis". <i>NeuroRehabilitation</i>. <b>22</b> (6): 451–461. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FNRE-2007-22608">10.3233/NRE-2007-22608</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18198431">18198431</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NeuroRehabilitation&amp;rft.atitle=The+role+of+physical+therapy+and+occupational+therapy+in+the+treatment+of+amyotrophic+lateral+sclerosis&amp;rft.volume=22&amp;rft.issue=6&amp;rft.pages=451-461&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.3233%2FNRE-2007-22608&amp;rft_id=info%3Apmid%2F18198431&amp;rft.aulast=Lewis&amp;rft.aufirst=M&amp;rft.au=Rushanan%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-asha-95"><span class="mw-cite-backlink">^ <a href="#cite_ref-asha_95-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-asha_95-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-asha_95-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-asha_95-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-asha_95-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120802064043/http://www.asha.org/public/speech/disorders/ALS/">"Amyotrophic Lateral Sclerosis (ALS)"</a>. American Speech-Language-Hearing Association, Rockville, MD. Archived from <a rel="nofollow" class="external text" href="http://www.asha.org/public/speech/disorders/ALS/">the original</a> on 2 August 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">30 November</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amyotrophic+Lateral+Sclerosis+%28ALS%29&amp;rft.pub=American+Speech-Language-Hearing+Association%2C+Rockville%2C+MD&amp;rft_id=http%3A%2F%2Fwww.asha.org%2Fpublic%2Fspeech%2Fdisorders%2FALS%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-ajop-96"><span class="mw-cite-backlink">^ <a href="#cite_ref-ajop_96-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ajop_96-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ajop_96-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFArbesmanSheard2014" class="citation journal cs1">Arbesman M, Sheard K (2014). <a rel="nofollow" class="external text" href="https://doi.org/10.5014%2Fajot.2014.008649">"Systematic review of the effectiveness of occupational therapy-related interventions for people with amyotrophic lateral sclerosis"</a>. <i>The American Journal of Occupational Therapy</i>. <b>68</b> (1): 20–26. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.5014%2Fajot.2014.008649">10.5014/ajot.2014.008649</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24367951">24367951</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Occupational+Therapy&amp;rft.atitle=Systematic+review+of+the+effectiveness+of+occupational+therapy-related+interventions+for+people+with+amyotrophic+lateral+sclerosis&amp;rft.volume=68&amp;rft.issue=1&amp;rft.pages=20-26&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.5014%2Fajot.2014.008649&amp;rft_id=info%3Apmid%2F24367951&amp;rft.aulast=Arbesman&amp;rft.aufirst=M&amp;rft.au=Sheard%2C+K&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.5014%252Fajot.2014.008649&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Cochrane_Tube_Feeding-97"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cochrane_Tube_Feeding_97-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cochrane_Tube_Feeding_97-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKatzbergBenatar2011" class="citation journal cs1">Katzberg HD, Benatar M (January 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163276">"Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2011</b> (1): CD004030. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD004030.pub3">10.1002/14651858.CD004030.pub3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163276">7163276</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21249659">21249659</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Enteral+tube+feeding+for+amyotrophic+lateral+sclerosis%2Fmotor+neuron+disease&amp;rft.volume=2011&amp;rft.issue=1&amp;rft.pages=CD004030&amp;rft.date=2011-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7163276%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21249659&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004030.pub3&amp;rft.aulast=Katzberg&amp;rft.aufirst=HD&amp;rft.au=Benatar%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7163276&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-EFNS_2012-98"><span class="mw-cite-backlink">^ <a href="#cite_ref-EFNS_2012_98-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-EFNS_2012_98-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-EFNS_2012_98-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAndersenAbrahamsBorasiode_Carvalho2012" class="citation journal cs1">Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P,  et&#160;al. (March 2012). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1468-1331.2011.03501.x">"EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force"</a>. <i>European Journal of Neurology</i>. <b>19</b> (3): 360–375. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1468-1331.2011.03501.x">10.1111/j.1468-1331.2011.03501.x</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21914052">21914052</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5746940">5746940</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Neurology&amp;rft.atitle=EFNS+guidelines+on+the+Clinical+Management+of+Amyotrophic+Lateral+Sclerosis+%28MALS%29+%E2%80%93+revised+report+of+an+EFNS+task+force&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=360-375&amp;rft.date=2012-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5746940%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21914052&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1468-1331.2011.03501.x&amp;rft.aulast=Andersen&amp;rft.aufirst=PM&amp;rft.au=Abrahams%2C+S&amp;rft.au=Borasio%2C+GD&amp;rft.au=de+Carvalho%2C+M&amp;rft.au=Chio%2C+A&amp;rft.au=Van+Damme%2C+P&amp;rft.au=Hardiman%2C+O&amp;rft.au=Kollewe%2C+K&amp;rft.au=Morrison%2C+KE&amp;rft.au=Petri%2C+S&amp;rft.au=Pradat%2C+PF&amp;rft.au=Silani%2C+V&amp;rft.au=Tomik%2C+B&amp;rft.au=Wasner%2C+M&amp;rft.au=Weber%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fj.1468-1331.2011.03501.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCarlesiPasqualiPiazzaLo_Gerfo2011" class="citation journal cs1">Carlesi C, Pasquali L, Piazza S, Lo Gerfo A, Caldarazzo Ienco E, Alessi R, Fornai F, Siciliano G (March 2011). "Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis". <i>Archives Italiennes de Biologie</i>. <b>149</b> (1): 151–167. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4449%2Faib.v149i1.1267">10.4449/aib.v149i1.1267</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21412722">21412722</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+Italiennes+de+Biologie&amp;rft.atitle=Strategies+for+clinical+approach+to+neurodegeneration+in+Amyotrophic+lateral+sclerosis&amp;rft.volume=149&amp;rft.issue=1&amp;rft.pages=151-167&amp;rft.date=2011-03&amp;rft_id=info%3Adoi%2F10.4449%2Faib.v149i1.1267&amp;rft_id=info%3Apmid%2F21412722&amp;rft.aulast=Carlesi&amp;rft.aufirst=C&amp;rft.au=Pasquali%2C+L&amp;rft.au=Piazza%2C+S&amp;rft.au=Lo+Gerfo%2C+A&amp;rft.au=Caldarazzo+Ienco%2C+E&amp;rft.au=Alessi%2C+R&amp;rft.au=Fornai%2C+F&amp;rft.au=Siciliano%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.als.org/navigating-als/living-with-als/fda-approved-drugs">"FDA-Approved Drugs for Treating ALS"</a>. <i>The ALS Association</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230425205601/https://www.als.org/navigating-als/living-with-als/fda-approved-drugs">Archived</a> from the original on 25 April 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">25 April</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+ALS+Association&amp;rft.atitle=FDA-Approved+Drugs+for+Treating+ALS&amp;rft_id=https%3A%2F%2Fwww.als.org%2Fnavigating-als%2Fliving-with-als%2Ffda-approved-drugs&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Therapeutic_Advances_in_Neurological_Disorders-101"><span class="mw-cite-backlink">^ <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_101-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDorstLudolphHuebers2018" class="citation journal cs1">Dorst J, Ludolph A, Huebers A (2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784546">"Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis"</a>. <i>Therapeutic Advances in Neurological Disorders</i>. <b>11</b>: 1756285617734734. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1756285617734734">10.1177/1756285617734734</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784546">5784546</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29399045">29399045</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Therapeutic+Advances+in+Neurological+Disorders&amp;rft.atitle=Disease-modifying+and+symptomatic+treatment+of+amyotrophic+lateral+sclerosis&amp;rft.volume=11&amp;rft.pages=1756285617734734&amp;rft.date=2018&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5784546%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29399045&amp;rft_id=info%3Adoi%2F10.1177%2F1756285617734734&amp;rft.aulast=Dorst&amp;rft.aufirst=J&amp;rft.au=Ludolph%2C+A&amp;rft.au=Huebers%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5784546&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Edaravone&#39;s_Clinical_Development-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-Edaravone&#39;s_Clinical_Development_102-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTakeiWatanabeYukiAkimoto2017" class="citation journal cs1">Takei K, Watanabe K, Yuki S, Akimoto M, Sakata T, Palumbo J (October 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21678421.2017.1353101">"Edaravone and its clinical development for amyotrophic lateral sclerosis"</a>. <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>. <b>18</b> (sup 1): 5–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21678421.2017.1353101">10.1080/21678421.2017.1353101</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28872907">28872907</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+and+Frontotemporal+Degeneration&amp;rft.atitle=Edaravone+and+its+clinical+development+for+amyotrophic+lateral+sclerosis&amp;rft.volume=18&amp;rft.issue=sup+1&amp;rft.pages=5-10&amp;rft.date=2017-10&amp;rft_id=info%3Adoi%2F10.1080%2F21678421.2017.1353101&amp;rft_id=info%3Apmid%2F28872907&amp;rft.aulast=Takei&amp;rft.aufirst=K&amp;rft.au=Watanabe%2C+K&amp;rft.au=Yuki%2C+S&amp;rft.au=Akimoto%2C+M&amp;rft.au=Sakata%2C+T&amp;rft.au=Palumbo%2C+J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1080%252F21678421.2017.1353101&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCenter_for_Drug_Evaluation_and_Research2022" class="citation web cs1">Center for Drug Evaluation and Research (16 June 2022). <a rel="nofollow" class="external text" href="https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-oral-form-treatment-adults-amyotrophic-lateral-sclerosis-als">"FDA Approves Oral Form for the treatment of adults with amyotrophic lateral sclerosis (ALS)"</a>. U.S. Food and Drug Administration. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220512203805/https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-oral-form-treatment-adults-amyotrophic-lateral-sclerosis-als">Archived</a> from the original on 12 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">25 April</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Approves+Oral+Form+for+the+treatment+of+adults+with+amyotrophic+lateral+sclerosis+%28ALS%29&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft.date=2022-06-16&amp;rft.au=Center+for+Drug+Evaluation+and+Research&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fnews-events-human-drugs%2Ffda-approves-oral-form-treatment-adults-amyotrophic-lateral-sclerosis-als&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.als.org/navigating-als/living-with-als/fda-approved-drugs/amx0035">"AMX0035 (RELYVRIO)"</a>. <i>The ALS Association</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230425205603/https://www.als.org/navigating-als/living-with-als/fda-approved-drugs/amx0035">Archived</a> from the original on 25 April 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">25 April</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+ALS+Association&amp;rft.atitle=AMX0035+%28RELYVRIO%29&amp;rft_id=https%3A%2F%2Fwww.als.org%2Fnavigating-als%2Fliving-with-als%2Ffda-approved-drugs%2Famx0035&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-FDA_Qalsody-105"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_Qalsody_105-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_Qalsody_105-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene">"FDA approves treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene"</a> (Press release). U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA). 25 April 2023. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230425172813/https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene">Archived</a> from the original on 25 April 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">25 April</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+treatment+of+amyotrophic+lateral+sclerosis+associated+with+a+mutation+in+the+SOD1+gene&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2023-04-25&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fnews-events-human-drugs%2Ffda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-NeuroRehabilitation_2015-106"><span class="mw-cite-backlink">^ <a href="#cite_ref-NeuroRehabilitation_2015_106-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NeuroRehabilitation_2015_106-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPaganoniKaramJoyceBedlack2015" class="citation journal cs1">Paganoni S, Karam C, Joyce N, Bedlack R, Carter G (2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223769">"Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis"</a>. <i>NeuroRehabilitation</i>. <b>37</b> (1): 53–68. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FNRE-151240">10.3233/NRE-151240</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223769">5223769</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26409693">26409693</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NeuroRehabilitation&amp;rft.atitle=Comprehensive+rehabilitative+care+across+the+spectrum+of+amyotrophic+lateral+sclerosis.&amp;rft.volume=37&amp;rft.issue=1&amp;rft.pages=53-68&amp;rft.date=2015&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5223769%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26409693&amp;rft_id=info%3Adoi%2F10.3233%2FNRE-151240&amp;rft.aulast=Paganoni&amp;rft.aufirst=S&amp;rft.au=Karam%2C+C&amp;rft.au=Joyce%2C+N&amp;rft.au=Bedlack%2C+R&amp;rft.au=Carter%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5223769&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMacphersonBassile2016" class="citation journal cs1">Macpherson CE, Bassile CC (July 2016). "Pulmonary Physical Therapy Techniques to Enhance Survival in Amyotrophic Lateral Sclerosis: A Systematic Review". <i>Journal of Neurologic Physical Therapy</i>. <b>40</b> (3): 165–175. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FNPT.0000000000000136">10.1097/NPT.0000000000000136</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27164308">27164308</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7279853">7279853</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurologic+Physical+Therapy&amp;rft.atitle=Pulmonary+Physical+Therapy+Techniques+to+Enhance+Survival+in+Amyotrophic+Lateral+Sclerosis%3A+A+Systematic+Review&amp;rft.volume=40&amp;rft.issue=3&amp;rft.pages=165-175&amp;rft.date=2016-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7279853%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27164308&amp;rft_id=info%3Adoi%2F10.1097%2FNPT.0000000000000136&amp;rft.aulast=Macpherson&amp;rft.aufirst=CE&amp;rft.au=Bassile%2C+CC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDanel-BrunaudTouzetChevalierMoreau2017" class="citation journal cs1">Danel-Brunaud V, Touzet L, Chevalier L, Moreau C, Devos D, Vandoolaeghe S, Lefebvre L (May 2017). "Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review". <i>Revue Neurologique</i>. <b>173</b> (5): 300–307. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.032">10.1016/j.neurol.2017.03.032</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28479121">28479121</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Ethical+considerations+and+palliative+care+in+patients+with+amyotrophic+lateral+sclerosis%3A+A+review&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=300-307&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.032&amp;rft_id=info%3Apmid%2F28479121&amp;rft.aulast=Danel-Brunaud&amp;rft.aufirst=V&amp;rft.au=Touzet%2C+L&amp;rft.au=Chevalier%2C+L&amp;rft.au=Moreau%2C+C&amp;rft.au=Devos%2C+D&amp;rft.au=Vandoolaeghe%2C+S&amp;rft.au=Lefebvre%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCheckowayLundinKelada2011" class="citation book cs1">Checkoway H, Lundin JI, Kelada SN (2011). "Chapter 22: Neurodegenerative diseases".  In Rothman N, Hainaut P, Schulte P, Smith M, Boffetta P, Perera F (eds.). <i>Molecular Epidemiology: Principles and Practices</i>. International Agency for Research on Cancer. pp.&#160;408–409. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-9283221630" title="Special:BookSources/978-9283221630"><bdi>978-9283221630</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+22%3A+Neurodegenerative+diseases&amp;rft.btitle=Molecular+Epidemiology%3A+Principles+and+Practices&amp;rft.pages=408-409&amp;rft.pub=International+Agency+for+Research+on+Cancer&amp;rft.date=2011&amp;rft.isbn=978-9283221630&amp;rft.aulast=Checkoway&amp;rft.aufirst=H&amp;rft.au=Lundin%2C+JI&amp;rft.au=Kelada%2C+SN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Global_Epidemiology-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-Global_Epidemiology_110-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChiòLogroscinoTraynorCollins2013" class="citation journal cs1">Chiò A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049265">"Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature"</a>. <i>Neuroepidemiology</i>. <b>41</b> (2): 118–130. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000351153">10.1159/000351153</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049265">4049265</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23860588">23860588</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroepidemiology&amp;rft.atitle=Global+epidemiology+of+amyotrophic+lateral+sclerosis%3A+a+systematic+review+of+the+published+literature&amp;rft.volume=41&amp;rft.issue=2&amp;rft.pages=118-130&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4049265%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23860588&amp;rft_id=info%3Adoi%2F10.1159%2F000351153&amp;rft.aulast=Chi%C3%B2&amp;rft.aufirst=A&amp;rft.au=Logroscino%2C+G&amp;rft.au=Traynor%2C+BJ&amp;rft.au=Collins%2C+J&amp;rft.au=Simeone%2C+JC&amp;rft.au=Goldstein%2C+LA&amp;rft.au=White%2C+LA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4049265&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Har2017-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-Har2017_111-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHardimanAl-ChalabiBrayneBeghi2017" class="citation journal cs1">Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, Martin S, Logroscino G, Rooney J (July 2017). <a rel="nofollow" class="external text" href="https://kclpure.kcl.ac.uk/portal/en/publications/the-changing-picture-of-amyotrophic-lateral-sclerosis(93e2a283-3125-4464-88ed-009897be906c).html">"The changing picture of amyotrophic lateral sclerosis: lessons from European registers"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>88</b> (7): 557–563. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2016-314495">10.1136/jnnp-2016-314495</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28285264">28285264</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52871105">52871105</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20191221151144/https://kclpure.kcl.ac.uk/portal/en/publications/the-changing-picture-of-amyotrophic-lateral-sclerosis(93e2a283-3125-4464-88ed-009897be906c).html">Archived</a> from the original on 21 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">22 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=The+changing+picture+of+amyotrophic+lateral+sclerosis%3A+lessons+from+European+registers&amp;rft.volume=88&amp;rft.issue=7&amp;rft.pages=557-563&amp;rft.date=2017-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52871105%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28285264&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2016-314495&amp;rft.aulast=Hardiman&amp;rft.aufirst=O&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Brayne%2C+C&amp;rft.au=Beghi%2C+E&amp;rft.au=van+den+Berg%2C+LH&amp;rft.au=Chio%2C+A&amp;rft.au=Martin%2C+S&amp;rft.au=Logroscino%2C+G&amp;rft.au=Rooney%2C+J&amp;rft_id=https%3A%2F%2Fkclpure.kcl.ac.uk%2Fportal%2Fen%2Fpublications%2Fthe-changing-picture-of-amyotrophic-lateral-sclerosis%2893e2a283-3125-4464-88ed-009897be906c%29.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-MMWR_2015-112"><span class="mw-cite-backlink">^ <a href="#cite_ref-MMWR_2015_112-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MMWR_2015_112-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MMWR_2015_112-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MMWR_2015_112-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-MMWR_2015_112-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMehtaKayeRaymondPunjabi2018" class="citation journal cs1">Mehta P, Kaye W, Raymond J, Punjabi R, Larson T, Cohen J, Muravov O, Horton K (November 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858037">"Prevalence of Amyotrophic Lateral Sclerosis – United States, 2015"</a>. <i>Morbidity and Mortality Weekly Report</i>. <b>67</b> (46): 1285–1289. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.15585%2Fmmwr.mm6746a1">10.15585/mmwr.mm6746a1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858037">5858037</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30462626">30462626</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Morbidity+and+Mortality+Weekly+Report&amp;rft.atitle=Prevalence+of+Amyotrophic+Lateral+Sclerosis+%E2%80%93+United+States%2C+2015&amp;rft.volume=67&amp;rft.issue=46&amp;rft.pages=1285-1289&amp;rft.date=2018-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5858037%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30462626&amp;rft_id=info%3Adoi%2F10.15585%2Fmmwr.mm6746a1&amp;rft.aulast=Mehta&amp;rft.aufirst=P&amp;rft.au=Kaye%2C+W&amp;rft.au=Raymond%2C+J&amp;rft.au=Punjabi%2C+R&amp;rft.au=Larson%2C+T&amp;rft.au=Cohen%2C+J&amp;rft.au=Muravov%2C+O&amp;rft.au=Horton%2C+K&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5858037&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Projected2016-113"><span class="mw-cite-backlink">^ <a href="#cite_ref-Projected2016_113-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Projected2016_113-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFArthurCalvoPriceGeiger2016" class="citation journal cs1">Arthur KC, Calvo A, Price TR, Geiger JT, Chiò A, Traynor BJ (11 August 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987527">"Projected increase in amyotrophic lateral sclerosis from 2015 to 2040"</a>. <i>Nature Communications</i>. <b>7</b> (12408): 12408. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2016NatCo...712408A">2016NatCo...712408A</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fncomms12408">10.1038/ncomms12408</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987527">4987527</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27510634">27510634</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Communications&amp;rft.atitle=Projected+increase+in+amyotrophic+lateral+sclerosis+from+2015+to+2040&amp;rft.volume=7&amp;rft.issue=12408&amp;rft.pages=12408&amp;rft.date=2016-08-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4987527%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27510634&amp;rft_id=info%3Adoi%2F10.1038%2Fncomms12408&amp;rft_id=info%3Abibcode%2F2016NatCo...712408A&amp;rft.aulast=Arthur&amp;rft.aufirst=KC&amp;rft.au=Calvo%2C+A&amp;rft.au=Price%2C+TR&amp;rft.au=Geiger%2C+JT&amp;rft.au=Chi%C3%B2%2C+A&amp;rft.au=Traynor%2C+BJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4987527&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Current_Issues_in_ALS_Epidemiology-114"><span class="mw-cite-backlink">^ <a href="#cite_ref-Current_Issues_in_ALS_Epidemiology_114-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Current_Issues_in_ALS_Epidemiology_114-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLunaLogroscinoCouratierMarin2017" class="citation journal cs1">Luna J, Logroscino G, Couratier P, Marin B (May 2017). "Current issues in ALS epidemiology: Variation of ALS occurrence between populations and physical activity as a risk factor". <i>Revue Neurologique</i>. <b>173</b> (5): 244–253. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.035">10.1016/j.neurol.2017.03.035</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28477849">28477849</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Current+issues+in+ALS+epidemiology%3A+Variation+of+ALS+occurrence+between+populations+and+physical+activity+as+a+risk+factor&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=244-253&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.035&amp;rft_id=info%3Apmid%2F28477849&amp;rft.aulast=Luna&amp;rft.aufirst=J&amp;rft.au=Logroscino%2C+G&amp;rft.au=Couratier%2C+P&amp;rft.au=Marin%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFZouZhouCheLiu2017" class="citation journal cs1">Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP (July 2017). "Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis". <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>88</b> (77): 540–549. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2016-315018">10.1136/jnnp-2016-315018</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28057713">28057713</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:41974606">41974606</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Genetic+epidemiology+of+amyotrophic+lateral+sclerosis%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=88&amp;rft.issue=77&amp;rft.pages=540-549&amp;rft.date=2017-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A41974606%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28057713&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2016-315018&amp;rft.aulast=Zou&amp;rft.aufirst=ZY&amp;rft.au=Zhou%2C+ZR&amp;rft.au=Che%2C+CH&amp;rft.au=Liu%2C+CY&amp;rft.au=He%2C+RL&amp;rft.au=Huang%2C+HP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-What&#39;s_in_a_name?-116"><span class="mw-cite-backlink">^ <a href="#cite_ref-What&#39;s_in_a_name?_116-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-What&#39;s_in_a_name?_116-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTeiveLimaGerminianiMunhoz2016" class="citation journal cs1">Teive HA, Lima PM, Germiniani FM, Munhoz RP (May 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1590%2F0004-282X20160040">"What's in a name? Problems, facts and controversies regarding neurological eponyms"</a>. <i>Arquivos de Neuro-Psiquiatria</i>. <b>74</b> (5): 423–425. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1590%2F0004-282X20160040">10.1590/0004-282X20160040</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27191240">27191240</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arquivos+de+Neuro-Psiquiatria&amp;rft.atitle=What%27s+in+a+name%3F+Problems%2C+facts+and+controversies+regarding+neurological+eponyms&amp;rft.volume=74&amp;rft.issue=5&amp;rft.pages=423-425&amp;rft.date=2016-05&amp;rft_id=info%3Adoi%2F10.1590%2F0004-282X20160040&amp;rft_id=info%3Apmid%2F27191240&amp;rft.aulast=Teive&amp;rft.aufirst=HA&amp;rft.au=Lima%2C+PM&amp;rft.au=Germiniani%2C+FM&amp;rft.au=Munhoz%2C+RP&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1590%252F0004-282X20160040&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFVisserde_Jongde_Visser2008" class="citation journal cs1">Visser J, de Jong JM, de Visser M (February 2008). "The history of progressive muscular atrophy: syndrome or disease?". <i>Neurology</i>. <b>70</b> (9): 723–727. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.wnl.0000302187.20239.93">10.1212/01.wnl.0000302187.20239.93</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18299524">18299524</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22629725">22629725</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=The+history+of+progressive+muscular+atrophy%3A+syndrome+or+disease%3F&amp;rft.volume=70&amp;rft.issue=9&amp;rft.pages=723-727&amp;rft.date=2008-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22629725%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18299524&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000302187.20239.93&amp;rft.aulast=Visser&amp;rft.aufirst=J&amp;rft.au=de+Jong%2C+JM&amp;rft.au=de+Visser%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWijesekeraMathersTalmanGaltrey2009" class="citation journal cs1">Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, Willey E, Ampong MA, Ellis CM, Shaw CE, Al-Chalabi A, Leigh PN (March 2009). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821838">"Natural history and clinical features of the flail arm and flail leg ALS variants"</a>. <i>Neurology</i>. <b>72</b> (12): 1087–1094. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.wnl.0000345041.83406.a2">10.1212/01.wnl.0000345041.83406.a2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821838">2821838</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19307543">19307543</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Natural+history+and+clinical+features+of+the+flail+arm+and+flail+leg+ALS+variants&amp;rft.volume=72&amp;rft.issue=12&amp;rft.pages=1087-1094&amp;rft.date=2009-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2821838%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19307543&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000345041.83406.a2&amp;rft.aulast=Wijesekera&amp;rft.aufirst=LC&amp;rft.au=Mathers%2C+S&amp;rft.au=Talman%2C+P&amp;rft.au=Galtrey%2C+C&amp;rft.au=Parkinson%2C+MH&amp;rft.au=Ganesalingam%2C+J&amp;rft.au=Willey%2C+E&amp;rft.au=Ampong%2C+MA&amp;rft.au=Ellis%2C+CM&amp;rft.au=Shaw%2C+CE&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Leigh%2C+PN&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2821838&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWilbourn1998" class="citation journal cs1">Wilbourn AJ (October 1998). "Clinical neurophysiology in the diagnosis of amyotrophic lateral sclerosis: The Lambert and the El Escorial criteria". <i>Journal of the Neurological Sciences</i>. <b>160</b> (Supplement 1): S25–29. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0022-510x%2898%2900194-4">10.1016/s0022-510x(98)00194-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9851644">9851644</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32884687">32884687</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=Clinical+neurophysiology+in+the+diagnosis+of+amyotrophic+lateral+sclerosis%3A+The+Lambert+and+the+El+Escorial+criteria&amp;rft.volume=160&amp;rft.issue=Supplement+1&amp;rft.pages=S25-29&amp;rft.date=1998-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32884687%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9851644&amp;rft_id=info%3Adoi%2F10.1016%2Fs0022-510x%2898%2900194-4&amp;rft.aulast=Wilbourn&amp;rft.aufirst=AJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBrooks1994" class="citation journal cs1">Brooks BR (July 1994). "El Escorial World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis". <i>Journal of the Neurological Sciences</i>. <b>124</b> (Supplement): 96–107. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0022-510x%2894%2990191-0">10.1016/0022-510x(94)90191-0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7807156">7807156</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32678612">32678612</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=El+Escorial+World+Federation+of+Neurology+Criteria+for+the+Diagnosis+of+Amyotrophic+Lateral+Sclerosis&amp;rft.volume=124&amp;rft.issue=Supplement&amp;rft.pages=96-107&amp;rft.date=1994-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32678612%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F7807156&amp;rft_id=info%3Adoi%2F10.1016%2F0022-510x%2894%2990191-0&amp;rft.aulast=Brooks&amp;rft.aufirst=BR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBrooksMillerSwashMunsat2000" class="citation journal cs1">Brooks BR, Miller RG, Swash M, Munsat TL (December 2000). "El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis". <i>Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders</i>. <b>1</b> (5): 293–299. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F146608200300079536">10.1080/146608200300079536</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11464847">11464847</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22725949">22725949</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+and+Other+Motor+Neuron+Disorders&amp;rft.atitle=El+Escorial+revisited%3A+Revised+criteria+for+the+diagnosis+of+amyotrophic+lateral+sclerosis&amp;rft.volume=1&amp;rft.issue=5&amp;rft.pages=293-299&amp;rft.date=2000-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22725949%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11464847&amp;rft_id=info%3Adoi%2F10.1080%2F146608200300079536&amp;rft.aulast=Brooks&amp;rft.aufirst=BR&amp;rft.au=Miller%2C+RG&amp;rft.au=Swash%2C+M&amp;rft.au=Munsat%2C+TL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-Awaji_Criteria_2008-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-Awaji_Criteria_2008_122-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFde_CarvalhoDenglerEisenEngland2008" class="citation journal cs1">de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J,  et&#160;al. (March 2008). "Electrodiagnostic criteria for diagnosis of ALS". <i>Clinical Neurophysiology</i>. <b>119</b> (3): 497–503. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinph.2007.09.143">10.1016/j.clinph.2007.09.143</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18164242">18164242</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:14851649">14851649</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Neurophysiology&amp;rft.atitle=Electrodiagnostic+criteria+for+diagnosis+of+ALS&amp;rft.volume=119&amp;rft.issue=3&amp;rft.pages=497-503&amp;rft.date=2008-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A14851649%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18164242&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clinph.2007.09.143&amp;rft.aulast=de+Carvalho&amp;rft.aufirst=M&amp;rft.au=Dengler%2C+R&amp;rft.au=Eisen%2C+A&amp;rft.au=England%2C+JD&amp;rft.au=Kaji%2C+R&amp;rft.au=Kimura%2C+J&amp;rft.au=Mills%2C+K&amp;rft.au=Mitsumoto%2C+H&amp;rft.au=Nodera%2C+H&amp;rft.au=Shefner%2C+J&amp;rft.au=Swash%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFShefnerAl-ChalabiBakerCui2020" class="citation journal cs1">Shefner JM, Al-Chalabi A, Baker MR, Cui LY, de Carvalho M, Eisen A,  et&#160;al. (August 2020). "A proposal for new diagnostic criteria for ALS". <i>Clinical Neurophysiology</i>. <b>131</b> (8): 1975–1978. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinph.2020.04.005">10.1016/j.clinph.2020.04.005</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32387049">32387049</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Neurophysiology&amp;rft.atitle=A+proposal+for+new+diagnostic+criteria+for+ALS&amp;rft.volume=131&amp;rft.issue=8&amp;rft.pages=1975-1978&amp;rft.date=2020-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clinph.2020.04.005&amp;rft_id=info%3Apmid%2F32387049&amp;rft.aulast=Shefner&amp;rft.aufirst=JM&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Baker%2C+MR&amp;rft.au=Cui%2C+LY&amp;rft.au=de+Carvalho%2C+M&amp;rft.au=Eisen%2C+A&amp;rft.au=Grosskreutz%2C+J&amp;rft.au=Hardiman%2C+O&amp;rft.au=Henderson%2C+R&amp;rft.au=Matamala%2C+JM&amp;rft.au=Mitsumoto%2C+H&amp;rft.au=Paulus%2C+W&amp;rft.au=Simon%2C+N&amp;rft.au=Swash%2C+M&amp;rft.au=Talbot%2C+K&amp;rft.au=Turner%2C+MR&amp;rft.au=Ugawa%2C+Y&amp;rft.au=van+den+Berg%2C+LH&amp;rft.au=Verdugo%2C+R&amp;rft.au=Vucic%2C+S&amp;rft.au=Kaji%2C+R&amp;rft.au=Burke%2C+D&amp;rft.au=Kiernan%2C+MC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-What_is_ALS?-124"><span class="mw-cite-backlink">^ <a href="#cite_ref-What_is_ALS?_124-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-What_is_ALS?_124-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.alsa.org/about-als/what-is-als.html">"What is ALS?"</a>. <i>The ALS Association</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20181221191534/http://www.alsa.org/about-als/what-is-als.html">Archived</a> from the original on 21 December 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">23 December</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+ALS+Association&amp;rft.atitle=What+is+ALS%3F&amp;rft_id=http%3A%2F%2Fwww.alsa.org%2Fabout-als%2Fwhat-is-als.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.mda.org/disease/amyotrophic-lateral-sclerosis">"ALS: Amyotrophic Lateral Sclerosis"</a>. <i>Muscular Dystrophy Association</i>. 18 December 2015. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180806173221/https://www.mda.org/disease/amyotrophic-lateral-sclerosis">Archived</a> from the original on 6 August 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">23 December</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Muscular+Dystrophy+Association&amp;rft.atitle=ALS%3A+Amyotrophic+Lateral+Sclerosis&amp;rft.date=2015-12-18&amp;rft_id=https%3A%2F%2Fwww.mda.org%2Fdisease%2Famyotrophic-lateral-sclerosis&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGoetz2000" class="citation journal cs1">Goetz CG (March 2000). "Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot". <i>Muscle &amp; Nerve</i>. <b>23</b> (3): 336–343. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F%28SICI%291097-4598%28200003%2923%3A3%3C336%3A%3AAID-MUS4%3E3.0.CO%3B2-L">10.1002/(SICI)1097-4598(200003)23:3&#60;336::AID-MUS4&#62;3.0.CO;2-L</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10679709">10679709</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5917354">5917354</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Muscle+%26+Nerve&amp;rft.atitle=Amyotrophic+lateral+sclerosis%3A+early+contributions+of+Jean-Martin+Charcot&amp;rft.volume=23&amp;rft.issue=3&amp;rft.pages=336-343&amp;rft.date=2000-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5917354%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10679709&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-4598%28200003%2923%3A3%3C336%3A%3AAID-MUS4%3E3.0.CO%3B2-L&amp;rft.aulast=Goetz&amp;rft.aufirst=CG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGordon2006" class="citation book cs1">Gordon PH (2006). "Chapter 1: History of ALS".  In Mitsumoto H, Przedborski S, Gordon PH (eds.). <i>Amyotrophic Lateral Sclerosis</i>. CRC Press. p.&#160;9. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0824729240" title="Special:BookSources/978-0824729240"><bdi>978-0824729240</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+1%3A+History+of+ALS&amp;rft.btitle=Amyotrophic+Lateral+Sclerosis&amp;rft.pages=9&amp;rft.pub=CRC+Press&amp;rft.date=2006&amp;rft.isbn=978-0824729240&amp;rft.aulast=Gordon&amp;rft.aufirst=PH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGordon2013" class="citation journal cs1">Gordon PH (October 2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794725">"Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials"</a>. <i>Aging and Disease</i>. <b>4</b> (5): 295–310. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.14336%2FAD.2013.0400295">10.14336/AD.2013.0400295</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794725">3794725</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24124634">24124634</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Aging+and+Disease&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis%3A+An+update+for+2013+Clinical+Features%2C+Pathophysiology%2C+Management+and+Therapeutic+Trials&amp;rft.volume=4&amp;rft.issue=5&amp;rft.pages=295-310&amp;rft.date=2013-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3794725%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24124634&amp;rft_id=info%3Adoi%2F10.14336%2FAD.2013.0400295&amp;rft.aulast=Gordon&amp;rft.aufirst=PH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3794725&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-UMN_Assessment-129"><span class="mw-cite-backlink">^ <a href="#cite_ref-UMN_Assessment_129-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-UMN_Assessment_129-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHuynhSimonGrosskreutzTurner2016" class="citation journal cs1">Huynh W, Simon NG, Grosskreutz J, Turner MR, Vucic S, Kiernan MC (July 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinph.2016.04.025">"Assessment of the upper motor neuron in amyotrophic lateral sclerosis"</a>. <i>Clinical Neurophysiology</i>. <b>127</b> (7): 2643–2660. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinph.2016.04.025">10.1016/j.clinph.2016.04.025</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27291884">27291884</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3757685">3757685</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Neurophysiology&amp;rft.atitle=Assessment+of+the+upper+motor+neuron+in+amyotrophic+lateral+sclerosis&amp;rft.volume=127&amp;rft.issue=7&amp;rft.pages=2643-2660&amp;rft.date=2016-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3757685%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27291884&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clinph.2016.04.025&amp;rft.aulast=Huynh&amp;rft.aufirst=W&amp;rft.au=Simon%2C+NG&amp;rft.au=Grosskreutz%2C+J&amp;rft.au=Turner%2C+MR&amp;rft.au=Vucic%2C+S&amp;rft.au=Kiernan%2C+MC&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.clinph.2016.04.025&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-bush-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-bush_130-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAlexander2014" class="citation news cs1">Alexander E (20 August 2014). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140821095115/http://www.independent.co.uk/news/people/george-bush-delivers-possibly-the-best-als-ice-bucket-challenge-yet-9680934.html">"George Bush delivers possibly the best ALS ice bucket challenge yet"</a>. <i>The Independent</i>. Archived from <a rel="nofollow" class="external text" href="https://www.independent.co.uk/news/people/george-bush-delivers-possibly-the-best-als-ice-bucket-challenge-yet-9680934.html">the original</a> on 21 August 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">20 August</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Independent&amp;rft.atitle=George+Bush+delivers+possibly+the+best+ALS+ice+bucket+challenge+yet&amp;rft.date=2014-08-20&amp;rft.aulast=Alexander&amp;rft.aufirst=E&amp;rft_id=https%3A%2F%2Fwww.independent.co.uk%2Fnews%2Fpeople%2Fgeorge-bush-delivers-possibly-the-best-als-ice-bucket-challenge-yet-9680934.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWicks2014" class="citation journal cs1">Wicks P (1 December 2014). <a rel="nofollow" class="external text" href="https://www.tandfonline.com/doi/full/10.3109/21678421.2014.984725">"The ALS Ice Bucket Challenge – Can a splash of water reinvigorate a field?"</a>. <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>. <b>15</b> (7–8): 479–480. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F21678421.2014.984725">10.3109/21678421.2014.984725</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/2167-8421">2167-8421</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25431828">25431828</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207581186">207581186</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+and+Frontotemporal+Degeneration&amp;rft.atitle=The+ALS+Ice+Bucket+Challenge+%E2%80%93+Can+a+splash+of+water+reinvigorate+a+field%3F&amp;rft.volume=15&amp;rft.issue=7%E2%80%938&amp;rft.pages=479-480&amp;rft.date=2014-12-01&amp;rft.issn=2167-8421&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207581186%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25431828&amp;rft_id=info%3Adoi%2F10.3109%2F21678421.2014.984725&amp;rft.aulast=Wicks&amp;rft.aufirst=P&amp;rft_id=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Ffull%2F10.3109%2F21678421.2014.984725&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AALS" class="Z3988"></span></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=ALS&amp;action=edit&amp;section=35" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1134653256">.mw-parser-output .side-box{margin:4px 0;box-sizing:border-box;border:1px solid #aaa;font-size:88%;line-height:1.25em;background-color:#f9f9f9;display:flow-root}.mw-parser-output .side-box-abovebelow,.mw-parser-output .side-box-text{padding:0.25em 0.9em}.mw-parser-output .side-box-image{padding:2px 0 2px 0.9em;text-align:center}.mw-parser-output .side-box-imageright{padding:2px 0.9em 2px 0;text-align:center}@media(min-width:500px){.mw-parser-output .side-box-flex{display:flex;align-items:center}.mw-parser-output .side-box-text{flex:1}}@media(min-width:720px){.mw-parser-output .side-box{width:238px}.mw-parser-output .side-box-right{clear:right;float:right;margin-left:1em}.mw-parser-output .side-box-left{margin-right:1em}}</style><div class="side-box side-box-right plainlinks sistersitebox"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409">
<div class="side-box-flex">
<div class="side-box-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" decoding="async" width="30" height="40" class="noviewer" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></div>
<div class="side-box-text plainlist">Wikimedia Commons has media related to <span style="font-weight: bold; font-style: italic;"><a href="https://commons.wikimedia.org/wiki/Category:Amyotrophic_lateral_sclerosis" class="extiw" title="commons:Category:Amyotrophic lateral sclerosis">Amyotrophic lateral sclerosis</a></span>.</div></div>
</div>
<ul><li><a rel="nofollow" class="external text" href="https://www.als.org/">ALS Association Official Website</a></li>
<li><a rel="nofollow" class="external text" href="https://www.als.net/">ALS Therapy Development Institute</a></li>
<li><a rel="nofollow" class="external text" href="https://www.als-mnd.org/">International Alliance of ALS/MND Associations</a></li>
<li><a rel="nofollow" class="external text" href="https://symposium.mndassociation.org/">International Symposium on ALS/MND</a></li></ul>
<div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-label="Navbox" style="width:100%; margin:0.5em 0 0.5em 0;;padding:3px"><table class="nowraplinks navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">Classification</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><div style="position:relative; float:right; font-size:0.8em;"><a href="https://www.wikidata.org/wiki/Q206901" class="extiw" title="d:Q206901">D</a></div><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-11" title="ICD-11">11</a></b>: <a rel="nofollow" class="external text" href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1982355687">8B60.0</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></b>: <a rel="nofollow" class="external text" href="https://icd.who.int/browse10/2019/en#/G12.2">G12.2</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10-CM" title="ICD-10-CM">10-CM</a></b>: <a rel="nofollow" class="external text" href="https://icdcodelookup.com/icd-10/codes/G12.21">G12.21</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></b>: <a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=335.20">335.20</a></li><li><b><a href="/wiki/Online_Mendelian_Inheritance_in_Man" title="Online Mendelian Inheritance in Man">OMIM</a></b>: <a rel="nofollow" class="external text" href="https://omim.org/entry/105400">105400</a></li><li><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b>: <a rel="nofollow" class="external text" href="https://meshb.nlm.nih.gov/record/ui?ui=D000690">D000690</a></li><li><b><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></b>: <a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb29148.htm">29148</a></li></ul></div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">External resources</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></b>: <a rel="nofollow" class="external text" href="https://www.nlm.nih.gov/medlineplus/ency/article/000688.htm">000688</a></li><li><b><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></b>: <a rel="nofollow" class="external text" href="https://emedicine.medscape.com/neuro/14-overview">neuro/14</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/emerg/topic24.htm#">emerg/24</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/pmr/topic10.htm#">pmr/10</a></li><li><b><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></b>: <a rel="nofollow" class="external text" href="https://patient.info/doctor/Motor-Neurone-Disease-(MND)">ALS</a></li><li><b><a href="/wiki/GeneReviews" title="GeneReviews">GeneReviews</a></b>: <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/books/NBK1450/">Amyotrophic lateral sclerosis</a></li><li><b><a href="/wiki/Orphanet" title="Orphanet">Orphanet</a></b>: <a rel="nofollow" class="external text" href="https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=803">803</a></li><li><b>Scholia</b>: <a class="external text" href="https://tools.wmflabs.org/scholia/topic/Q206901">Q206901</a></li></ul></div></div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"></div><div role="navigation" class="navbox" aria-labelledby="Diseases_of_the_nervous_system,_primarily_CNS" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Central_nervous_system_disease" title="Template:Central nervous system disease"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Central_nervous_system_disease" title="Template talk:Central nervous system disease"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Central_nervous_system_disease&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Diseases_of_the_nervous_system,_primarily_CNS" style="font-size:114%;margin:0 4em">Diseases of the <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>, primarily <a href="/wiki/Central_nervous_system_disease" title="Central nervous system disease">CNS</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Brain" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_brain" title="Human brain">Brain</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Encephalitis" title="Encephalitis">Encephalitis</a>
<ul><li><a href="/wiki/Viral_encephalitis" title="Viral encephalitis">Viral encephalitis</a></li>
<li><a href="/wiki/Herpesviral_encephalitis" title="Herpesviral encephalitis">Herpesviral encephalitis</a></li>
<li><a href="/wiki/Limbic_encephalitis" title="Limbic encephalitis">Limbic encephalitis</a></li>
<li><a href="/wiki/Encephalitis_lethargica" title="Encephalitis lethargica">Encephalitis lethargica</a></li></ul></li>
<li><a href="/wiki/Cavernous_sinus_thrombosis" title="Cavernous sinus thrombosis">Cavernous sinus thrombosis</a></li>
<li><a href="/wiki/Brain_abscess" title="Brain abscess">Brain abscess</a>
<ul><li><a href="/wiki/Amoebic_brain_abscess" title="Amoebic brain abscess">Amoebic</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Brain and <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">Encephalomyelitis</a>
<ul><li><a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated</a></li></ul></li>
<li><a href="/wiki/Meningitis" title="Meningitis">Meningitis</a></li>
<li><a href="/wiki/Meningoencephalitis" title="Meningoencephalitis">Meningoencephalitis</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_brain" title="Human brain">Brain</a>/<br /><a href="/wiki/Encephalopathy" title="Encephalopathy">encephalopathy</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">Degenerative</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Extrapyramidal_system" title="Extrapyramidal system">Extrapyramidal</a> and<br /><a href="/wiki/Movement_disorders" class="mw-redirect" title="Movement disorders">movement disorders</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Basal_ganglia_disease" title="Basal ganglia disease">Basal ganglia disease</a>
<ul><li><a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a>
<ul><li><a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">PD</a></li>
<li><a href="/wiki/Postencephalitic_parkinsonism" class="mw-redirect" title="Postencephalitic parkinsonism">Postencephalitic</a></li>
<li><a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">NMS</a></li></ul></li>
<li><a href="/wiki/Neurodegeneration_with_brain_iron_accumulation" title="Neurodegeneration with brain iron accumulation">NBIA</a>
<ul><li><a href="/wiki/Pantothenate_kinase-associated_neurodegeneration" title="Pantothenate kinase-associated neurodegeneration">PKAN</a></li></ul></li>
<li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul><li><a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">PSP</a></li></ul></li>
<li><a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">Striatonigral degeneration</a></li>
<li><a href="/wiki/Hemiballismus" title="Hemiballismus">Hemiballismus</a></li>
<li><a href="/wiki/Huntington%27s_disease" title="Huntington&#39;s disease">HD</a></li>
<li><a href="/wiki/Olivopontocerebellar_atrophy" title="Olivopontocerebellar atrophy">OA</a></li></ul></li></ul>
<ul><li><a href="/wiki/Dyskinesia" title="Dyskinesia">Dyskinesia</a>
<ul><li><a href="/wiki/Dystonia" title="Dystonia">Dystonia</a>
<ul><li><a href="/wiki/Status_dystonicus" title="Status dystonicus">Status dystonicus</a></li>
<li><a href="/wiki/Spasmodic_torticollis" title="Spasmodic torticollis">Spasmodic torticollis</a></li>
<li><a href="/wiki/Meige%27s_syndrome" title="Meige&#39;s syndrome">Meige's</a></li>
<li><a href="/wiki/Blepharospasm" title="Blepharospasm">Blepharospasm</a></li></ul></li>
<li><a href="/wiki/Athetosis" title="Athetosis">Athetosis</a></li>
<li><a href="/wiki/Chorea" title="Chorea">Chorea</a>
<ul><li><a href="/wiki/Choreoathetosis" title="Choreoathetosis">Choreoathetosis</a></li></ul></li>
<li><a href="/wiki/Myoclonus" title="Myoclonus">Myoclonus</a>
<ul><li><a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a></li></ul></li>
<li><a href="/wiki/Akathisia" title="Akathisia">Akathisia</a></li></ul></li></ul>
<ul><li><a href="/wiki/Tremor" title="Tremor">Tremor</a>
<ul><li><a href="/wiki/Essential_tremor" title="Essential tremor">Essential tremor</a></li>
<li><a href="/wiki/Intention_tremor" title="Intention tremor">Intention tremor</a></li></ul></li>
<li><a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">Restless legs</a></li>
<li><a href="/wiki/Stiff-person_syndrome" title="Stiff-person syndrome">Stiff-person</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Dementia" title="Dementia">Dementia</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul><li><a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's</a>
<ul><li><a href="/wiki/Early-onset_Alzheimer%27s_disease" title="Early-onset Alzheimer&#39;s disease">Early-onset</a></li></ul></li>
<li><a href="/wiki/Primary_progressive_aphasia" title="Primary progressive aphasia">Primary progressive aphasia</a></li></ul></li>
<li><a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a>/<a href="/wiki/Frontotemporal_lobar_degeneration" title="Frontotemporal lobar degeneration">Frontotemporal lobar degeneration</a>
<ul><li><a href="/wiki/Pick%27s_disease" class="mw-redirect" title="Pick&#39;s disease">Pick's</a></li></ul></li>
<li><a href="/wiki/Lewy_bodies_dementia" class="mw-redirect" title="Lewy bodies dementia">Lewy bodies dementia</a></li>
<li><a href="/wiki/Posterior_cortical_atrophy" title="Posterior cortical atrophy">Posterior cortical atrophy</a></li></ul>
<ul><li><a href="/wiki/Vascular_dementia" title="Vascular dementia">Vascular dementia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Mitochondrial_disease" title="Mitochondrial disease">Mitochondrial disease</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Leigh_syndrome" title="Leigh syndrome">Leigh syndrome</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/CNS_demyelinating_autoimmune_diseases" title="CNS demyelinating autoimmune diseases">Autoimmune</a></li>
<li><a href="/wiki/Inflammatory_demyelinating_diseases_of_the_central_nervous_system" title="Inflammatory demyelinating diseases of the central nervous system">Inflammatory</a></li>
<li><a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Demyelinating_diseases_of_CNS" title="Template:Demyelinating diseases of CNS">Template:Demyelinating diseases of CNS</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Episodic/<br /><a href="/wiki/Paroxysmal_attack" title="Paroxysmal attack">paroxysmal</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Epileptic_seizure" class="mw-redirect" title="Epileptic seizure">Seizures</a> and <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Focal_seizure" title="Focal seizure">Focal</a></li>
<li><a href="/wiki/Generalized_epilepsy" title="Generalized epilepsy">Generalised</a></li>
<li><a href="/wiki/Status_epilepticus" title="Status epilepticus">Status epilepticus</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Epilepsy" class="mw-redirect" title="Template:Epilepsy">Template:Epilepsy</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Headache" title="Headache">Headache</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Migraine" title="Migraine">Migraine</a></li>
<li><a href="/wiki/Cluster_headache" title="Cluster headache">Cluster</a></li>
<li><a href="/wiki/Tension_headache" title="Tension headache">Tension</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Headache" title="Template:Headache">Template:Headache</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cerebrovascular_disease" title="Cerebrovascular disease">Cerebrovascular</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Transient_ischemic_attack" title="Transient ischemic attack">TIA</a></li>
<li><a href="/wiki/Stroke" title="Stroke">Stroke</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Cerebrovascular_diseases" title="Template:Cerebrovascular diseases">Template:Cerebrovascular diseases</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Sleep_disorders" class="mw-redirect" title="Sleep disorders">Sleep disorders</a>
<ul><li>For more detailed coverage, see <a href="/wiki/Template:Sleep" title="Template:Sleep">Template:Sleep</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">CSF</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Intracranial_pressure" title="Intracranial pressure">Intracranial hypertension</a>
<ul><li><a href="/wiki/Hydrocephalus" title="Hydrocephalus">Hydrocephalus</a></li>
<li><a href="/wiki/Normal_pressure_hydrocephalus" title="Normal pressure hydrocephalus">Normal pressure hydrocephalus</a></li>
<li><a href="/wiki/Choroid_plexus_papilloma" title="Choroid plexus papilloma">Choroid plexus papilloma</a></li>
<li><a href="/wiki/Idiopathic_intracranial_hypertension" title="Idiopathic intracranial hypertension">Idiopathic intracranial hypertension</a></li></ul></li>
<li><a href="/wiki/Cerebral_edema" title="Cerebral edema">Cerebral edema</a></li>
<li><a href="/wiki/Spontaneous_cerebrospinal_fluid_leak" class="mw-redirect" title="Spontaneous cerebrospinal fluid leak">Intracranial hypotension</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Brain_herniation" title="Brain herniation">Brain herniation</a></li>
<li><a href="/wiki/Reye_syndrome" title="Reye syndrome">Reye syndrome</a></li>
<li><a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">Hepatic encephalopathy</a></li>
<li><a href="/wiki/Toxic_encephalopathy" title="Toxic encephalopathy">Toxic encephalopathy</a></li>
<li><a href="/wiki/Hashimoto%27s_encephalopathy" title="Hashimoto&#39;s encephalopathy">Hashimoto's encephalopathy</a></li>
<li><a href="/wiki/Fetal_alcohol_spectrum_disorder" title="Fetal alcohol spectrum disorder">Static Encephalopathy</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Both/either</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Degenerative" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">Degenerative</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Spinocerebellar_ataxia" title="Spinocerebellar ataxia">SA</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Friedreich%27s_ataxia" title="Friedreich&#39;s ataxia">Friedreich's ataxia</a></li>
<li><a href="/wiki/Ataxia%E2%80%93telangiectasia" title="Ataxia–telangiectasia">Ataxia–telangiectasia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Motor_neuron_disease" class="mw-redirect" title="Motor neuron disease">MND</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">UMN</a> only:</i>
<ul><li><a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">Primary lateral sclerosis</a></li>
<li><a href="/wiki/Pseudobulbar_palsy" title="Pseudobulbar palsy">Pseudobulbar palsy</a></li>
<li><a href="/wiki/Hereditary_spastic_paraplegia" title="Hereditary spastic paraplegia">Hereditary spastic paraplegia</a></li></ul></li></ul>
<ul><li><i><a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">LMN</a> only:</i>
<ul><li><a href="/wiki/Distal_hereditary_motor_neuronopathies" title="Distal hereditary motor neuronopathies">Distal hereditary motor neuronopathies</a></li>
<li><a href="/wiki/Spinal_muscular_atrophies" title="Spinal muscular atrophies">Spinal muscular atrophies</a>
<ul><li><a href="/wiki/Spinal_muscular_atrophy" title="Spinal muscular atrophy">SMA</a></li>
<li><a href="/wiki/Spinal_and_bulbar_muscular_atrophy" title="Spinal and bulbar muscular atrophy">SMAX1</a></li>
<li><a href="/wiki/X-linked_spinal_muscular_atrophy_type_2" title="X-linked spinal muscular atrophy type 2">SMAX2</a></li>
<li><a href="/wiki/Distal_spinal_muscular_atrophy_type_1" title="Distal spinal muscular atrophy type 1">DSMA1</a></li>
<li><a href="/wiki/Congenital_distal_spinal_muscular_atrophy" title="Congenital distal spinal muscular atrophy">Congenital DSMA</a></li>
<li>Spinal muscular atrophy with lower extremity predominance (SMALED)
<ul><li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_1" title="Spinal muscular atrophy with lower extremity predominance 1">SMALED1</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2A" title="Spinal muscular atrophy with lower extremity predominance 2A">SMALED2A</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2B" title="Spinal muscular atrophy with lower extremity predominance 2B">SMALED2B</a></li></ul></li>
<li><a href="/wiki/Pontocerebellar_hypoplasia" title="Pontocerebellar hypoplasia">SMA-PCH</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_progressive_myoclonic_epilepsy" title="Spinal muscular atrophy with progressive myoclonic epilepsy">SMA-PME</a></li></ul></li>
<li><a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">Progressive muscular atrophy</a></li>
<li><a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">Progressive bulbar palsy</a>
<ul><li><a href="/wiki/Fazio%E2%80%93Londe_disease" title="Fazio–Londe disease">Fazio–Londe</a></li>
<li><a href="/wiki/Infantile_progressive_bulbar_palsy" title="Infantile progressive bulbar palsy">Infantile progressive bulbar palsy</a></li></ul></li></ul></li></ul>
<ul><li><i>both:</i>
<ul><li><a href="/wiki/Amyotrophic_lateral_sclerosis" class="mw-redirect" title="Amyotrophic lateral sclerosis">Amyotrophic lateral sclerosis</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"></div><div role="navigation" class="navbox" aria-labelledby="Amyotrophic_lateral_sclerosis" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Amyotrophic_lateral_sclerosis" title="Template:Amyotrophic lateral sclerosis"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Amyotrophic_lateral_sclerosis" title="Template talk:Amyotrophic lateral sclerosis"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Amyotrophic_lateral_sclerosis&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Amyotrophic_lateral_sclerosis" style="font-size:114%;margin:0 4em"><a href="/wiki/Amyotrophic_lateral_sclerosis" class="mw-redirect" title="Amyotrophic lateral sclerosis">Amyotrophic lateral sclerosis</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">General</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Genetics_of_amyotrophic_lateral_sclerosis" title="Genetics of amyotrophic lateral sclerosis">Genetics of ALS</a></li>
<li><a href="/wiki/Amyotrophic_lateral_sclerosis_research" title="Amyotrophic lateral sclerosis research">ALS research</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Organizations in the United States</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/ALS_Association" title="ALS Association">ALS Association</a></li>
<li><a href="/wiki/ALS_Therapy_Development_Institute" title="ALS Therapy Development Institute">ALS Therapy Development Institute</a></li>
<li><a href="/wiki/Les_Turner_ALS_Foundation" title="Les Turner ALS Foundation">Les Turner ALS Foundation</a></li>
<li><a href="/wiki/Muscular_Dystrophy_Association" title="Muscular Dystrophy Association">Muscular Dystrophy Association</a></li>
<li><a href="/wiki/Project_ALS" title="Project ALS">Project ALS</a></li>
<li><a href="/wiki/Prize4Life" title="Prize4Life">Prize4Life</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">International organizations</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/ALS_Society_of_Canada" title="ALS Society of Canada">ALS Society of Canada</a></li>
<li><a href="/wiki/Motor_Neurone_Disease_Association" title="Motor Neurone Disease Association">Motor Neurone Disease Association</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Events</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/ALS_Awareness_Month" title="ALS Awareness Month">ALS Awareness Month</a></li>
<li><a href="/wiki/Ice_Bucket_Challenge" title="Ice Bucket Challenge">Ice Bucket Challenge</a></li>
<li><a href="/wiki/Annual_ALS_Awareness_Game" class="mw-redirect" title="Annual ALS Awareness Game">Annual ALS Awareness Game</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">People</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/O.J._Brigance" class="mw-redirect" title="O.J. Brigance">O.J. Brigance</a></li>
<li><a href="/wiki/Paul_Cellucci" title="Paul Cellucci">Paul Cellucci</a></li>
<li><a href="/wiki/Dwight_Clark" title="Dwight Clark">Dwight Clark</a></li>
<li><a href="/wiki/Jay_S._Fishman" title="Jay S. Fishman">Jay Fishman</a></li>
<li><a href="/wiki/Pete_Frates" title="Pete Frates">Pete Frates</a></li>
<li><a href="/wiki/Lou_Gehrig" title="Lou Gehrig">Lou Gehrig</a></li>
<li><a href="/wiki/Richard_Glatzer" title="Richard Glatzer">Richard Glatzer</a></li>
<li><a href="/wiki/Steve_Gleason" title="Steve Gleason">Steve Gleason</a></li>
<li><a href="/wiki/Stephen_Hawking" title="Stephen Hawking">Stephen Hawking</a></li>
<li><a href="/wiki/Stephen_Heywood" title="Stephen Heywood">Stephen Heywood</a></li>
<li><a href="/wiki/Stephen_Hillenburg" title="Stephen Hillenburg">Stephen Hillenburg</a></li>
<li><a href="/wiki/Jacob_Javits" title="Jacob Javits">Jacob Javits</a></li>
<li><a href="/wiki/Jason_Becker" title="Jason Becker">Jason Becker</a></li>
<li><a href="/wiki/Augie_Nieto" title="Augie Nieto">Augie Nieto</a></li>
<li><a href="/wiki/Jon_Stone" title="Jon Stone">Jon Stone</a></li>
<li><a href="/wiki/Kevin_Turner_(running_back)" title="Kevin Turner (running back)">Kevin Turner</a></li>
<li><a href="/wiki/Henry_A._Wallace" title="Henry A. Wallace">Henry Wallace</a></li>
<li><a href="/wiki/Mickey_Marvin" title="Mickey Marvin">Mickey Marvin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Related</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/List_of_people_with_amyotrophic_lateral_sclerosis" class="mw-redirect" title="List of people with amyotrophic lateral sclerosis">List of people with ALS</a></li>
<li><a href="/wiki/Lou_Gehrig_Memorial_Award" title="Lou Gehrig Memorial Award">Lou Gehrig Memorial Award</a></li>
<li><i><a href="/wiki/Ice_Bucket_Challenge:_Pete_Frates_and_the_Fight_Against_ALS" title="Ice Bucket Challenge: Pete Frates and the Fight Against ALS">Ice Bucket Challenge: Pete Frates and the Fight Against ALS</a></i></li></ul>
</div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"><style data-mw-deduplicate="TemplateStyles:r1038841319">.mw-parser-output .tooltip-dotted{border-bottom:1px dotted;cursor:help}</style></div><div role="navigation" class="navbox authority-control" aria-label="Navbox" style="padding:3px"><table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a>: National <a href="https://www.wikidata.org/wiki/Q206901#identifiers" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" class="noprint" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><span class="uid"><a rel="nofollow" class="external text" href="https://catalogue.bnf.fr/ark:/12148/cb12110754p">France</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://data.bnf.fr/ark:/12148/cb12110754p">BnF data</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="http://uli.nli.org.il/F/?func=find-b&amp;local_base=NLX10&amp;find_code=UID&amp;request=987007294733105171">Israel</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://id.loc.gov/authorities/sh85004728">United States</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://kopkatalogs.lv/F?func=direct&amp;local_base=lnc10&amp;doc_number=000125199&amp;P_CON_LNG=ENG">Latvia</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://id.ndl.go.jp/auth/ndlna/01127913">Japan</a></span></li>
<li><span class="uid"><span class="rt-commentedText tooltip tooltip-dotted" title="amyotrofická laterální skleróza"><a rel="nofollow" class="external text" href="https://aleph.nkp.cz/F/?func=find-c&amp;local_base=aut&amp;ccl_term=ica=ph397748&amp;CON_LNG=ENG">Czech Republic</a></span></span></li></ul>
</div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw1486
Cached time: 20230625162629
Cache expiry: 1814400
Reduced expiry: false
Complications: [vary‐revision‐sha1, show‐toc]
CPU time usage: 1.533 seconds
Real time usage: 1.689 seconds
Preprocessor visited node count: 9388/1000000
Post‐expand include size: 455696/2097152 bytes
Template argument size: 5762/2097152 bytes
Highest expansion depth: 13/100
Expensive parser function count: 15/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 519696/5000000 bytes
Lua time usage: 0.879/10.000 seconds
Lua memory usage: 15013706/52428800 bytes
Number of Wikibase entities loaded: 1/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 1400.678      1 -total
 58.49%  819.192      1 Template:Reflist
 41.67%  583.635    111 Template:Cite_journal
 13.97%  195.684      9 Template:Navbox
 11.50%  161.105      1 Template:Medical_resources
  8.24%  115.426      2 Template:Hlist
  5.67%   79.378      1 Template:Infobox_medical_condition_(new)
  4.62%   64.757      1 Template:Infobox
  4.58%   64.175      1 Template:ICD11
  4.41%   61.808      2 Template:Short_description
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:19375577-0!canonical and timestamp 20230625162653 and revision id 1161884281. Rendering was triggered because: edit-page
 -->
</div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript>
<div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=ALS&amp;oldid=1161884281">https://en.wikipedia.org/w/index.php?title=ALS&amp;oldid=1161884281</a>"</div></div>
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Amyotrophic_lateral_sclerosis" title="Category:Amyotrophic lateral sclerosis">Amyotrophic lateral sclerosis</a></li><li><a href="/wiki/Category:Motor_neuron_diseases" title="Category:Motor neuron diseases">Motor neuron diseases</a></li><li><a href="/wiki/Category:Rare_diseases" title="Category:Rare diseases">Rare diseases</a></li><li><a href="/wiki/Category:Unsolved_problems_in_neuroscience" title="Category:Unsolved problems in neuroscience">Unsolved problems in neuroscience</a></li><li><a href="/wiki/Category:Systemic_atrophies_primarily_affecting_the_central_nervous_system" title="Category:Systemic atrophies primarily affecting the central nervous system">Systemic atrophies primarily affecting the central nervous system</a></li><li><a href="/wiki/Category:Cytoskeletal_defects" title="Category:Cytoskeletal defects">Cytoskeletal defects</a></li><li><a href="/wiki/Category:Neuromuscular_disorders" title="Category:Neuromuscular disorders">Neuromuscular disorders</a></li><li><a href="/wiki/Category:Idiopathic_diseases" title="Category:Idiopathic diseases">Idiopathic diseases</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_matches_Wikidata" title="Category:Short description matches Wikidata">Short description matches Wikidata</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_September_2020" title="Category:Use dmy dates from September 2020">Use dmy dates from September 2020</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li><li><a href="/wiki/Category:Commons_category_link_is_on_Wikidata" title="Category:Commons category link is on Wikidata">Commons category link is on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_BNF_identifiers" title="Category:Articles with BNF identifiers">Articles with BNF identifiers</a></li><li><a href="/wiki/Category:Articles_with_BNFdata_identifiers" title="Category:Articles with BNFdata identifiers">Articles with BNFdata identifiers</a></li><li><a href="/wiki/Category:Articles_with_J9U_identifiers" title="Category:Articles with J9U identifiers">Articles with J9U identifiers</a></li><li><a href="/wiki/Category:Articles_with_LCCN_identifiers" title="Category:Articles with LCCN identifiers">Articles with LCCN identifiers</a></li><li><a href="/wiki/Category:Articles_with_LNB_identifiers" title="Category:Articles with LNB identifiers">Articles with LNB identifiers</a></li><li><a href="/wiki/Category:Articles_with_NDL_identifiers" title="Category:Articles with NDL identifiers">Articles with NDL identifiers</a></li><li><a href="/wiki/Category:Articles_with_NKC_identifiers" title="Category:Articles with NKC identifiers">Articles with NKC identifiers</a></li><li><a href="/wiki/Category:Wikipedia_medicine_articles_ready_to_translate" title="Category:Wikipedia medicine articles ready to translate">Wikipedia medicine articles ready to translate</a></li><li><a href="/wiki/Category:Wikipedia_neurology_articles_ready_to_translate" title="Category:Wikipedia neurology articles ready to translate">Wikipedia neurology articles ready to translate</a></li></ul></div></div>
				</div>
			</main>
			
		</div>
		<div class="mw-footer-container">
			
<footer id="footer" class="mw-footer" role="contentinfo" >
	<ul id="footer-info">
	<li id="footer-info-lastmod"> This page was last edited on 25 June 2023, at 16:26<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike License 4.0</a><a rel="license" href="//creativecommons.org/licenses/by-sa/4.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places">
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Universal_Code_of_Conduct">Code of Conduct</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=ALS&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
	<li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation" loading="lazy" /></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img src="/static/images/footer/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"></a></li>
</ul>

</footer>

		</div>
	</div> 
</div> 
<div class='vector-settings'>
	
<button
	id=""
	class="cdx-button cdx-button--icon-only vector-limited-width-toggle"
	><span class="vector-icon mw-ui-icon-fullScreen mw-ui-icon-wikimedia-fullScreen"></span>

<span>Toggle limited content width</span>

</button>

</div>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw1411","wgBackendResponseTime":124,"wgPageParseReport":{"limitreport":{"cputime":"1.533","walltime":"1.689","ppvisitednodes":{"value":9388,"limit":1000000},"postexpandincludesize":{"value":455696,"limit":2097152},"templateargumentsize":{"value":5762,"limit":2097152},"expansiondepth":{"value":13,"limit":100},"expensivefunctioncount":{"value":15,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":519696,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 1400.678      1 -total"," 58.49%  819.192      1 Template:Reflist"," 41.67%  583.635    111 Template:Cite_journal"," 13.97%  195.684      9 Template:Navbox"," 11.50%  161.105      1 Template:Medical_resources","  8.24%  115.426      2 Template:Hlist","  5.67%   79.378      1 Template:Infobox_medical_condition_(new)","  4.62%   64.757      1 Template:Infobox","  4.58%   64.175      1 Template:ICD11","  4.41%   61.808      2 Template:Short_description"]},"scribunto":{"limitreport-timeusage":{"value":"0.879","limit":"10.000"},"limitreport-memusage":{"value":15013706,"limit":52428800}},"cachereport":{"origin":"mw1486","timestamp":"20230625162629","ttl":1814400,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"ALS","url":"https:\/\/en.wikipedia.org\/wiki\/ALS","sameAs":"http:\/\/www.wikidata.org\/entity\/Q206901","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q206901","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2003-01-28T09:18:07Z","dateModified":"2023-06-25T16:26:27Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/1\/16\/ALS_Affected_neurons_and_muscles.png","headline":"rare neurodegenerative disease"}</script><script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"ALS","url":"https:\/\/en.wikipedia.org\/wiki\/ALS","sameAs":"http:\/\/www.wikidata.org\/entity\/Q206901","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q206901","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2003-01-28T09:18:07Z","dateModified":"2023-06-25T16:26:27Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/1\/16\/ALS_Affected_neurons_and_muscles.png","headline":"rare neurodegenerative disease"}</script>
</body>
</html>